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'While holidaying in the Highlands in August of 1919, I was asked by the parochial
authorities to report on the condition of the eyes of the family ofA.C., a labouring
man dwelling in the Benderloch.
The parents were young, healthy-looking individuals, and lived in a cottage on the
loch-side. The external appearance of their eyes was quite normal, and they had no
complaint of visual defect. Apart from the condition of their eyes the four children
appeared quite healthy. ... The local doctor, Dr. McNichol, who visited the house
with me, informed me that there had been no inflammation of, or discharge from, the
children's eyes at or after birth. The appearance of their eyes was entirely one of
underdevelopment... there had been no similar condition of the eyes of the parentage
on either side.
C.C., female, 3 years of age. The right eye was undeveloped, the cornea absent, and
the eye blind. The left eye was more developed, the cornea was clear, and there was
a downward coloboma iridis congenitalis. The child was able to distinguish a penny-
piece held out to her.
J.C., male, 3 years of age, was absolutely blind. The right socket was empty,
anophthalmos, and the cavity was contracted. The left eyeball was undeveloped, the
cornea being absent.
C.C., male, 2 years of age. This boy was also practically blind. A small dark spot hi
the centre of the front of the right eyeball represented the cornea, and through this
light and darkness could be distinguished. The left socket was empty, another case of
anophthalmos.
M.C., 1 year old. The right eye resembled those seen in the other children,
undeveloped, opaque, and blind. The left eye was the most normal-looking in any of
the children. It was clear, bright, and healthy looking. ... The child coidd see well
enough to take hold ofobjects held out to her.
I recommended that an attempt should be made to educate the eldest and the
youngest children in the ordinary way, and that the second and third should be
educated in a blind asylum. The parents are young and evidently prolific. Whatever
the cause may be, the outlookfor anyfuture children is to me simply appalling.'
Lewis McMillan MD., British Journal ofOphthalmology, 1921.
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ABSTRACT
The Genetic And Environmental Aetiology Of Ocular Congenital
Anophthalmos, Microphthalmos And Uveal Coloboma
Introduction
Microphthalmos, anophthalmos, and uveal coloboma (MAC) are a related group of
congenital eye abnormalities that may result in significant visual impairment. The
aetiology of these eye conditions is poorly understood and a variety of genetic and
environmental causes have been postulated.
This thesis argues that microphthalmos, anophthalmos and uveal coloboma have not
been adequately defined. The difficulties in trying to establish a genetic or
environmental cause of these complex conditions have been exacerbated by poor
definition. The correct investigation of a cause relies on first establishing a
phenotypic definition.
Methods
Scottish children born between 1981 and 1996 with a reported diagnosis of MAC
were traced (n=338) and examined (n=152) for congenital eye and systemic
anomalies. Eye (globe) size was determined using B-scan ultrasound (n=86). In
selected cases, DNA was extracted from blood samples or mouthwashes. Mutation
screening studies were done on the homeobox genes PAX6 and CHX10, both of
which are candidate genes for these eye conditions.
Results
The birth prevalence of MAC for Scotland for the period 1981-1996 was 1.78 per
10,000 live births. The prevalence in each of the fifteen health board regions was
calculated.
An ultrasound study on 86 eyes showed that eye size cannot be used to define
microphthalmos.
A new phenotypic classification of MAC, not dependent on eye size, is presented.
The term microphthalmos does not feature in the new classification.
The prevalence of retinal detachment in eyes with uveal coloboma was calculated at
3.96% and the association of iris coloboma with iris heterochromia was firmly
established, occurring in 17% of cases.
Systemic congenital anomalies were common and affected 37% of those examined.
More than one case was confirmed within eight families, which suggested possible
modes of inheritance. The empirical recurrence risk of inheritance was calculated for
the purpose of genetic counselling.
PAX6 gene mutations were not found in 83 selected individuals, using denaturing
high performance liquid chromatography. A PAX6 gene missense mutation was
found in one individual with an ocular phenotype similar to aniridia. In three subjects
tested, no CHX10 gene mutations were found.
Conclusions
Microphthalmos cannot be defined easily as it represents a number of different
structural eye malformations. Microphthalmos cannot be defined by measuring the
size of the eye. The term microphthalmos has very limited use.
V
A new phenotypic classification of MAC is proposed, based on the structural eye
abnormality and without reference to eye size. The term microphthalmos does not
feature in the new classification.
The large number of congenital systemic anomalies associated with the eye
anomalies studied, and the occurrence of cases with a family history, suggests a
complex genetic and environmental aetiology, with both factors possibly acting in
combination.
Empirical recurrence risk estimates have been calculated for genetic counselling.
It is unlikely that PAX6 gene mutations play a major role in the aetiology ofMAC.
Further studies on these eye anomalies are indicated using this well phenotyped
clinical and genetic database. This could include screening for other proposed
candidate genes, studies on microdeletions and monitoring ofbirth prevalence. Large
families of affected individuals are being sought for linkage analysis.
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ANOPHTHALMOS AND MICROPHTHALMOS: CAN THEY BE DEFINED?
'Sed infanti null oculi erant.'
But the child had no eyes. (Bartholini, 1657).
Summary
Anophthalmos and microphthalmos have not been clearly defined and are not easy to
define.
Current definitions based on eye size alone are inadequate. Eye size alone is
inappropriate to define microphthalmos. The term microphthalmos has very limited
use and conveys no specific meaning.
The terms anophthalmos and microphthalmos represent clinically inseparable entities.
There is a continuous spectrum from true anophthalmos to mild microphthalmos.




The fact that a case of anophthalmos was well described more than 300 years ago by
Thomas Bartholini (Bartholini, 1657) is ofmore than just historical interest. The child
had no eyes, with additional malformations (face, Polydactyly of hands and one foot),
and normal parents.
Many features of Bartholini's case report have a broad similarity to those written up
more recently. The chapters to follow will demonstrate the significance of
observations then and now with regard to the aetiology of this condition.
Anophthalmos (anophthalmia, Greek 'eyeless') is the congenital absence of an eye,
which can be unilateral or bilateral. To a layperson, such a diagnosis would appear to
be straightforward, but this is not so (Sorsby, 1934). True anophthalmos is a
histological (post-mortem) diagnosis. It is the complete absence of any recognisable
eye tissue or embryological remnant, and this can only be confirmed by serial sections
of the orbital contents. Consequently, the more useful term clinical anophthalmos
(Duke-Elder, 1964) was introduced to describe the apparent absence of an eye. This
term is not always being used as it should, and is applied to many cases of extreme
microphthalmos.
It should already be apparent that anophthalmos and extreme microphthalmos are
being conflated. There is some justification for grouping them together but, as we
shall see in the discussions of microphthalmos, there is great confusion over the
diagnosis of microphthalmos, be it 'extreme' or 'severe' microphthalmos, 'remnant
only' microphthalmos (Tucker et al. 1996), or 'mild' microphthalmos. The result is
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that anophthalmos and all forms of microphthalmos are now commonly grouped
together as the same condition, which they are not.
Before turning to the classification of anophthalmos, it is necessary to review the
relevant stages of early eye development with respect to anophthalmos and the tissues
that will eventually give rise to the eye. These tissues are derived from surface
ectoderm, neural ectoderm, neural crest and mesodermal mesenchyme.
Developmentally and functionally the eye is an extension of the central nervous
system. The central nervous system differentiates from the ectoderm on the dorsal
surface of the developing embryo, in an area which has thickened to form the neural
plate, the cells of which are known as the neural ectoderm (Bron et al. 1997). A
depression develops in the neural plate to form a groove, and the neural folds then
grow and converge toward each other, forming the recognisable neural tube (eighteen
days of gestation).
The first appearance of anlage of the future eyes, the optic sulcus, is before closure of
the anterior end of the neural tube. These small lateral grooves are apparent at twenty
days' gestation (2 mm stage). The sulcus enlarges to form the optic evaginations
{optic pits internally), which later become the optic vesicles.
The optic vesicles enlarge and appear as hollow, symmetrical hemispherical
outgrowths on the lateral side of what is now the forebrain vesicle. The cavity of the
hollow optic vesicle therefore communicates with that of the forebrain, which will
develop into the telencephalon (future cerebral hemispheres) and the diencephalon. It
is from the side walls of the diencephalon that the paired optic stalks arise.
Returning now to anophthalmos, Ida Mann (Mann, 1959) described three types:
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In primary anophthalmos there is failure of the optic pit to deepen and form an optic
outgrowth from the forebrain.
In secondary anophthalmos there is an abnormality of the whole of the forebrain so
that absence of the eyes is a consequence of a wider developmental abnormality of the
forebrain.
The third type, consecutive (degenerative) anophthalmos, is when the optic vesicle
formed but has subsequently degenerated and disappeared. Consecutive anophthalmos
links up with extreme microphthalmos, and the two are only distinguishable
microscopically.
Histopathology of anophthalmos
As mentioned earlier, histological examination of the orbital contents has confirmed
the complete absence of an eye in several cases (Duke-Elder, 1964). However, in
many cases of anophthalmos, a nodule representing some of the ocular tissues is
embedded near the apex of the orbit. Within this nodule there may be several types of
tissue mixed up and present in varying amounts: fibrous scleral tissue, pigmented and
vascularised uveal tissue, cartilage. If neuroectodermal elements are found, then
technically the case is one of extreme microphthalmos. This distinction has always
been considered an academic one not of clinical importance. As we shall see in later
discussions on aetiology and its investigation, when describing individual cases and
syndromes, and when looking at the prevalence of anophthalmos, the lack of an
adequate definition combined with varying diagnostic criteria has been detrimental to
the process of understanding anophthalmos.
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The histological findings within the orbit are extremely variable, and have been
reported by several authors (Treacher Collins, 1887). Typically, the extraocular
muscles are present and well formed and supplied by their appropriate nerves;
insertion is into a nodule or mass of fibrous tissue, which represents the sclera. The
muscles are not often sharply differentiated and may be inserted in an indiscriminate
and tangled manner, altering their movement pattern. The lacrimal gland and
apparatus are usually present, along with the orbital fat.
In consecutive (degenerative) anophthalmos, formation of the optic vesicle is followed
by degeneration (Brownstein et al. 1977). In these cases, fragments of tissue derived
from neuroectoderm (neurosensory retina, retinal pigment epithelium, choroid) will be
found. The lens or lens elements (often calcified) are typically absent but may be
present (Pearce et al. 1974).
The histopathology and postmortem findings posterior to the globe are just as
variable. The absence of any optic nerve and the optic tracts/chiasm at post mortem is
further confirmation of a case of true primary or secondary anophthalmos
(Hesselberg, 1951). The optic foramen is absent or obliterated in a few cases.
Replacement of the optic nerve by a rudimentary optic nerve or fibrous band is
described in some cases. These abnormalities are reflected in the lateral geniculate
nuclei and visual cortex being small or rudimentary (Brunquell et al. 1984).
The post-mortems of the nineteenth century (Hesselberg, 1951) and the later part of
the last century (Duke-Elder, 1964) have been superseded by high resolution modern
imaging techniques, and it is to these which we shall turn briefly.
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Computerised tomography (CT) and magnetic resonance imaging (MRI) have
confirmed many of the earlier pathological descriptions (O'Keefe et al. 1987) as well
as revealing any associated brain pathology (Albernaz et al. 1997). Caution must be
exercised in interpreting CT or MRI of the orbital contents for the presence of true
ocular tissue because of the varying absorptions of the orbital tissues and its
condensation.
Clinical appearance of anophthalnios
As stated in the opening paragraph, extraocular congenital abnormalities are not
uncommon with anophthalmos. This aspect will be discussed in chapter two
(aetiology).
The external facial appearance of a neonate or small child with anophthalmos may be
unremarkable, but there are sometimes signs or the typical features of a closed sunken
eyelid with the 'eye' appearing to be deeply set. The palpebral fissure length is usually
significantly reduced, with normal eyelid margins, lacrimal puncta and glands.
Epicanthic folds may be present. The orbit is reduced in size, and is lined with
conjunctiva. The lacrimal gland is usually present and functioning (Brunquell et al.
1984).
In all cases of anophthalmos there will be no vision at all (no perception of light) on
the affected side.
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Figure 1.1: Right clinical anophthalmos
Laterality of anophthalmos
Both unilateral and bilateral anophthalmos occur, and the possible significance of this
will be discussed in the section on aetiology (chapter two). Treacher-Collins
(Treacher Collins, 1887) summarised the cases of the earlier literature. He collected
30 bilateral and 12 unilateral cases. Von Hippel (von Hippel, 1899) added a further 34
bilateral and 11 unilateral cases. The impression is that bilateral anophthalmos is more
common, but it may be that reporting of what is a far more disabling defect is more
frequent. However, as we shall see later, a normal fellow eye does not always
accompany unilateral anophthalmos.
Congenital cystic eye
Closely related to congenital anophthalmos is 'congenital cystic eye' (Hesselberg,
1951). Returning to the stage of early eye development discussed earlier in this
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section, it will be recalled that at the 2 mm embryo stage the optic vesicles appear as
hollow outgrowths from the wall of the forebrain vesicle (Bron et al. 1997). At this
stage (3-4.5 mm, 24-27 days) each optic vesicle will normally invaginate to form an
optic cup by the anterior part of the vesicle lying in apposition to the posterior part.
This anterior layer of the vesicle will go on to form the neuroretina, and is apposed to
the posterior part (the future retinal pigment epithelium). A potential space between
these two layers persists. The partial or complete failure of the optic vesicle to
invaginate can result in the formation of a cyst in the potential space between the two
layers of the optic cup, which may replace the globe of the eye. The cyst can vary
between very small, presenting as clinical anophthalmos, and large, occupying the
whole orbit and causing the eyelids to bulge (Dollfus et al. 1968). Congenital cystic
eyeball has also been called 'orbital cyst with anophthalmos'. However, this name is
incorrect: histologically, the anterior wall of the cyst is made up of primitive retinal
cells, with the posterior wall being a layer of primitive retinal pigment epithelium
(RPE). The cyst is lined by an epithelium identical with ependyma. No primitive lens
is present, confirming the fact that this type of malformation dates to before the 7 mm
stage of embryonic development.
From the discussion above, it is already apparent that anophthalmos is variable in its
clinical appearance and at the microscopic level, with eye tissue being present in
quantities varying from nil to remnants. The point at which clinical anophthalmos
transforms into extreme microphthalmos has yet to be established. It would therefore
seem appropriate to start here with a description of microphthalmos, from which the
lack of a current satisfactory definition should emerge.
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MICROPHTHALMOS
Microphthalmos (microphthalmia, Greek 'small eye') is, quite simply, an eye that
appears to be congenitally small. As with anophthalmos, the uninitiated might expect
the definition and diagnosis to be straightforward, but this is far from the case. A
number of significant factors have meant that no adequate definition exists:
1. As discussed under anophthalmos, there is no precise point at which clinical
anophthalmos becomes extreme microphthalmos.
2. The transition point between microphthalmos and the normal eye, with respect to
size, has not been established.
3. Microphthalmos is a very heterogeneous condition encompassing many different
structural ocular abnormalities.
4. Both specialists and non-specialists are loosely applying the term 'microphthalmos'
in the clinical sense.
Each of these points will be discussed in turn.
The fact that clinical anophthalmos and extreme (severe) microphthalmos (Figure 1.2)
are very similar has long been recognised (Hesselberg, 1951). In extreme
microphthalmos, only a small remnant of the globe is visible, and CT scans may be
required to confirm the presence of a globe.
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Figure 1.2: Right extreme clinical microphthalmos and left iris coloboma with
clinical microphthalmos (ID 97)
Microphthalmos, according to Duke-Elder, was a term 'used to include a great variety
of conditions and is justified in that in practically all cases the eye is smaller than
normal'. This statement is true, but such a loose definition has contributed to the vast
number of eye conditions in which microphthalmos has been diagnosed. All of the
abnormalities resulting after the budding of the primary optic vesicle may be classed
under the comprehensive category of microphthalmos (Duke-Elder, 1964).
(Classification of microphthalmos will be discussed later in this chapter). The
transition point between the normal eye and the microphthalmic one has yet to be
determined. The size of the globe can be measured ultrasonically by A or B scans
(Weiss et al. 1989b), CT or MRI (Wright et al. 1987). An effort to define
microphthalmos has been made by Weiss (Weiss et al. 1989b), and this definition has
been generally accepted by those who have recognised the need for a more rigorous
diagnostic criterion (Warburg, 1993). Microphthalmos is said to be present when the
axial length, adjusted for age, is at least two standard deviations (SDs) below the
mean. In adults, this equates to an axial length of less than 18.5 mm The 22 affected
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patients whose data were used to establish the definition ofmicrophthalmos (Weiss et
al. 1989a) in fact had nanophthalmos ('simple', or 'pure', microphthalmos), which is
a structurally and clinically distinct eye condition (see nanophthalmos below). When
'complex' microphthalmos was studied (Weiss et al. 1989b), microphthalmos was
diagnosed on the basis of an adult axial length below 20.9 mm. However, subjects
were selected for inclusion on the basis of this predetermined definition. A better
study method would be to determine clinically or designate eyes as microphthalmic
and then to measure the axial length. Many of the microphthalmic eyes in Weiss's
study do not fulfil the author's own criteria, and a scatter graph has arbitrarily
excluded some of the tabulated data. Microphthalmos has therefore been based
erroneously on this definition. Furthermore, was this definition correct, refinement
would be required by the addition of the phrase 'in an eye with a structural
malformation.' The authors did state this but the phrase appears to have been ignored
by those embracing the definition. This important point is a clear acknowledgement
that it is the structural abnormality which is of significance, a point to which we shall
return repeatedly. If microphthalmos were diagnosed on the basis of the definition
above (more than two SDs below the mean), 2.5% of the normal population's eyes
would be microphthalmic. This is considerably more than the estimated birth
prevalence of microphthalmos of 1 in 10,000 live births, i.e. about 0.01% of the
population (chapter two). Furthermore, there would not necessarily be any structural
abnormality or visual impairment. We need to consider more accurate or appropriate
means of'diagnosing' microphthalmos.
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Eye growth and size
Normal eye growth has been studied by a number of authors. The axial length of the
eye has been measured in newborns, children and adults. The mean axial length
(anterior corneal surface to retina) of the newborn eye is approximately 17 mm
(Larsen, 1971). In 80 newborn boys the mean axial length was 16.78 mm and in 80
newborn girls slightly less, at 16.40 mm. The full adult size is almost attained by age
thirteen years (Larsen, 1971). A small but significant increase in axial length of 0.4-
0.5 mm occurs during puberty (Fledelius, 1982b). The adult eye has a mean axial
length of 23.16 mm and 22.68 mm for males and females respectively (Larsen, 1971).
Fledelius (Fledelius, 1982b) gives male and female axial lengths of 24.19 and
23.73 mm respectively.
Most (about two thirds) of the postnatal growth of the eye with respect to axial length
occurs in the first 24-30 months of life (Fledelius and Christensen, 1996). The growth
of the eye can be divided into three growth phases: a rapid postnatal phase with an
increase of axial length of 3.7-3.8 mm in the first eighteen months of life, a slower
childhood phase lasting to age five years with increase of 1.1-1.2 mm, followed by a
juvenile phase up to the age of thirteen years with an increase of 1.3-1.4 mm (Larsen,
1971).
One factor that exerts a constant influence on the axial length of the eye from birth to
adult life is low birth weight (Fledelius, 1982a). Low birth weight (defined as less than
2000 g) results in a reduction of adult axial length of 0.4-0.5 mm. This general and




The concept of the eye appearing to be small rather than actually being small (as
defined by axial length) is an important one. As stated above, many cases of true
microphthalmos are correctly diagnosed on this basis clinically. The appearance of a
small eye is strongly suggested by a real or apparent reduction in corneal diameter.
Horizontal corneal diameter (HCD) increases with eye growth, but not in the same
way as axial length (Hymes, 1929). One cannot directly correlate HCD with axial
length. Microcornea is a term often used to denote a cornea of reduced size and this
may occur in several eye conditions including oculodentodigital dysplasia (Judisch et
al. 1979), aniridia (David et al. 1978), congenital cataract (Salmon et al. 1988), and
retinopathy of prematurity (Kelly and Fielder, 1987) but the definition of what size of
HCD constitutes microcornea has not been established. Duke-Elder (Duke-Elder,
1964) defined microcornea as an adult corneal diameter of less than 11 mm. Many,
but not all, cases ofmicrocornea do in fact have a reduced ocular axial length (Judisch
et al. 1979; Bateman and Maumenee, 1984). Weiss (Weiss et al. 1989b) found a
significant correlation between corneal diameter and axial length in subjects with
complex microphthalmos. Several authors have determined values and normal ranges
for HCD (Hymes, 1929). Nearly all of the postnatal growth, from 10 mm in the
newborn, to about 11.8 mm in the adult, takes place in the first two years of life
(males). Values for females are generally smaller by about 1 mm compared to males.
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Clinical microphthalmos
The current accepted definitions of microphthalmos are inadequate. Consider how the
diagnosis is made clinically. The clinical diagnosis is suggested by inspection and the
label 'microphthalmos' is given. Microphthalmos, when extreme or severe, is easy to
recognise. However, it is not necessarily the eyeball or globe size that is the first
feature to be noticed. What is in fact noticed is the often-reduced palpebral fissure
length, a flattening of the upper eyelid, and the suggestion or appearance of a reduced
corneal size/diameter (Bateman and Maumenee, 1984). It is these features which
when seen clinically make the appearance of microphthalmos. An eye may appear
small when there is facial asymmetry, ptosis, or blepharophimosis (Warburg, 1995). A
real reduction in size of the globe may occur in these situations. However, many cases
of microphthalmos do not in fact have a small eye (Pallotta et al. 1998), but
externally the eye does look small. Other reasons for an eye appearing small include
its size relative to the other eye: it may be that the fellow eye or cornea is enlarged,
such as in congenital glaucoma. The presence of other structural anomalies of the
anterior segment, such as a cataract, may give the impression of a smaller eye.
So there are small eyes that are small and small eyes that are normal in size and small
eyes that are big. They can only be distinguished by CT/MRI or ultrasound images. In
practice, it is not possible to do this in every child with microphthalmos, nor would it
be desirable. The diagnosis is therefore based on a clinical impression. This raises the
very important question: how much does the size of the eye matter? Far more
important than size is the presence of a structural abnormality in the eye. Later, the
argument will be proposed that the term microphthalmos does not serve any useful
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purpose as currently used. A definition is required for many purposes, such as
documentation in congenital malformation registers. One could argue that precision is
not vital here, and that as long as there is a consistent over- or underestimation, then
the trends and overall changes in prevalence are still reliable. However, as will be seen
in the next chapter (aetiology), precise numbers do matter. These are extremely rare
congenital eye disorders, and the addition or subtraction of a single case can have a
significant influence on the overall distribution or prevalence in even a large
population. A major problem we are faced with is inconsistency in making the
diagnosis of microphthalmos. Because of this inconsistency, it is impossible to
determine from one clinician to another (or even from the same clinician) what is
actually meant by microphthalmos. What has the clinician actually seen?
Microphthalmos is a heterogeneous condition and, unless it is very extreme, structural
eye abnormalities can be distinguished. The structural abnormalities differ from one
case to another. The microphthalmos is a secondary feature and is in addition to the
underlying structural defect of the eye. It may be that the reduced eye size is the result
of a process common to the different structural eye conditions associated with
microphthalmos. It could also be that the different structural eye abnormalities cause
microphthalmos by a different mechanism.
Therefore, we are presented with no adequate clinical definition and no adequate
scientific definition ofmicrophthalmos.
Classification ofmicrophthalmos
The most recent classification is that by Warburg (Warburg, 1993)(Table 1.1). Both
phenotypic and aetiological classifications are proposed, and it is the recognition of
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structural abnormality and phenotypic differences which makes the classification
useful. Phenotype and structural abnormality is a key topic to which we will return in
subsequent chapters. (The aetiology ofmicrophthalmos is introduced in chapter two).
The phenotypic classification includes apparent (or clinical) anophthalmos and
congenital cystic eye. Simple microphthalmos (nanophthalmos), mentioned earlier, is
also included (Brockhurst, 1974). Nanophthalmos is characterised by a small, typically
hypermetropic eye. Axial length is usually around 16 mm, and hypermetropia of+ 10
dioptres is not unusual. Some of the underlying structural abnormalities include
reduced corneal diameter, a disproportionately large lens and choroidal thickening.
Complications can occur in adult life as a result of these structural abnormalities:
angle closure glaucoma, a distinctive macular appearance of yellow pigmentation
(Serrano et al. 1998), crowded optic discs, scleral thickening, uveal effusion,
choroidal detachment and secondary (non-rhegmatogenous) retinal detachment.
Nanophthalmos may be sporadic, as well as dominant and recessive inheritance
occurring (Cross and Yoder, 1976). Nanophthalmos is a separate and distinct clinical
entity from microphthalmos and, despite the wealth of literature written on the
subject, clinicians have failed to recognise this. As a result, the confusion over the
definition has been exacerbated.
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Table 1.1: Phenotypic classification ofmicrophthalmos (Warburg, 1993)
I Total microphthalmos
(A) Congenital cystic eye
(B) Apparent microphthalmos
(C) Simple microphthalmos (nanophthalmos)
(D) Microphthalmos with intraocular malformations
(1) Congenital cataract
(2) Anterior chamber malformations
(3) Coloboma
(a) Coloboma of the uvea
(b) Coloboma of the optic nerve
(c) Cystic coloboma
(E) Multiple ocular malformations
II Partial microphthalmos
(A) Anterior segment microphthalmos
(B) Posterior segment microphthalmos
Microphthalmos is always associated with structural eye abnormalities and this has
formed the basis ofWarburg's phenotypic classification (Warburg, 1993). By far the
commonest structural abnormality seen in microphthalmic eyes is a coloboma -more
specifically, a uveal coloboma (Warburg, 1993). So significant is the occurrence of
coloboma in microphthalmos that Bateman's classification considers microphthalmos
as colobomatous or non-colobomatous. Warburg includes colobomatous
microphthalmos as a subgroup ofmicrophthalmos with intraocular malformations.
The literal meaning of coloboma is 'mutilation'. To understand the mechanism of how
this structural ocular defect is thought to arise, we must again return to embryology
and early eye development.
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As described above, when the embryo is around the age of 24-27 days (3-4.5 mm
stage) each optic vesicle will normally invaginate to form an optic cup by the anterior
part of the vesicle lying in apposition to the posterior part (Bron et al. 1997). This
anterior layer of the vesicle will go on to form the neuroretina, and is apposed to the
posterior part (the future RPE). The optic vesicle remains in contact with the surface
ectoderm and continues to be connected with the forebrain by a constriction, the optic
stalk. The cavity of the diencephalon, which will later form the third ventricle, is
continuous with that of the optic stalk. At about 27 days of gestation (4.0-4.5 mm)
the surface ectoderm lying over the optic vesicle thickens to form the lens placode,
which gradually invaginates to form the lens vesicle. Eventually, the lens vesicle
separates from the surface ectoderm.
With the development of the optic vesicles into optic cups up to day 28 (7.6-7.8 mm
stage) there is differential growth and movement of the cells of the optic vesicle. This
differential growth causes the temporal and lower walls of the optic vesicle to move
inward against the upper and posterior walls. The two laterally growing edges of the
cup and stalk meet ventrally, with a resulting fissure, known as the embryonic, fetal,
choroidal, or optic fissure (Figure 1.0). The precise events involved in closure of the
optic fissure, which is such a critical event and crucial to normal eye development,
have not been documented as well as one would expect. This is partly because of the
early timing of the event. The result of errors in closure of the optic fissure provide
explanations for much of the pathogenesis of some of the congenital eye conditions to
be studied and discussed below and in later chapters: coloboma, microphthalmos with
cyst, and orbital cysts. Studies of animal models have provided some insight into the
Figure 1.0: Diagrammatic representation of the development of the optic cup
and optic (choroidal) fissure in a 7.5 mm human embryo. The optic vesicle and












mechanism of closure (Geeraets, 1976). Cells at the margin of the fissure become
inverted into the fissure and fuse after multiple appositional contacts develop. At the
same time as fusion, there is programmed cell death at the sites of fusion. The closure
of the optic fissure is generally accepted to occur at 5-6 weeks of gestation (10-
13 mm stage) (Pagon, 1981). This timing can be considered in more detail, i.e. does
closure begin at five weeks and end at six weeks, or does the timing refer to the range
of onset of the time of closure? How long the process of closure actually takes may be
minutes or days. It is also relevant to consider the actual mechanism of closure of the
fissure with regard to direction and orientation. This is of great importance when
considering the range of pathology that is thought to arise as a direct result of errors
in the process of optic fissure closure. The lips of the fissure/cleft were once believed
to meet in the central part (Duke-Elder, 1964), followed by anterior or posterior
closure, a type of 'zipping up'. It is almost certain that the lips of the fissure meet at
any point from anterior to posterior, that the point of initial closure is variable (Suzuki
et al. 1988), and that the process of fusion is simultaneous. This, as we shall see later,
explains the variety of pathologies that occur from the anterior end of the fissure (the
iris and anterior segment of the eye) to the posterior end (the retina and optic disc).
In summary, the closure of the optic fissure probably takes place over a period of 1-2
days, commencing at some point between five and six weeks' gestation. This wide
range of a number of critical events in eye development gives a huge scope for a




Having understood the process of normal optic fissure closure, we can now return to
one of the variants of microphthalmos often mentioned, microphthalmos with cyst.
The mechanism by which this occurs is quite different from the congenital cystic eye
described earlier, although similarities in terminology, aetiology, and clinical
appearance have lead to confusion.
Microphthalmos with cyst (microphthalmos with orbital cyst, orbito-palpebral cyst,
cystic coloboma) occurs as a result of faulty closure of the optic fissure (Duke-Elder,
1964).
Clinically, the appearance of microphthalmos with cyst is very variable (Weiss et al.
1985). Typically, there is distension of the (usually lower) eyelid with cystic masses
that usually transilluminate. The cyst may also be small and not detectable clinically,
and is usually located inferonasally to the globe, although orientation is not always
easy to determine. In contrast to congenital cystic eyeball, a small displaced globe will
be present in addition to the cyst, and the two communicate, although the channel of
communication may have closed off. The eye is usually only apparent after imaging or
surgical exploration. With large cysts, ultrasound or CT scan usually detects a
microphthalmic globe. The microphthalmic eye, if it is large enough to visualise detail
within it, will often have a number of different structural abnormalities, most
significantly a coloboma of the uvea (see coloboma page 22). Other abnormalities
described frequently are corneal opacification and cataract. Within the microphthalmic
globe, calcification may be seen (Porges et al. 1992). Rudimentary optic nerves are
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present. The pathology of the cyst is a cellular lining of primitive retinal cells and RPE
(Foxman and Cameron, 1984).
The pathophysiology ofmicrophthalmos with cyst is a failure of normal closure of the
optic fissure (Waring et al. 1976). In simple terms, the lips of the optic fissure are
composed of an inner layer of neuroectoderm (which will later become the
neuroretina) and an outer layer of neuroectoderm (later to become the RPE).
Between these two layers of neuroectoderm, which make up the optic cup, is a
potential space. The improper fusion of the lips of the optic fissure results in a number
of complex abnormalities. If the optic fissure fails to close, a defect remains (a
coloboma) that is lined only by the immature retina and retinal pigment epithelium.
The outer layer of the coloboma will consist of a layer of sclera, which will be present
to varying degrees and is ectatic. It is this scleral ectasia and herniation that produces
the cystic structure, the cyst being in continuity with the contents of the globe. A
second mechanism of cyst formation is if the neuroectoderm at the lips of the fissure
proliferates: cysts can form at one or both edges of the fissure, which is continuous
with the space between the two layers of the optic cup. Such a cyst can also originate
from the optic nerve.
That the eye in microphthalmos with cyst is microphthalmic is probably secondary to
the presence of the attached cyst. Possibilities are that the large cyst has inhibited
growth of the eye, or that the cyst is a direct consequence of the eye being small due




The significance of uveal colobomas and defects of closure of the optic fissure to this
discussion of microphthalmos is vital. That the pathophysiology of extreme
microphthalmos and anophthalmos is a result of events taking place in the early
development of the eye has already been demonstrated. It is tempting to separate the
subject of extreme microphthalmos and anophthalmos (which blur into one another)
from coloboma on the grounds of aetiology (chapter two) or pathophysiology.
However, we have already seen that microphthalmos and coloboma frequently occur
in the same eye (Gopal et al. 1996). To this we must add the huge number of
descriptions in the literature of coloboma occurring in one eye and anophthalmos or
microphthalmos (with or without coloboma) occurring in the fellow eye of the same
individual or affecting different members of the same family (Porges et al. 1992). This
suggests that the pathological mechanisms and aetiology (chapter two) are
fundamentally similar, and that the vast array of differences that exist can be explained
by subtle changes in the timing of events during ocular embryogenesis. Therefore, no
discussion of anophthalmos or microphthalmos would be complete without a
description of coloboma.
Microphthalmos with cyst illustrates clearly how one particular variety of
microphthalmos occurs as a consequence of a failure of closure of the optic fissure.
Here, we see that the primary defect or phenotype is probably the coloboma, and that
the microphthalmos is most likely to be a consequence of this malformation. What
then of colobomas occurring without microphthalmos? Is there something that
distinguishes colobomatous microphthalmos from coloboma without microphthalmos?
-23 -
There does not appear to be any difference in the basic pathophysiology of these two
broad categories. Certainly, 'cystic coloboma' of the choroid exists in eyes of
'normal' size, these types of cyst often being referred to as staphylomas (Warburg,
1993). The condition occurs by the same mechanism as microphthalmos with cyst, but
for a change in terminology. Here, the emphasis and significance is (appropriately)
placed on the presence of the coloboma, the size of the eye not being a notable
feature. That the eye is 'normal' size is debatable since a common outcome of this
structural abnormality is an eye of increased axial length: macrophthalmia (Bateman
and Maumenee, 1984).
As stated earlier, the term coloboma indicates a condition in which a portion of a
structure of the eye is lacking (Duke-Elder, 1964). In ophthalmology the word refers
to any notch, gap, defect, hole or fissure in any ocular structure. Consequently, the
word has developed a broad meaning that often lacks specificity.
There are many types of coloboma, only some ofwhich are relevant to this discussion.
The colobomas with which we are concerned are those due to or at least considered
to be caused by defects resulting from faulty closure of the optic fissure. Warburg
(Warburg, 1993) classified coloboma according to phenotype, but this does not
correlate with the underlying pathophysiology or the aetiology (Table 1.2).
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Table 1.2: J'henotypic classification of coloboma, from Warburg 1993.
Classification ofmicrophthalmos and coloboma (Warburg, 1993)
Considering those colobomas not relevant to this discussion first, these would be
those regarded as 'special' colobomas of the optic nerve: pits of the optic nerve,
Pedler coloboma, morning glory disc, and optic nerve hypoplasia. Pits are crater-like
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depressions of the optic nerve head, situated mostly at the temporal side (Corbett et
al. 1980). The difference between an optic pit and an optic disc (nerve head)
coloboma can be quite subtle at times, and this has caused confusion in the literature
with regard to the correct naming and description of these abnormalities when seen
(Sugar, 1967). Pedler coloboma (Pedler, 1998) is an abnormality of the optic nerve
head that gives the impression of a tumour. There is elevation and distortion of the
adjacent peripapillary retina. The underlying defect may be in the formation of the
posterior sclera. Equally rare is the morning glory malformation (Pollock, 1987).
Here, the optic nerve head is funnel-shaped, contains a dot of white tissue in its
centre, and is surrounded by an elevated annulus of chorioretinal pigment disturbance.
The retinal vessels appear as multiple narrow branches at the edge of the disc.
None of these congenital defects of the optic nerve occur with anophthalmos,
microphthalmos, or true uveal coloboma (Pollock, 1987), or in the fellow eye of a
patient affected with one of these abnormalities.
Another form of coloboma that appears in the literature is the 'macular coloboma'.
This refers to a wide range of abnormalities that are characterised by a pigmented
lesion or malformation at the anatomical macula (Warburg, 1993). They are not
colobomas caused by or resulting from defects in closure of the optic fissure.
The colobomas that remain to be discussed are those thought to arise as a result of
defective closure of the optic fissure. However, we shall see that the mechanisms by
which some of these abnormalities arise are not entirely clear.
Uveal coloboma arises from an abnormal closure of the optic fissure and the subject
has been well reviewed (Pagon, 1981). Therefore, the defect is likely to occur around
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the stage of closure of the optic fissure. As has already been discussed, this is likely to
be at five to six weeks' gestation. However, what is not known is whether the factors
affecting fissure closure, which are not understood, take effect before or during the
period of abnormal closure. We will return to the subject of causes in chapter two.
For example, it is possible that in some circumstances where abnormalities arise, there
is a delayed onset of fissure closure, a prolonged process of closure, or an accelerated
or premature closure. All of these mechanisms would produce different structural
abnormalities.
It was Duke-Elder (Duke-Elder, 1964) who classified colobomas into typical and
atypical. Typical coloboma referred to those colobomas due to defective closure of
the optic fissure, whereas atypical included all those ocular malformations of a
different (usually unknown) aetiology (Brodsky et al. 1988). However, we shall see
that the pathogenesis of some of the atypical colobomas might best be described or
explained in terms of optic fissure defects (Duke-Elder, 1964). The term 'typical
coloboma' has not been applied consistently. Warburg's 1993 classification sub-
classifies the special colobomas of the optic nerve (pits, Pedler coloboma, morning
glory disc, optic nerve hypoplasia) under the typical (defective optic fissure closure)
category although, as discussed above, the pathophysiology of these colobomas is not
explained (Warburg, 1993).
The optic fissure runs from the anterior segment of the eye and extends posteriorly
along the infero-nasal aspect of the eye as far as the optic disc, continuing as a
fissure/clefl of the optic stalk. A typical coloboma may therefore affect any of the
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structures along this line. Colobomas affecting all of the aforementioned structures
have been called complete, and those which are less extensive partial.
Iris colobomas are shown in Figure 1.3 and Figure 1.4. The usual position is inferior
or nasal, which is consistent with the site of the optic fissure. The defect may extend
to the limbus, where it varies in width, and when this occurs it almost invariably
continues onto the retina.
Figure 1.3: Left iris coloboma
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Figure 1.4: Right iris coloboma with clinical microphthalmos
Coloboma of the retina (or fundus coloboma) is a misnomer, since the coloboma is
not just of the retina but refers to the absence or disruption of the retina and RPE that
overlies the abnormal outer scleral coat.
The closure of the optic fissure was described above and errors in this process can
lead to colobomas with cysts, by a mechanism similar to that in microphthalmos with
cyst.
It is the variable nature of coloboma that has caused so many other conditions to be
incorrectly labelled as coloboma and being confused with uveal coloboma An
example of this is the iris defect that occurs in Rieger's anomaly (Pearce and Kerr,
1965), in which full thickness iris defects interrupt the pupillary margin. Similarly, the
absence of large sectors of the iris in aniridia has led to the use of the term coloboma
(Hittner et al. 1980). The mechanism of such defects is not well understood, but they
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are not considered to be related to closure of the optic fissure. Another congenital iris
abnormality, which can be confused with an iris coloboma at first glance, is corectopia
(Atkinson et al. 1994).
Before describing the pathology of coloboma, a brief mention of normal iris formation
is necessary.
Three successive waves of neural crest cells contribute to the formation of the
anterior segment of the developing eye (Bron et al. 1997). It is the second wave of
neural crest cells, as mesenchymal cells, which will form the iris stroma and pupillary
membrane. The lens vesicle separates from the surface ectoderm after 33 days and it is
at this stage that an anterior chamber is first visible. The iris is the anterior part of the
uveal tract, which is made up of the ciliary body and choroid more posteriorly. The
uveal tract is derived from the neural crest cells, neuroectoderm and vascular
channels. Following the mesenchymal tissue, the neuroectoderm of the optic cup
margin's anterior layer will develop into pupillary sphincter and dilator muscles. The
posterior layer of the iris, the posterior pigmented epithelium, is a continuation of the
neuroectoderm that forms the neural retina.
In iris coloboma, the abnormality arises due to failure of optic fissure closure. Normal
iris development is dependent on complete closure of the fissure and is associated
with the formation of the anterior portion of the tunica vasculosa lentis, the vascular
channels of which arise at about the sixth week of gestation from an annular vessel
that encircles the rim of the optic cup. These vascular channels extend into the
mesenchyme covering the anterior surface of the lens.
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Duke-Elder (Duke-Elder, 1964) favoured a vascular event being the cause of
coloboma. Vascular events are an essential component of iris development and could
explain the presence of isolated iris coloboma arising in the absence of any retinal
involvement. Conversely, defects in fissure closure could cause abnormal iris
vascularisation leading to an iris coloboma.
Due to the fact that an iris coloboma represents the absence of tissue, little is
understood about the histopathology. Clinically, a full thickness iris defect, which
includes the pupil margin, is seen. The defect may extend partly to the limbus, and
may be bridged by strands of iris stromal tissue. A persistent pupillary membrane is
not uncommon (Pagon, 1981). It is possible that stromal defects of the iris in the
infero-nasal position are minimal expressions of iris coloboma (Pagon, 1981).
A further type of coloboma, 'atypical coloboma', needs to be discussed, as its
mechanism is so poorly understood. It refers to iris defects not located in the 'typical'
infero-nasal position. These are not generally considered to be due to faulty closure of
the embryonic fissure. Examples include the 'coloboma' of Rieger's anomaly, and
some of the pupil abnormalities in aniridia. We shall return to this later (chapter six
classification of coloboma), as many aspects of atypical coloboma are not easily
explained. The site of the optic fissure is not absolutely constant, with the optic
vesicle being invaginated from below and slightly medially. It is probable that the line
of the fissure can become altered by unequal growth of the two sides of the retina.
Therefore, it is possible that some so-called atypical colobomas may be typical, that is,
due to defective optic fissure closure. Other complex factors could stimulate the
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fissure to appear in a different position, or produce an accessory fissure (Duke-Elder,
1964).
Retinal colobomas (fundus colobomas, chorioretinal colobomas) have a very broad
spectrum of clinical appearances (Gopal et al. 1996). The first indication of the
existence of a retinal coloboma is the presence of a typical iris coloboma, although
this is not always present. Other external features may be nystagmus or a squint, both
of which are direct consequences of the visual impairment (see causes below), a
'white' fundus reflex, caused by the reflection of light from the sclera that is deficient
in its pigmented layers. It is the retinal appearance that is so variable. An attempt has
been made to classify this according to the degree of optic disc involvement, itself
very variable (Gopal et al. 1996). Retinal colobomas usually appear as white defects
in the inferior or nasal retina. Almost the entire posterior pole of the eye may be
involved and the retinal coloboma may be accompanied by varying degrees of optic
disc involvement (see optic disc coloboma below). The edge of the defect is well
demarcated, bulging posteriorly to varying degrees, forming a staphyloma (bulge of
the sclera) when severe (Weiss et al. 1985). Sometimes at the edge there is a variable
amount of irregular pigment from the atrophic RPE. The floor of the coloboma is
irregular. Retinal vessels may pass over the coloboma, but are usually disturbed and
irregular in distribution. They frequently disappear from view as they curve over the
edges of the coloboma onto the area of unaffected (or at least not colobomatous in
appearance) retina. This unaffected retina, often described as normal, is not normal in
the strict sense. The retinal vascular pattern is irregular, often with straightening of the
vessels, and the macula or anatomical fovea, when not directly involved by the
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coloboma, is often indistinct. Within the coloboma, choroidal vessels may be seen.
The coloboma often extends anteriorly to involve the ciliary body and so the anterior
edge is not seen. The width of the coloboma anteriorly does not correspond in size
with the width or exact position of any iris coloboma defect, if this is present.
Much milder and less extensive forms of coloboma may be seen, where the optic disc
and macula are not involved and the anatomy of the posterior pole and its vascular
pattern is essentially normal. The coloboma begins some distance from the optic disc
and extends anteriorly. It may appear as a localised defect anywhere along the line of
the (presumed) optic fissure.
As stated earlier, colobomas of the retina are due to primary pathology in both the
neural retina and retinal pigment epithelium that overlies the abnormal outer scleral
coat. The sclera is thinned by the loss of its inner layers, hence the ectasia. The
choroid is absent, only the larger choroidal vessels sometimes being seen. The neural
retina is absent, or atrophic, thinned and stretched to varying degrees to form a
membranous sheet (Duke-Elder, 1964). The abnormal and ectatic sclera is important
to note, as it is this which may give rise to an irregular profile or shape of the eye on
ultrasound, CT or MRI (Fledelius, 1996), or produce an unexpectedly long axial
length (Bateman and Maumenee, 1984) or axial myopia (see below).
Before returning to the subject ofmicrophthalmos, it is worth considering the causes
of visual impairment that occur as a result of coloboma. This will enhance our
understanding of coloboma and emphasise its significance as a structural abnormality
that occurs in spite ofmicrophthalmos (Duke-Elder, 1964).
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That the cornea is often reduced in size has been established. One effect of this can be
to increase the curvature and cause myopia or astigmatism, which in turn may lead to
amblyopia if uncorrected. Cataract or lens opacities do occur with colobomas, but
they are not usually visually significant. Mild photophobia often occurs with iris
coloboma due to an inability of the pupil to constrict in the absent segment. The
retinal involvement ranges from a small to a large field defect, and retinal detachments
do occur in a small but significant number of cases (Daufenbach et al. 1998).
Involvement of the anatomical macula and/or fovea leads to impaired acuity, but the
precise effect on vision is not easy to predict (Olsen et al. 1996). A staphyloma or
ectasia may cause axial myopia. Optic nerve involvement probably causes significant
visual impairment, but this is often difficult to assess since it is often present in
conjunction with the other abnormalities described. Recently, Brodsky (Brodsky,
1999) has demonstrated hypoplasia of the intracranial optic nerve on MR1 in patients
with retinochoroidal coloboma.
Optic disc coloboma (optic nerve head coloboma, optic nerve coloboma,
coloboma of the optic nerve entrance), Figure 1.5
This requires separate discussion. As stated above, some colobomas are probably not
related to defective optic fissure closure and some of these were described briefly.
However, the inclusion of these congenital structural eye anomalies under the broad
and non-specific heading 'coloboma' is what has led to such difficulty in trying to
establish the aetiology (genetic and/or environmental) of these conditions. We will see
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(chapter two) that efforts to establish a cause have been hampered by this loose
terminology and lack of definition.
Figure 1.5: Left optic nerve head coloboma
Optic disc coloboma is as variable in its manifestations as anophthalmos or
microphthalmos. Furthermore, unlike the vast majority of iris and retinal colobomas, it
is difficult to attribute their presence to defective optic fissure closure or to another
mechanism. The pathophysiological cause of pure (isolated) optic disc coloboma is
not well understood, although it would seem to be a defect in closure or formation of
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the head of the optic nerve and/or along the optic groove, manifesting itself clinically
as a structural abnormality at the optic nerve head (Savell and Cook, 1976).
For those optic disc colobomas which occur in eyes already having an iris and/or
retinal coloboma it is easy to explain the mechanism as being due to defective optic
fissure closure. Such optic disc colobomas are seen to be within or are adjacent to
retinal colobomas (Figure 1.6) (Gopal et al. 1996). The colobomas vary considerably
in clinical appearance and are not easily classified (Duke-Elder, 1964): the defect is
usually larger than a normal optic disc, may occupy almost the entire posterior pole,
and is oval, round or irregular in shape. Within the white colobomatous area the optic
disc, often distorted or tilted and sometimes its typical pink colour, may be seen. In
other cases, no recognisable disc is apparent. The disc may be excavated, usually has
no central blood vessels, and the blood vessels that do emerge are displaced to the
edge of the colobomatous area and tortuous in appearance. Hyaloid remnants may
appear at the optic disc. Cases of crescented myopic disc or tilted disc are frequently
(incorrectly) labelled as colobomatous. It is important to realise that the optic disc
may be within the retinal/fundus coloboma, but normal in appearance when inspected
closely.
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Figure 1.6: Left retinal coloboma involving the optic disc. The edge of the
coloboma is indicated with a white arrow and the origin of the optic nerve by a
black arrow
In isolated optic disc coloboma, the clinically gross structural abnormalities are
confined to the optic nerve itself, the nerve head appearing to be excavated, often
quite deeply. The entire disc area may be involved, with only a thin rim of neural
tissue (Savell and Cook, 1976). Comparisons with deep glaucomatous cupping have
justifiably been made (Gopal et al. 1996).
Having introduced and discussed the subject of colobomas, it is time to return to the
classification of microphthalmos according to Warburg (Warburg, 1993). (See page
17 and Table 1.1: Warburg's phenotypic classification of microphthalmos.) Here,
'microphthalmos with intraocular malformations' is given a separate category. It is
this category of microphthalmos which encompasses such a broad phenotypic
spectrum, so extensive are the number of congenital eye conditions which have been
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described as belonging to this category (Table 1.3). The result of this is that the term
microphthalmos carries no specificity, and can include several eye conditions that are
clearly not of the same pathological aetiology.
Table 1.3: Congenital ocular malformations associated with microphthalmos.
Congenital eye anomaly Reference
Anterior segment dysgenesis (Ghoseetal. 1991)
Cataract (Walpole et al. 1990)
Corneal opacification/cloudy corneas (Siber, 1984)
Peters' Anomaly (Traboulsi and Maumenee, 1992)
Persistent Hyperplastic Primary Vitreous (Haddadetal. 1978)
Retinal folds (Young et al. 1987)
Retinopathy ofPrematurity (Kelly and Fielder, 1987)
Sclerocornea (Bessant et al. 1998)
All of the conditions in this category of microphthalmos with other ocular
malformations have abnormalities which would be better described with the primary
diagnoses/phenotypes in their own right, as attaching the term microphthalmos
conveys no further information of use other than that the eye appears to be small
(which may or may not be true). A real or apparent reduction in corneal size has
already been mentioned as being highly suggestive of a small globe. It would be
preferable if the clinically descriptive term was dropped completely or (since it would
be too much for this drastic change in perception to occur overnight without great
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disruption) at least appended to these clinical conditions, e.g. 'Peters' anomaly with
microphthalmos'.
Colobomatous microphthalmos is not like the above tabulated ocular malformations,
since it occurs within individuals having anophthalmos in the fellow socket (Pagon,
1981), and also within different affected members of the same family or pedigree
(McMillan, 1921). The weight of evidence is that colobomas resulting from defects of
the optic fissure are related to anophthalmos by a similar aetiology or pathophysiology
(Bateman, 1984), probably acting at different times.
So far, discussion of the classification of microphthalmos has centred on Warburg's
classification system (Warburg, 1993). Duke-Elder (Duke-Elder, 1964) used the term
'complicated microphthalmos' to describe the heterogeneous group of congenital
ocular malformations in which microphthalmos is a feature (Table 1.3). Bateman
(Bateman, 1984) categorised microphthalmos as colobomatous or non-colobomatous.
Like these other classifications, Francois (Francois et al. 1983) recognised the
significance of colobomatous microphthalmos as a separate group.
Cryptophthalmos
This unusual and rare condition is often mentioned in discussions of anophthalmos or
microphthalmos. Cryptophthalmos is a term used to describe an eye covered with
continuous sheets of skin extending from forehead to cheeks. There are three ocular
variants of cryptophthalmos, as well as the occasional coexistence of cryptophthalmos
with specific systemic features: cryptophthalmos syndrome, Francois syndrome or
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Fraser syndrome. In the first variant of cryptophthalmos, complete cryptophthalmos,
the lids are replaced by a sheet of skin running from forehead to cheek with absence
or poor development of the eyebrow. The covered globe gives rise to an elevation in
the overlying skin, which is adherent to the underlying cornea. In incomplete
cryptophthalmos, rudimentary lids are present with a palpebral aperture of about one-
third of normal length. The globe is almost completely covered by skin. In the third
form of cryptophthalmos, abortive cryptophthalmos or congenital symblepharon, the
upper lid does not have a defined margin and covers and adheres to most of the
cornea. There is no upper lid punctum or conjunctival fornix (Walton et al. 1990).
Microphthalmos or a small globe is said to occur sometimes in all three variants,
although closer inspection of several case reports (Thomas et al. 1986; Brazier et al.
1986) does not bear this out. It seems reasonable to assume that detailed examination
of a globe covered by skin has not been possible, and that the narrow palpebral
aperture in many cases has given the impression of a small eye (see page 14).
Cryptophthalmos arises because of a failure of lid fold development: the ectoderm
overlying the cornea is converted into skin and no conjunctival sac forms. The
association between cryptophthalmos and multiple congenital malformations such as
syndactyly, renal agenesis and abnormal genitalia has been well reviewed by Thomas
(Thomas et al. 1986). Many cases of cryptophthalmos seem to have an autosomal
recessive mode of inheritance (Thomas et al. 1986).
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Summary, chapter one
• Anophthalmos and microphthalmos have not been satisfactorily defined and are not
easy to define.
• The current definition ofmicrophthalmos, based on eye (globe) size, is inadequate
and eye size cannot be used to define microphthalmos.
• Anophthalmos and microphthalmos are quite distinct structurally, but are also very
difficult to separate.
• There is a continuous spectrum from true anophthalmos to mild microphthalmos.
• Microphthalmos is not a useful term and conveys no specific meaning.
• Colobomas resulting from aberrant optic fissure closure occur in normal-sized eyes
and microphthalmic eyes. Emphasis here is placed on the structural abnormality
(coloboma), not the eye size.
• Anophthalmos and uveal colobomas result from errors in the early stages of eye
development. It is difficult to narrow this period down precisely, there being a
relatively large 'window' in which things can go wrong (gestation weeks three to
eight approximately).
We are still faced with the problem of meaningful names for the structural eye
anomalies discussed above. Clearly, anophthalmos and mild microphthalmos (at
opposing ends of the spectrum) are very different. Clinical anophthalmos remains a
clinically useful and specific term. However, microphthalmos, severe microphthalmos,
extreme microphthalmos and mild microphthalmos are not useful, as these terms can
attach a different meaning to the same structural congenital eye abnormality (or the
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same meaning to different structural congenital eye abnormalities). It is the structural
ocular abnormality, or phenotype, which carries significance and meaning, and it is
this term that should be used. The term anophthalmos, although varying in timing and
possibly in cause, cannot be refined any further as a clinical ocular phenotype, as no
structural abnormality is present to be described. This seems an obvious point, but is
well worth stating.
As we will see in the next chapters, appropriate terminology would allow progress to
be made in our understanding of the aetiology of these distressing eye malformations.
From the discussion within this section, in which a case has been put forward that
anophthalmos and microphthalmos are almost impossible to define, we are now faced
with the difficult problem of establishing aetiology for these very same and loosely
defined congenital eye anomalies. This is the subject of chapter two, in which the






Zeiter, in a discussion about the frequent occurrence of extraocular abnormalities in
microphthalmos (Zeiter, 1963). This is a topic that concerns much of this chapter.
Summary
Anophthalmos/microphthalmos has features that suggest both a genetic and an
environmental aetiology. The failure to define adequately these conditions has made it
increasingly difficult to determine a cause.
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In chapter one, it was proposed that anophthalmos and microphthalmos have no clear
definition. The problems that this absence of a satisfactory definition has presented to
clinicians from a wide range of specialities, as well as to scientists, will be illustrated.
Lack of definition and specificity is a subject that will recur.
The discussion that follows summarises the evidence for anophthalmos and
microphthalmos being genetic or environmental in aetiology.
Epidemiology of anophthalmos/microphthalmos
Before presenting some of the genetic and environmental evidence, it is useful to
consider how the birth prevalence and incidence of these congenital eye
malformations is estimated. The quality of data is very poor for a number of reasons:
1. Anophthalmos/microphthalmos has never been properly defined (Dolk et al.
1998). There is a wide use (and abuse) of these terms by both specialists and non-
specialists.
2. The diagnosis may not be apparent within the time period within which notification
must be made, usually the first ten days of life (Working Group of the Registrar
General's Medical Advisory Committee, 1995).
3. Late diagnoses/notifications cannot be included (Working Group of the Registrar
General's Medical Advisory Committee, 1995).
4. Notification is voluntary (Working Group of the Registrar General's Medical
Advisory Committee, 1995).
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5. The diagnosis may be seen but not documented if the 'cause' is presumed to be
known or understood. This occurs when it is part of a well-recognised syndrome
(Bianchi et al. 1994). An example of this is trisomy 13 (below).
At best, therefore, one can only consider current data to be crude estimates. In itself,
this would not be such a problem, as one could look at trends and fluctuations.
However, there is no consistent pattern of over- or under-diagnosis from one clinician
to another, or within a geographical region. Case ascertainment is highly inconsistent.
The rarity of these conditions (as few as 1 in 100,000 live births for anophthalmos)
means that a single case can have a profound effect on the overall prevalence for a
country.
The congenital malformations (anomalies) registers, in their current forms in Scotland
(Scottish Morbidity Record, SMR) and England and Wales (Office of Population
Censuses and Surveys, OPCS), are not suited to some of the uses for which the data
is being applied (Working Group of the Registrar General's Medical Advisory
Committee, 1995). These registers were originally established for the purpose of
surveillance and rapid reporting of congenital malformations. This came about in 1964
following the thalidomide epidemic (Working Group of the Registrar General's
Medical Advisory Committee, 1995; Office of Population Censuses and Surveys,
1995). For many reasons, including some of those listed above and specific to eye
malformations, these registers are unsuitable for detailed analysis.
Some of the data are summarised in Table 2.1. Methods of data acquisition vary
widely from one country to another, as does the inclusion and definition of, for
example, stillborns, neonatal deaths and therapeutic abortions. Some data are
- 45 -
presented for coloboma, which, as we have seen, overlaps extensively with the
category of microphthalmos.
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Anophthalmos and microphthalmos are responsible for a small but significant amount
of blind and partially sighted registrations (BP1 forms in Scotland, BD8 in England
and Wales). However, they are not a good source of information on these conditions,
since the time between diagnosis and certification (voluntary) is very variable, and
only bilaterally affected children will be recorded. Between April 1990 and March
1991 in England and Wales, congenital anophthalmos was the documented cause of
registration in 3 children (age 1-15). For the same group, microphthalmos was listed
11 times (Evans, 1995).
In a Japanese survey on the causes of visual handicap among schoolchildren,
microphthalmos was ranked third (Fujiki et al. 1982).
Sex ratio of anophthalmos/microphthalmos
Kallen did not find any significant difference between the two sexes (Kallen et al.
1996).
Clusters of anophthalmos/microphthalmos
In recent years, much of the research involving anophthalmos/microphthalmos,
whether genetic or environmental, has sprouted from the suggestion that the
prevalence is increasing or that there are geographic clusters. The research on which
some of this thesis is based is no exception. Certainly, it is beyond the scope of this
thesis to discuss the subject of clustering at length and to provide an answer, but
clustering is relevant to the subject of establishing a cause for these congenital eye
anomalies.
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In the early 1990s, reports began to appear in the national press (Paduano et al.
1993) that anophthalmos and/or microphthalmos were increasing in prevalence, that
in parts of Scotland (Fife) and England (Lincolnshire) there were 'clusters' in time and
place, and that the alleged cause of these clusters was pesticide use in the environment
(Dyer, 1996). This was not the first occasion on which concern had been raised about
possible clusters of anophthalmos/microphthalmos (Lenihan, 1985; Scottish Home
and Health Department, 1988).
The publicity, concern and debate around this issue, which continue to the present
day, highlighted the inadequacy of current congenital malformation registers in the
UK (Watterson, 1993) and Europe, as no definite or rapid answers were available
(Dolk and Elliott, 1993).
The presence or absence of clusters, whilst being of immense interest and a significant
public health and legal issue, does not in fact alter significantly the correct approach to
finding a cause for anophthalmos/microphthalmos. Rarely does cluster analysis, itself
an extremely complicated science, lead to the finding of a cause (Olsen et al. 1996).
Cluster analysis does remain important in addressing public concern with the possible
adverse effects of environmental pollutants (Olsen et al. 1996). This is a subject that
we shall return to later in this chapter.
There is no data at present that suggests that there are clusters of
anophthalmos/microphthalmos in time or space. The registers that do exist are not
accurate enough (see above) to detect any statistically significant variation. Increased
awareness of these conditions will probably have an effect on the level of reporting,
although the difference may not be measurable.
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The cause of anophthalmos/microphthalmos is considered by many to be
environmental. Environmental means any external agent that can cause harm to a
developing foetus during the critical early stages of eye development and maternal
factors (illness, drug intake). Paternal exposure to chemicals before conception is a
theoretical possibility (Robaire and Hales, 1993), though a case has not been reported.
Clearly, and this will become more apparent later, the complete separation of causes
into environmental or genetic, if one is to believe there is more than one cause, is
artificial but is convenient for the purpose of discussion. It is equally possible that
these two major factors could be interacting (Kaprio, 2000). This chapter begins with
the statement that there are some features of congenital
anophthalmos/microphthalmos that suggest the causes are environmental and genetic.
Where possible, anophthalmos and microphthalmos are discussed separately. As
should be apparent from chapter one, the possible inaccuracy of these diagnoses and
reporting does mean that close inspection of any clinical case report is necessary, but
this may not always be possible. One can be fairly certain of what the author is
conveying by the term anophthalmos, which at least is likely to be extreme
microphthalmos, but microphthalmos, as we have seen, could represent any one of a
large number of ocular phenotypes.
What are the 'environmental' features, that is, those characteristics that
together suggest an environmental aetiology?
External factors and the environment have for a long time been considered as a
possible cause of anophthalmos (Treacher Collins, 1887). The factors are as follows:
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1. The sporadic nature and rarity. It is very unusual for these conditions to occur in
an individual with a previous family history or with a sibling with a similar or
related eye condition. Such sporadic cases have been reported many times
(Treacher Collins, 1887; Brownstein et al. 1977; O'Keefe et al. 1987).
2. Frequent reports of the occurrence of these eye conditions in the presence of or
with a good history of exposure to a potential toxin or illness at a critical stage of
embryogenesis. This could of course be coincidental, but the rarity, particularly of
anophthalmos, makes the evidence for such substances (Tables 2.2 and 2.3 page
51) as being harmful very convincing. Such reports should always be taken
seriously.
3. Clusters allegedly related to environmental pollutants, pesticides being the most
commonly cited (Dolk and Elliott, 1993). The scientific evidence for the toxic
effect of pesticides is the effect of large doses fed experimentally to pregnant rats.
A significant number of the rat embryos developed microphthalmos and some were
anophthalmia with additional brain malformations (Hoogenboom et al. 1991).
4. The fact that these eye conditions are so variable in appearance/phenotype possibly
implicates an environmental cause/influence.
5. The occurrence of so many unilaterally affected individuals (Tucker et al. 1996)
(but see later discussion on laterality under genetic causes).
6. The fact that anophthalmos/microphthalmos so frequently occurs in the presence of
other (extraocular) congenital malformations, as unrecognisable and unexplainable
new 'syndromes', with unusual constellations of physical signs or dysmorphology
(Treacher Collins, 1887; Brownstein et al. 1977; O'Keefe et al. 1987). O'Keefe's
series of 15 cases of clinical anophthalmos found multiple anomalies in 9 cases.
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Warburg (Warburg, 1993) went as far as to classify anophthalmos/microphthalmos
according to aetiology. This seems rather ambitious in view of the fact that it is not
easy in the majority of cases to attribute a likely 'cause', a point which the author
herself acknowledged. 'Prenatally acquired' was used for a group which included
disruptions due to drugs/irradiation or maternal disease.
Table 2.2: Possible causes of anophthalmos
Maternal drug ingestion of teratogens
Thalidomide (Smithells, 1973)
Carbamazepine(Sutcliffe et al.
Retinoids (Autret et al. 1997)
Ethambutol (Perz, 1987)
LSD (Lysergic Acid Diethylam
1998)
ide) (Margolis and Martin, 1980)
Maternal illness
Nutritional factors
Vitamin A deficiency (Sarma, 1959)
It is not a useful exercise to discuss at length the environmental causes of
microphthalmos, as it has already been made clear that microphthalmos is not a single
diagnosis or recognisable phenotype but a group of great heterogeneity. However,
some of the causes are listed, as the cases described may have been recognisable as
clinical anophthalmos or colobomatous.
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Table 2.3 Possible causes ofmicrophthalmos
LSD (Bogdanoff et al. 1972)
Thalidomide (Smithells, 1973)
Carbamazepine (Sutcliffe et al. 1998)
Maternal exposure during pregnancy .
Oxydemeton-methyl (organophosphate) (Romero et al. 1989)
Chlorpyrifos (Dursban) (Sherman, 1996)
Maternal iliness/intrauterine infection
. T • " :=
Rubella (Gregg, 1941)
Cytomegalovirus (Miklos and Orban, 1964; Tarkkanen et al. 1972)
Varicella (Kriss et al. 1997)
Toxoplasmosis (Kriss et al. 1997)
Parvovirus B19 (Weiland et al. 1987)
Some of the more familiar established 'causes' ofmicrophthalmos warrant discussion,
as many of these are based on questionable data or assumptions which have continued
to be passed on. For example, it has long been accepted that microphthalmos is a
feature of the fetal alcohol syndrome. However, it is the typical facies of short
palpebral fissures that gives the impression of microphthalmos. The ptosis that can
occur is also a feature that can give the misleading impression of microphthalmos
(Stromland, 1987).
Congenital TORCH infection, an acronym for Toxoplasma, Rubella, Cytomegalovirus
and Herpes virus, is one of the most frequently stated causes. Again, closer inspection
of the literature does not demonstrate this. The eye abnormalities associated with
most of these infections are quite specific, and the pathology is usually very
recognisable.
It was Gregg (Gregg, 1941) who summarised the characteristic ocular features of
congenital rubella syndrome (typical cataract, corneal haze, pigmentary retinopathy,
mild microphthalmia) (Alfano, 1966; Wolff, 1972). In Wolffs series of 30 eyes
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described as microphthalmia, none was without other evidence of ocular congenital
rubella. It is notable that these features only occur within the context of the systemic
congenital rubella syndrome. Of course, it is possible that the very characteristic
ocular pathology could occur as an isolated ocular lesion. The microphthalmos that
Gregg described was 'very mild' and in all cases there was typical 'rubella' cataract
Again, we are reminded of the inadequacy of the term microphthalmos. Microcornea
would be a more suitable description in these cases (Wolff, 1972).
Congenital toxoplasmosis and congenital varicella are both listed in standard
textbooks as causes of microphthalmos (Lambert, 1997). In toxoplasmosis, it is the
retinochoroiditis that is the diagnostic feature (Noble and Carr, 1982).
Intrauterine cytomegalovirus infection manifests itself in the eye as a chorioretinitis,
usually (but not always) within the context of the systemic features.
Congenital varicella is more notable for the chorioretinitis and/or cataract. It is more
than likely that these are the primary phenotypic features.
Neonatal herpes simplex infection following intrauterine infection has not been
described as causing microphthalmos.
Anophthalmos, iris or fundus coloboma due to defective optic fissure closure, have
not been described in any of the TORCH infections.
Summarising the TORCH infections, they have never been documented as a cause of
anophthalmos or extreme microphthalmos, and when they do cause microphthalmos,
it has a typical 'mild' appearance, the other ocular features being the primary feature
and of diagnostic importance. However, it is theoretically possible that sub-clinical
infection could be responsible for these eye defects, although there is no evidence for
this.
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The mild forms of microphthalmos that result from some of these infections are
probably the result of a generalised inhibition of ocular growth in the later stages of
development secondary to the infective process and intraocular inflammation of a
structurally normal eye. Infection at an earlier stage of embryogenesis (i.e. around the
time of optic fissure closure) would almost certainly result in far more severe
disruption to the eye.
If environmental factors were causative or influential, one would expect that they
would exert their effects during the critical early stages of eye development. Such an
effect would not have to be sustained to inflict serious damage. The human embryo
shows the earliest signs of eye development at the 2 mm stage. Only a very small
amount of toxin (e.g. a virus) would be required to exert a major influence on an
organ that is a fraction of a millimetre in size.
Possible causes of coloboma
Due to the large degree of overlap between microphthalmos and coloboma, and the
fact that most cases of microphthalmos are colobomatous, the two are similar and
difficult to separate (see Table 2.3 for microphthalmos).
Vitamin A deficiency has been mentioned as a cause (Lamba and Sood, 1968) as well
as thalidomide (Smithells, 1973). Like microphthalmos, TORCH infections have been
overemphasised as a possible cause of coloboma (Mintz-Hittner et al. 1976), and
probably account for an insignificant number of sporadic cases.
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Genetic aetiology
There is little doubt that in a number of cases, anophthalmos and microphthalmos
have an aetiology that one would consider to be 'genetic' (Box 2.1). This is a word
that needs to be defined and explored further. 'Genetic' encompasses a number of
very different mechanisms. Firstly, that the underlying mechanism is inherited in some
way. Secondly, there may be a chromosome abnormality that can be identified on
laboratory testing. Thirdly, there may be no identifiable chromosome abnormality but
a previously recognised group of systemic malformations in conjunction with the eye
abnormality that has a known pattern of inheritance (a clinical genetic syndrome), or a
clinical genetic association. These clinical genetic aetiologies do overlap to a degree,
and the separation is slightly artificial. Categorisation does however assist
understanding.
If anophthalmos/microphthalmos were genetic in aetiology, one would expect to see
some or all of the following features:
1. Families in which more than one individual was affected with the same (or related)
structural eye abnormalities. These would follow recognised patterns ofMendelian
inheritance ( dominant, recessive, X-linked). If recessive, one would expect there to
be a high proportion of consanguineous parental relationships with respect to the
proband.
2. An excess of bilaterally affected individuals (see environmental causes above). It
may be that there is underreporting of unilateral cases, especially if the fellow eye is
normal (Tucker et al. 1996). Bilateral pathology is not a prerequisite to having a
genetic cause. Many individuals with a known (probable) genetic cause are
unilaterally affected (McMillan, 1921; Francois, 1968; Pagon et al. 1981b), Briggs
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quoted in Sorsby (Sorsby, 1934; Brunquell et al. 1984). Conversely, many
individuals with no detectable genetic cause (presumed non-genetic) are bilaterally
affected.
3. The presence of chromosomal abnormalities in individuals and their parents, if the
parents are also affected.
4. Well-recognised ocular clinical genetic syndromes and associations. These are
supposed to exist but closer examination doesn't confirm this, as it may be that
features are being made to 'fit' a previously described syndrome e.g. in Lenz's
syndrome or Waardenburg's syndrome (see below).
Box 2.1: Possible genetic aetiologies of microphthalmos/anophthalmos
Mendelian inheritance





In one of the earliest cases of anophthalmos described at the beginning of chapter one,
(Bartholini, 1657) the child was affected with other (systemic) congenital
abnormalities. This is of fundamental importance since it suggests that the eye
abnormality is part of a wider developmental defect that has manifested itself in more
than one major organ. As stated earlier, this could be considered as strengthening the
case for an environmental insult. From a genetic point of view however, it can be
argued that one or many genes may be involved or are interacting to produce complex
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patterns of malformation. A single gene could be involved in multiple developmental
pathways. In both cases (genetic and environmental) one could explain the
inconsistency and variation by considering variable gene expression or doses of
teratogen. The presence of eye malformations in so many different clinical genetic
syndromes is not easily explained. The environment can mimic the effects of
inheritance.
In many of the previous cases and reports and descriptions, an attempt has been made
to distinguish cases in which the congenital abnormalities were confined to one or
both eyes (isolated), with no systemic anomaly. This is not always possible as
systemic examination may be incomplete or not sufficiently well documented to do
this with certainty.
Anophthalmos has been described in several families and pedigrees. The better quality
published cases are summarised in Table 2.4. Listed alongside each case is the
likely/presumed pattern of inheritance. Other congenital malformations are listed in
some cases. None are documented to have a chromosomal abnormality.
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Waardenburg's recessive anophthalmos syndrome
Waardenburg's recessive anophthalmos syndrome (see Table 2.4) is useful to discuss
as it reveals much about the inadequacies of our understanding of the aetiology of
anophthalmos.
In 1935 Waardenburg described the occurrence of bilateral anophthalmos with limb
defects (syndactyly) in two girls, the offspring of first cousins. This familial recessive
syndrome has since been described in two other families. However, the additional
systemic anomalies vary from case to case. Traboulsi reported a male propositus with
simian creases, absent prepuce and widely spaced nipples (Traboulsi et al. 1984).
Richieri-Costa's first case (Richieri-Costa et al. 1983) describes widespread
dysmorphism (low set ears, hypoplastic upper helix, retrognathia, high arched palate).
These varying observations may reflect different levels of reporting, but may also
reflect a different phenotype. The real difficulty arises when new cases are described
and the features 'fitted in' to comply with the (ill-recognised) syndrome (Pallotta,
1985). The spectrum of features of the clinical genetic syndrome is then expanded to
accommodate each case, often with the mention of major and minor diagnostic
criteria. It can be worthwhile with respect to prognosis and parental reassurance to fit
a severely disabled child into a named/recognised syndrome or diagnosis, but
sometimes this is not helpful in counselling or risk assessment.
How does one explain such variation of expression? It could be that these cases
described are different conditions, or if they are the same condition there may be a
disturbance in temporal synchronisation and sequential progression of the affected
developmental fields (eye and distal limb). It is possible that a single gene could cause
-63 -
not anophthalmos with limb abnormalities, but a disturbance of eye and distal limb
formation with a resulting variable phenotype (Richieri-Costa et al. 1983).
It is interesting that Bartholini's case report of 1657 describes a child with
anophthalmos and Polydactyly of the hands and one foot: Is this the first description
of the syndrome named after Waardenburg? (Bartholini, 1657).
Chromosome abnormalities
Numerous chromosome malformations and rearrangements have been reported:
1. Translocation 7/15 [46, XY, t(7, 15)] delayed neuropsychomotor development,
translocation 4, 14.(Wajntal et al. 1978).
2. 14 (q22.1-22.3) deletion (Elliott et al. 1993), 14q22q23 (Bennett et al. 1991).
3. Trisomy 13.
Since the case first described by Patau, (Patau et al. 1960) trisomy 13 has been a
recognised cause of anophthalmos and microphthalmos. (The case described by Patau
had apparent anophthalmos.) Patau's syndrome is useful to discuss with respect to
both anophthalmos and microphthalmos, because it typifies some of the difficulties in
diagnosis and accurate documentation in cases of multiple severe congenital
anomalies. The frequency of these eye deformities is far from 100% of cases.
However, accurate or precise documentation of eye anomalies is (understandably) not
necessarily of the highest priority in these very sick babies. Taylor (Taylor, 1968)
looked in detail at 27 cases of Patau's syndrome (clinical and post mortem findings).
88% had eye defects, 76% microphthalmos, and 33% iris coloboma. Facial
deformities such as epicanthic folds and eyelid oedema in these cases can certainly
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make the assessment of apparent eye size difficult (chapter one). In Taylor's series,
there was just one case of anophthalmos ('Eyes not visible, anophthalmia suspected').
In summary, trisomy 13 probably accounts for a small but significant number of cases
of apparent anophthalmos. The frequency of occurrence of anophthalmos in trisomy
13 is probably approaching nil (Hoepner and Yanoff, 1972).
Genetic aspects of microphthalmos
It is not possible to summarise the vast body of literature on the hereditary aspects of
microphthalmos. This is because of terminology and the imprecise meaning of the
word microphthalmos. Even careful examination of each paper or clinical report does
not often lead to an adequate phenotypic description, and photographs, where
present, are unreliable and difficult to interpret. This problem is not confined to the
older literature and descriptions, as some of these are documented in sufficient detail
to recognise a structural eye abnormality. Again, it is the structural eye abnormality
that is of fundamental importance when trying to understand the genetic aetiology.
With this in mind, a brief attempt will be made to discuss some of the work on the
clinical genetics of microphthalmos. No apology is made for exclusions or criticism,
and the reader is reminded that such an argument lies at the core of this chapter, and
indicates why determining aetiology is so difficult.
That microphthalmos represents a number of separate eye conditions, each with a
distinctive phenotype, was discussed in the last chapter. Coloboma and colobomatous
microphthalmos will be discussed separately, and special mention of these cases will
be made where possible.
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As with anophthalmos, there is no easy way to classify or categorise the genetics of
microphthalmos. Warburg (Warburg, 1991) states that there are more than 100
genetic traits with microphthalmos and coloboma. At the time, there were
approximately 50 different autosomal dominant syndromes, 67 autosomal recessive
syndromes, and 16 X-linked syndromes. It is a great pity that coloboma and
microphthalmos are so often 'lumped' together, as this makes the task of sifting out
the reports on coloboma very difficult. An ocular malformation described as a
'coloboma' will more than likely be accurate and actually represent the ocular
phenotype of uveal coloboma although, as described in the previous chapter, this is a
term also subjected to misuse.
Abnormal karyotypes are common in patients with microphthalmos and coloboma
associated with delayed mental development and minor abnormalities (Warburg and
Friedrich, 1987).
Warburg reviewed coloboma and/or microphthalmos in chromosomal aberrations
(Warburg and Friedrich, 1987). In the 500 papers reviewed, abnormalities were
reported in almost every chromosome. The authors concluded that deletions and
duplications were non-specific for these disorders when trying to determine loci for
the Mendelian types of colobomas or microphthalmos. This study could have been
considerably improved and made more specific by phenotypically classifying and
separating the various ocular malformations. This may have led to determination of
some loci (Brewer et al. 1998).
It is practically impossible to attempt to separate those disorders in which eye
malformations are the only pathology, there being no systemic anomalies. The
justification for doing this (or not) was discussed above (page 56 item 4).
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Many descriptions are erroneous. For example, closer inspection of some papers will
suggest that the microphthalmos described is in fact nanophthalmos (Wolff, 1930).
This distinctive ocular malformation was described in chapter one.
The On-line Mendelian Inheritance in Man (OMIM)
(http://www3.ncbi.nlm.nih.gov/Omim) refers to 'microphthalmos-cataract' and lists a
paper by Zeiter (Zeiter, 1963). This paper describes autosomal dominant cataract.
Capella (Capella et al. 1963) is also listed under 'microphthalmos-cataract' and this
paper describes both X-linked and dominant cataract. Microphthalmos and
microcornea are key words in the paper's title, but certainly the microphthalmos is not
remarkable in the phenotypic description. Comparison with previous work in these
papers and summaries of the literature at the time of publication reflect the confusion
that is bound to arise when obviously different conditions are compared and
contrasted. This pattern has continued, with very recent papers apparently identifying
the locus for autosomal recessive microphthalmos (Bessant et al. 1998). This is
admirable and diligent work but the ocular phenotype in this particular paper is in fact
sclerocornea. This simple fact seems to have been lost in the title, the paper
disappearing into the mass of literature already existing on the subject of
'microphthalmos '.
Many papers referring to congenital microphthalmos and its inheritance patterns are
concerned with colobomatous microphthalmos, which is possibly no different to
'ordinary' or non-colobomatous microphthalmos.
Chromosomal disorders may present with microphthalmos as a feature and trisomy 13
was discussed earlier. Closer examination of the eyes in cases of chromosomal
abnormality with microphthalmos reveals that there is a range of different but distinct
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ocular phenotypes (Ginsberg and Bove, 1974) rather than just microphthalmos.
Yokoyama (Yokoyama et al. 1992) describes autosomal dominant congenital
cataract and microphthalmos with a familial t (2; 16) translocation. Again, the primary
pathology in this family is the cataract described.
Taylor's series (Taylor, 1968) of 27 cases of trisomy 18 (Edwards' syndrome) records
29% as having an eye defect, the same percentage with microphthalmos. Notably, iris
coloboma was not present in any case.
Warburg (Warburg and Friedrich, 1987) postulated that the reason for autosomal
chromosome aberrations producing such a wide range of systemic malformations is
due to disturbance of the neural crest developmental field. The differentiation of the
neural crest cells is influenced by an environment in which (defective) non-neural crest
cells carry important genetic information.
Immense difficulty arises when performing literature searches on databases such as
The London Dysmorphology Database for inherited conditions or syndromes (Winter
and Baraitser, 1997) and a term such as microphthalmos is introduced as a search
feature or criterion. Microphthalmos encompasses so many diagnoses that the term is
a hindrance. The situation produced then requires consideration of several clearly
unsuitable diagnoses for that particular case, as very likely the previous literature will
have described at some time in the past 'a case of (almost any well-known or rare
syndrome) with microphthalmos'. Many of these case reports are worthy attempts to
further delineate or define well-known or barely recognised syndromes. However,
there is certainly the danger of artificially introducing new or incorrect diagnostic
criteria. Even with good clinical data it is not an easy task to recognise or clarify a
new syndrome (Baraitser and Winter, 1988).
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To illustrate this point one or two of the better-known microphthalmic syndromes are
discussed further.
The Lenz microphthalmos syndrome (Traboulsi et al. 1988): In 1955 Lenz (Lenz,
1955) described an X-linked malformation syndrome characterised by
microphthalmos, mental retardation, and aural, digital, skeletal and urogenital
abnormalities. Traboulsi (Traboulsi et al. 1988) reviewed the post mortem findings on
Lenz's original patient and reviewed the twelve cases recorded in the literature up to
that time, which included a description of two of their own cases. The first describes a
boy with bilateral colobomatous microphthalmos, head circumference/weight/height
all below fifth percentile, delayed mental development, abnormal ears, widely
interspaced teeth, small right hand with hypoplastic thumb and clinodactyly of left
toes. Mother had 'a number of similarly affected male relatives none of whom were
available for examination.' The second case described was a boy with bilateral
colobomatous microphthalmos (the published photo and dimensions would suggest
unilateral), ear abnormalities, conductive/neural deafness, imperforate anus and
hypospadias. The right hand had pre-axial duplication of the thumb, the left partially
so. The right foot had an appendage to the second toe and syndactyly of toes three
and four, the left foot syndactyly of toes two and three. Family history was
unremarkable. The authors are mistaken here, as firstly they have described two
patients, one of whom has a questionable family history and the other none at all. So
to state that the condition is X-linked (or familial at all) is incorrect. Secondly, the
two cases have few systemic features in common, either with each other, or with
Lenz's original description. What they do have is uveal colobomas with systemic
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abnormalities. Chromosome results were not stated for the first case; the other is
recorded as normal.
The postmortem findings from Lenz's original patient, who died of uraemia aged 28
years, included bicuspid aortic valve with mild coarctation of the aorta, aplastic left
kidney, ureter and renal vessels, hydronephrosis of right kidney, cryptorchidism, and
spina bifida occulta. The ocular features listed (translated from German) included
microphthalmos, microcornea with corneal diameter approximately 4 mm and cloudy
remains of lens. There is no mention of any type of ocular coloboma.
The authors (Traboulsi et al. 1988) summarised the systemic features in a table
showing some ten different categories, including 'other' anomalies. Closer
examination reveals that not only do the ocular phenotypes differ (including Lenz's
original case), but also only six of the cases in the table have any family history at all.
In summary, we have a poorly defined syndrome, of uncertain prognostic outcome.
Most of these cases are not definitely Lenz's syndrome, or any other syndrome for
that matter. For example, the proband of Hoefnagel et al (Hoefnagel et al. 1963)
listed in the table had bilateral clinical anophthalmos. The geneticist is therefore not
equipped with the quality of information required to make anything more than the
crudest assessment of recurrence risk.
The many publications (Francois et al. 1983) that have inappropriately adopted the
term microphthalmos would be impossible to list and discuss here: for example, the
MIDAS syndrome (Microphthalmos, Dermal Aplasia, and Sclerocornea), where the
phenotype is simply sclerocornea (Happle et al. 1993). It is possible that in some
cases microphthalmos has been diagnosed on the basis of finding blepharophimosis
(Happle et al. 1993). Similarly, the X-linked Nance-Horan syndrome (cataracts with
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distinctive dental features and characteristic facies) is distinguished by the ocular
findings of cataract, with microphthalmos or microcornea not being diagnostic criteria
(Walpole et al. 1990).
Microdeletions
The reporting of normal chromosomes (usually by G-banding) does not exclude
microscopic chromosome deletions that are now being recognised more frequently
(Shapira, 1998). The deletion or duplication may have been previously unrecognised
because the abnormality of the chromosome was not detected at the level of
resolution of standard chromosome analysis. The features of deletion and
microdeletion syndromes result from loss of one copy of a gene or genes contained
within the deleted segment. In some conditions, the deleted gene is dose-sensitive,
such that haploinsufficiency occurs because of only 50% activity coming from the
remaining copy of the gene. In other conditions, e.g. retinoblastoma, deletion of the
gene results in unmasking of recessive alleles or polymorphic variants in the remaining
copy of the gene. In some deletion conditions, the phenotype arises as a consequence
of loss of the only 'functioning' copy of an imprinted gene. Such a case exists in
Angelman syndrome, where the deletion is maternally derived.
Iris coloboma has been described in the Rubinstein-Taybi syndrome (Guion-Almeida
and Richieri-Costa, 1992), now considered to be caused by a microdeletion of
chromosome 16p 13.3 (Hennekam et al. 1993). However, in the paper by Hennekam,
none of the described affected subjects had structural eye abnormalities.
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Genetic aspects of coloboma
In chapter one the significance of coloboma as an ocular malformation was described,
as well as its frequent occurrence within the context of clinical microphthalmos.
Deliberately, no attempt has been made to distinguish coloboma from colobomatous
microphthalmos/macrophthalmos (Bateman and Maumenee, 1984) or from
colobomatous microphthalmos with cyst. Emphasis is placed on the structural
abnormality and not the (often subjective or arbitrary) assignment ofmicrophthalmos.
Mendelian inheritance of coloboma
In many of the cases described the ocular abnormalities vary extensively, from a
simple iris coloboma to clinical anophthalmos (Pagon, 1981).
Autosomal recessive: ocular abnormalities only (Pagon et al. 1981b).
Autosomal dominant: often with variable penetration and expressivity (Duke-Elder,
1964; Francois, 1968; Bateman and Maumenee, 1984).
X-linked: with microcephaly, short stature and mental retardation (Goldberg and
McKusick, 1971).
Incomplete documentation of ocular and systemic abnormalities, particularly in the
older literature, and over-reporting of families with particular forms of over or under-
expression, make it difficult to calculate the penetration (Pagon, 1981). Maumenee
empirically estimated the recurrence figures for the subsequent child of healthy
unrelated parents being affected with coloboma as 9%, and for the children of an
affected person as 46% (Maumenee and Mitchell, 1990). For all new cases, new
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sporadic mutations, reduced penetrance and non-genetic aetiology need to be
considered.
No single gene for colobomatous malformation has been identified to date. This is
understandable given the absence of large pedigrees and the lack of significance of
chromosomal aberrations as pointers in the search for a gene. Developmental fields
were briefly mentioned when anophthalmos and its presence in so many chromosomal
abnormalities was discussed. Developmental fields are body parts that can be affected
in an identical manner by different insults (genetic or environmental). Maumenee
(Maumenee and Mitchell, 1990) proposed that single gene defects exist which act in
the early stages of the developing embryo before definition of 'limb', 'axial' and
'ocular' fields. This mechanism would exist in parallel with the likely existence of
pathogens that may affect the different tissues during the sensitive developmental
period.
Many systemic associations are associated with colobomatous defects, as either part
of a chromosomal abnormality and/or clinical genetic syndrome. The extensive
overlap of these categories and poor understanding of their aetiology makes
classification difficult. The systemic malformations have been listed in several reviews
(Kriss et al. 1997) or case series (Leppig and Pagon, 1993) and are listed in OMIM.
As with microphthalmos, but much less so as the phenotype is relatively distinct, the
description of coloboma in some of these papers is questionable. For example, closer
inspection of the literature reveals that the 'retinal colobomas' described in Joubert's
syndrome, the most characteristic feature of which is neonatal tachypnoea, are in fact
macular hypoplasia and retinal pigment epithelium changes (King et al. 1984).
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Some of the chromosomal aberrations associated with coloboma include:
Trisomy 13 occurred in 33% of 18 cases (Taylor, 1968) and in more than half of the
cases reported by Hoepner (Hoepner and Yanoff, 1972).
Trisomy 18 is very rarely associated with coloboma (Mullaney, 1978).
Other types of chromosome rearrangement, including translocations (Friling et al.
1995) and inversions (Pallotta, 1991) are frequently reported.
The Cat Eye Syndrome is the association of iris coloboma with anal atresia (Cory and
Jamison, 1974). Patients have an extra acrocentric chromosome that is small and
abnormal in appearance. Additional major and minor congenital malformations occur
frequently.
Clinical genetic associations are non-random concurrences of several particular, but
variable, malformations which are not pathogenetically related, or which are not
known to have the same principal aetiology. Associations may be the result of
teratogens that act at a certain time on a certain area in a person who responds in a
certain way. Therefore, associations could represent embryological relationships and
timing, not specific causes. It follows that associations can have either a genetic or an
environmental aetiology.
The CHARGE association
It was Pagon (Pagon et al. 1981a) who proposed the acronym CHARGE, having
described 21 patients with choanal atresia, ocular coloboma or both, who had
associated anomalies. CHARGE = Coloboma, Heart disease, Atresia Choanae,
Retarded growth and development and/or CNS anomalies, Genital hypoplasia and Ear
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anomalies. The colobomas described ranged from iris coloboma without visual
impairment to clinical anophthalmos. A cause or pathological mechanism has yet to be
defined.
In conclusion, none of the many systemic malformation and dysmorphology
syndromes described with coloboma (whether accurate or not), as varied as focal
dermal hypoplasia (Goltz syndrome) (Temple et al. 1990) or the branchio-oculo-
facial syndrome (Fielding and Fryer, 1992) have contributed significantly to our
knowledge of how these eye defects arise.
Genetic aspects of optic nerve head type coloboma
Optic nerve head coloboma, in the absence of iris or retinal coloboma, was discussed
in chapter one. The developmental basis of this abnormality is unclear, and it is
uncertain whether it arises as a result of a defect in optic fissure closure. Autosomal
dominant inheritance has been well described (Savell and Cook, 1976). More recently,
dominant optic nerve coloboma and renal disease have been shown to arise as a result
of PAX2 gene mutations. (Sanyanusin et al. 1995). It is possible that PAX2 gene
mutations are responsible for isolated optic nerve coloboma (Cunliffe et al. 1998).
Summary, chapter 2
• Epidemiological data is of poor quality and inconsistent diagnostic criteria and
variation makes much of the data difficult to draw useful conclusion from. The
congenital malformation registers, in their present state, do not meet all the needs
for which they are now used, i.e. detailed scrutiny and statistical analysis of very
rare congenital eye disorders.
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Anophthalmos/microphthalmos and coloboma have features that suggest both a
genetic and environmental aetiology.
One cannot easily distinguish environmental from genetic causes. In a sporadic
case, significant similarities are present in the absence of an obvious 'genetic'
cause.
Genetic features of anophthalmos/microphthalmos include family histories
consistent with dominant, recessive and X-linked inheritance. Other genetic
features include the frequent association of these eye malformations with
chromosomal disruptions, clinical genetic syndromes and associations.
Environmental features of anophthalmos/microphthalmos include the sporadic
nature of occurrence, associated congenital malformations not fitting into a
recognised pattern or syndrome, the frequent description of occurrence with
teratogens, maternal drugs or maternal illness, and the wide variation of ocular
phenotype.
Bilateral and unilateral defects are equally common in genetic cases as in
sporadic/environmental ones. Unilateral pathology does not imply or increase the
likelihood of a genetic cause.
Microphthalmos has been overused in the literature when describing many
phenotypically distinct ocular abnormalities occurring in systemic syndromes.
The failure to define adequately anophthalmos/microphthalmos has made it difficult
to determine a cause.
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This chapter has concentrated on the environmental and genetic background of
anophthalmos/microphthalmos and coloboma. In chapter three, the use of mouse
genetics to explore human eye developmental disorders is introduced.
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CHAPTER THREE
SEARCHING FOR GENETIC CAUSES OF DEVELOPMENTAL EYE
DISORDERS IN HUMANS: MOUSE MODELS AND CANDIDATE GENES
'A human is like a mouse, only more so' (Erickson, 1989).
Much of the discussion in this chapter is based on mouse models of human genetic
disease. Mouse genetics is one of many approaches to finding the genetic basis of an
inherited condition. As with humans, the choice of inappropriate terms for phenotypic
description has not always been helpful and confusion does arise.
The proper investigation into a cause rests on establishing a phenotypic definition.
This is equally relevant whether searching for genetic or environmental causes. All
terms must be clearly understood, with no ambiguity. Names should be based on the
structural abnormality present and not be highly subjective or irrelevant to the defect.
This is not easy. Ocular malformations must be phenotyped and described in detail. It
may be useful or necessary to reclassify structural abnormalities to maintain
consistency with current and emerging understanding of development and the genetics
of development.
Searching for genetic causes of eye disorder in humans
By 'genetic' is meant locating a specific gene at a chromosomal location, in which a
gene mutation causes a particular eye abnormality either by itself or in combination
with other genetic or environmental factors
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To look for genetic causes, certain information is required. This information is listed
below and a possible sequence of events is illustrated in Figure 3.1.
1. A phenotype is identified, defined and classified.
2. The collection of tissue samples for DNA extraction from correctly
phenotyped affected individuals.
3. DNA analysis (methods/techniques below).
4. Localise gene i.e. link to specific chromosome region.
5. Sequence the gene.
6. Identify disease-causing mutations. In mice, these can be natural mutations or
experimental models with induced mutations. Human mutations are natural.
Failure on the first point, phenotypic definition and characterisation, can make
progress difficult or impossible.
A number of well-established methods (Box 3.1) can be used to determine whether or
not a disease has a genetic component and if so how to identify the disease-causing
gene. The classical method is where large pedigrees are available for gene mapping by
linkage analysis. These techniques work well for Mendelian-inherited (single gene)
eye diseases. Other approaches used are positional cloning and the candidate gene
approach. These techniques and their limitations are described briefly below.
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Figure 3.1 Summary and flow chart of some of the methods used to determine
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Box 3.1 Methods to determine the gene causing a disorder
1. Linkage analysis
2. Positional cloning
3. Position independent candidate gene
4. Positional candidate gene
5. Chromosomal deletions or rearrangements
6. Mutation analysis
1. Linkage analysis
Genetic linkage analysis is often the first step in identifying a disease-causing gene.
The aim is to compare, within a family, the inheritance of a disease gene with the
inheritance of specific DNA segments (markers). Co-inheritance of the disease
markers with the disease-causing gene links the disease (localises it) to a specific
chromosomal region (Musarella, 1992).
2. Positional cloning
Through linkage studies, a gene is located solely on the basis ofmap position (without
any knowledge of the gene's function). The genomic region implicated by the linkage
analysis is covered with a 'contig' (contiguous DNA clones) of genomic clones, which
may be cosmids, BACS (bacterial artificial chromosomes), PACS (PI-artificial
chromosomes) or YACS (yeast artificial chromosomes). Genes are identified from the
sequencing. All genes identified in the vicinity are considered as possible candidates.
3. Position-independent candidate gene
The gene is a candidate for the disease of interest. The disease gene is searched for on
the basis of the function or likely role of the protein involved, its amino acid
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sequence, or the biochemical or pathophysiological consequences. It may be that the
gene is expressed in the tissues of the affected organ. Unfortunately, for most eye
disorders, there is little information about the disease gene or its function. This
approach is discussed later in this chapter.
4, Positional candidate
Often, because so little is known about eye disease genes and their function, a
combined strategy may be used. A gene is mapped to a chromosomal region by
linkage analysis, and then attractive candidates in the area are surveyed. Some genes
mapping in that area may already be known, and sequencing can identify new ones.
This approach is considered further in the second half of this chapter.
5, Chromosomal deletions or rearrangements
These can help localise a gene by the occurrence of the disorder with the missing or
disrupted segment e.g. retinoblastoma and 13q 14, aniridia and 1 lp 13 (Churchill and
Booth, 1996). Once a genomic region has been implicated by a chromosomal
rearrangement, the same positional cloning or positional candidate approaches may be
used as for linkage. Some chromosomal rearrangements already described in
individuals with anophthalmos and colobomas are listed in chapter two page 68.
Chromosomal microdeletions were also discussed in chapter two.
6, Mutation analysis
The above methodologies merge into one another and are not always used in
isolation. They are summarised in Figure 3.1. The approach used for anophthalmos
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and microphthalmos and PAX6 (described in chapter nine) is 'pure candidate gene'.
Often, a combination of techniques is employed, based on increasing knowledge and
location of human genes.
Relative risk studies (chapter eight), which have not been done for
anophthalmos/microphthalmos and coloboma, estimate the risk to sibs versus the
general population, and can provide a measure of the genetic component.
There are several possible reasons why the genes causing human
anophthalmos/microphthalmos have not been localised:
1. To detect linkage, there needs to be a sufficient number of affected individuals
within a pedigree to provide the statistical power. This also depends on
inheritance pattern and the structure of the pedigree. Rarely are there sufficient
affected relatives in anophthalmos/microphthalmos.
2. Anophthalmos/microphthalmos does not always demonstrate the clear patterns
of Mendelian inheritance that typify single gene disorders. They are complex
traits, which may be due to multiple gene interactions or gene and environment
interaction.
3. The gene(s) responsible may have variable expression and penetrance.
4. There are possibly several genes which when mutated can cause
anophthalmos/microphthalmos but the phenotypes are lumped together, the
phenotype being way 'downstream' of the failed developmental step. Therefore,
it is difficult to assess from the phenotype the degree of involvement of different
genes.
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Some genetic aspects of eye development
Eye development involves two intertwined processes (Graw, 1996). One is an
ongoing series of inductive signals, which determines the initial architecture of the
major components of the eye. The other is the co-ordinated differentiation of these
components. The action of transcription factors and inductive signals ensures the
correct development of the different eye components. Some of the knowledge of how
genes control human eye development has come from studies in mice, when
spontaneous and induced mutations have been analysed. Mutations affecting the eye
can be easily identified and many mouse mutants have been described.
Before discussing some of these mouse mutants and the role of particular genes in
development of some eye structures (lens, retina, optic nerve), some of the
shortcomings, assumptions, and difficulties of using mouse models are considered.
Mouse models do not always replicate the human disease associated with the same
mutations. Erickson has suggested three general mechanisms why this is so (Erickson,
1989):
1. Different biochemical pathways between mouse and man, such as the human
inability to synthesise vitamin C. Different genetic defects may result in a similar
disease phenotype but the animal model is not a precise one, since the deletion or
elimination of an additional factor necessary for the regulation of other unlinked
genes could occur.
2. Different developmental pathways between mouse and man. The size difference
influences some developmental pathways: e.g. carbonic anhydrase (CA II) deficient
mice do not develop osteopetrosis like CA II deficient humans due to differences in
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bone remodelling. The different nervous systems in mice and man reflect variation
in neurodevelopment.
3. The fact that some pathological processes possibly occur at the same absolute rate
in man and mice instead of being related to life span. A time dependent rate of
onset may explain the mild phenotype ofmcbc; this is the probable mouse homolog
of the dystrophin locus, the human X-linked locus at which some mutations cause
the childhood onset of severe Duchenne muscular dystrophy, while others cause a
milder adult muscular dystrophy (Becker's). The symptoms in mdx hemizygous
mice suggest that the mutation has resulted in either a Becker-like disease with a
lifespan-related onset or a Duchenne-like disease with an absolute time-related
onset, since humans do not usually show symptoms until several years of age, a
length of time greater than the usual survival ofmice.
Although mice carrying mutations homologous to those causing human disease can
differ from their human counterparts, even imperfect models can be useful. This
subject will be discussed later in this chapter, and is well illustrated by previous work
on human and mouse paired box genes.
Aspects of early eye development relevant to anophthalmos and coloboma were
described in chapter one. It is to these particular aspects of genetics and eye
development that attention must be paid: development of the optic vesicle, optic cup,
and iris.
A brief description follows of some of the many mouse mutants in which the early
stages of eye development are affected (Graw, 1996). It is worth noting at this point
- 85 -
that the lack of rigour in defining ocular phenotypes is not confined to humans, and
that many of the names applied to the mice are also misnomers.
Eyeless (eyl, ev2).
Eyeless causes anophthalmos. Its chromosomal localisation is unknown. The
apposition of optic vesicles and surface ectoderm, a process thought to be critical to
lens induction, is affected. Homozygous eyl mutants have a smaller than normal lens
which is decentred from the optic cup.
The interaction between optic cup and overlying surface ectoderm is a very important
step in eye development, this interaction being affected in a number of mutants, as
well as in the Pax6/Sey mutation (see below).
Aphakia (ak)
Autosomal recessive mice mutants have an abnormal extracellular material form
between the lens and optic cup during invagination of the optic cup, with abnormal
deposits of material between lens epithelial cells. The rudimentary lens becomes
disorganised.
Head blebs (heb)
Heb mice produce abnormal or absent eyes due to prenatal blebs, usually on the head.
Myelencephalic blebs (my)
In mouse mutants with myelencephalic blebs, extracellular matrix forms between the
optic vesicle and overlying presumptive lens ectoderm. An increased concentration of
glycosaminoglycan in the extracellular matrix later causes rupture of the lens capsule.
Other defects affect the neural retina. By El4, the cornea and other structures of the
eye cannot be identified.
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Extra-toes (GU3)
Mice homozygous for the dominant mutation Extra-toes die perinatally with multiple
malformations of the eye and other organs. In one class of homozygote the
developing eye has distorted optic cups and small lens vesicles, and goes on to
develop coloboma and small eyes secondary to failure of optic fissure closure. In
another category the optic cup and lens placode are not formed and there is
anophthalmos (Franz and Besecke, 1991). The mutations have been mapped to
chromosome 13 and are due to a deletion within the gene GIi3, which is a
transcription factor and oncogene.
Small eye (Pax6) and ocular retardation (ChxlO) are described later in this chapter.
Having identified a mouse mutant, the next task is to determine which chromosome is
involved, the locus of any proposed genes, and the nature of any mutations
responsible for a particular phenotype. In addition, detailed knowledge of the
expression pattern of the gene products (proteins) at different stages of
embryogenesis is required.
Returning to GH3 as an example, this gene is a candidate for the autosomal dominant
human disorder Greig cephalopolysyndactyly syndrome (GCPS). Mutations in one
allele of Gli3 cause GCPS. Gli3 is widely expressed in human tissues and GCPS is
characterised mainly by post-axial Polydactyly of the hands and pre-axial Polydactyly
of the feet, craniofacial defects including macrocephaly and broad nasal root. Defects
in heterozygous mice are not dissimilar (Vortkamp et al. 1991; Hui and Joyner,
1993). Similarities between mouse and human mutants can lead to important
discoveries regarding the genetic aetiology of congenital eye defects, although in the
case ofGCPS there is no ocular abnormality.
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That the term microphthalmos carries no clearly defined meaning in mouse molecular
genetics is illustrated by consideration of the mouse microphthalmia (Mi) mutation.
The eyes of the mutants develop poorly (small or absent eyes) because of defects in
the retinal pigment epithelium, making the primary pathology abnormal retinal
development. Other cell types affected are the neural crest derived melanocytes,
which cause deafness due to lack of inner ear melanocytes. (Jackson and Raymond,
1994; Steingrimsson et al. 1994).
A human homologue has been identified for the mouseMi gene, referred to asMITF.
Mutations within MITF have been found in patients suffering from Waardenburg
Syndrome type 2, a dominantly inherited syndrome associated with hearing loss and
pigmentary disturbances such as a white forelock and iris colour defects. No
microphthalmia exists in this condition.
That microphthalmia is a descriptive term applied so frequently in mouse
developmental genetics, with little regard for the precise structural phenotype, is well
illustrated when some of the genes controlling development of the lens, retina and
optic nerve are considered.
As with humans, mouse eye conditions in which the primary ocular pathology is
abnormal lens, retina or optic nerve development may have (or appear to have)
smaller eyes, but only as a consequence of the primary ocular abnormality. The
question we should be asking ourselves is:
Is it 'microphthalmia' or 'something else with small eyes'?
Several other important mouse genes and their human counterparts illustrate this
confusion. Homeobox genes are important because they are highly conserved in the
animal kingdom. Two such homeobox genes are ChxJO and Pax6:
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Very small eyes are produced in mice homozygous for the gene ocular retardation
(or) (Truslove, 1962). It was noted subsequently that the most significant
morphological pathology was the effect on the neuroretinal layer, degeneration of
which somehow impairs the overall development of the eye. Ocular retardation is
caused by a mutation in the ChxlO gene (Burmeister et al. 1996). Although these
mice are microphthalmic, the primary pathology is probably within the bipolar cells of
the inner nuclear layer, along with absence of the optic nerves. This information was
ascertained by careful examination of the expression pattern of the ChxlO protein in
the developing mouse eye being localised to these cells. ChxlO will be discussed in
more detail in chapter nine.
Small eye: what's in a name? The Small eye mouse and Pax6
Pax6 belongs to the paired-like class of developmental genes first described in
Drosophila (Bopp et al. 1986). Mutations in the Pax6 gene cause mouse small eye
(Sey) (Hill et al. 1991). Sey is a semidominant mutation that in the homozygous
condition results in complete lack of eyes and nasal primordia. Heterozygotes have a
reduced eye size. However, of more significance may be the delayed closure of the
optic cup in embryos that alters the shape of the opening. There is little further
elaboration of the phenotypic description, and this is surprising, given that a more
precise description would almost certainly enhance our understanding of the function
of this gene and its protein, a transcription regulator. The other structural
abnormalities described in the small eye mouse are failure of or incomplete separation
of the lens from the cornea, lens abnormalities such as reduced size and vacuolation,
and reduced anterior chamber size. The word coloboma is used to describe the
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phenotype but, as is the case with clinicians in humans, the structural abnormality seen
has not been made clear. It is likely that the coloboma is some form of defect of the
iris or of the whole eye (Theiler et al. 1978). Observations on the small eye
phenotype show that the iris is thin and diaphanous, i.e. like tissue paper (Jordan et al.
1992). This is not too dissimilar to the human aniridia phenotype and illustrates the
point that small eye is a slight misnomer: a better term would be 'mouse aniridia' or
'mouse iris hypoplasia'. 'Small eye' tells us little, if anything, about the mouse ocular
phenotype.
In humans, mutations of the PAX6 gene cause aniridia (Ton et al. 1991; Jordan et al.
1992), as well as mutations being found in several other human eye conditions, each
having relatively indistinct phenotypes (Hanson et al. 1994). The PAX6 gene is of
fundamental importance to this thesis, and will be discussed in more detail in chapter
nine.
PAX2 is also a member of the PAX gene family, characterised by containing a paired
box of highly conserved genes first identified in Drosophila melanogoster. The human
PAX2 gene maps to chromosome 10q24-q25. PAX2 is expressed in the developing
eye and kidney. Heterozygous mutations of the PAX2 gene are associated with renal-
coloboma syndrome (Sanyanusin et al. 1995; Sanyanusin et al. 1995). However, the
phenotype associated with PAX2 mutations shows a great deal of variability and it is
possible that mutation ofPAX2 causes a proportion of isolated optic nerve colobomas
(Cunliffe et al. 1998).
The second part of this chapter concerns one of these techniques that may help to
identify the causative gene(s) for anophthalmos, microphthalmos and coloboma. This
is the candidate gene approach.
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THE CANDIDATE GENE APPROACH TO GENETIC AETIOLOGY
The different approaches to finding a genetic cause and locating a gene have been
outlined. This section is an introduction to the candidate gene approach. A more
detailed exploration of why particular candidate genes were selected is discussed in
methods and results (chapter nine). Included in this section is some discussion of the
current status of progress using the candidate gene approach and methodology.
How candidate genes can be used to consider the genetic aetiology: luck or
judgement?
Phenotypic similarities are one of the most important factors when using the candidate
gene approach to find the cause of a genetic abnormality. Identifying a disease gene
can start with the assumption of a candidate gene: a particular gene is hypothesised to
be the locus for the disease, and the hypothesis is then tested by checking for evidence
that the candidate gene is associated with the disease.
The candidate gene approach may be based on particular properties of the product of
the candidate gene which are consistent with its involvement in the pathogenesis, e.g.
by appropriate gene expression pattern in embryological tissue sections demonstrated
by in situ hybridisation against messenger RNA (mRNA). The candidate genes may be
suggested for some disorders without knowing the subchromosomal location of the
disease gene and/or candidate gene (position-independent candidate gene approach).
However, the confidence in a particular candidate disease gene is increased if it can be
shown to map to the same subchromosomal region as the disease gene (positional
candidate gene approach). An example of the positional candidate gene approach is
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the identification of the rhodopsin gene in autosomal dominant retinitis pigmentosa
(Dryja et al. 1990).
If an animal phenotype shows a striking similarity to a human disorder, then it might
result from mutations in the animal ortholog of the human disease gene. Knowledge
of the animal ortholog can be used to help identify and characterise the human gene.
This can then be tested for its involvement in the disease. The animal model may have
originated spontaneously or have been created artificially (X-ray or chemical
mutagenesis or gene targeting).
Mutations at more than one locus may produce the same clinical result. In some cases,
the phenotypes caused by mutations in different genes can be distinguished, in others
not (e.g. PAX6). If a gene is identified as the locus for one such disease, then genes
loosely related to it in sequence or function may be candidates for closely similar
diseases e.g. PITX2, PITX3.
Mouse models as an illustration of how to find the cause
Candidate genes can be used to establish the genetic basis and exact cause of
developmental eye disorders. Using knowledge gathered from other species-
Drosophila melanogoster and mice in particular, has made this possible. On
morphological grounds the relationship between the human eye and the Drosophila
eye is not immediately apparent, but from the developmental gene point of view, there
are several important genes that are similar in sequence, i.e. there is structural and
(probably) functional similarity. Such genes are highly conserved across several
species (human, Drosophila, mouse, zebrafish) and are thought to be 'protected' on
the basis of their fundamental importance.
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Many developmental genes contain a segment ofDNA called a homeobox. This DNA
sequence (motif) encodes a DNA binding motif called a homeodomain that controls
the production of mRNA by other genes at a precise time during development and
tissue differentiation. Mammalian PAX genes were given their name because of
sequence homology to the Drosophila segmentation gene paired (Bopp et al. 1986).
To date, nine PAX genes have been identified in humans (Traboulsi, 1998). The PAX
genes are characterised by a conserved DNA sequence, the paired box. Some PAX
genes, such as PAX6, also contain a homeobox. The PAX6 gene is homologous to
human aniridia, mouse small eye and Drosophila eyeless genes. The Drosophila
eyeless gene initiates eye formation (Haider et al. 1995).
Because of homology between humans, mice and Drosophila, PAX6 and other
conserved genes can be used to increase our understanding of the role of these genes
in eye development. Having a gene which when mutated naturally or experimentally
causes a known defect allows parallels to be drawn between different species and
organisms. PAX6 is therefore thought to have a fundamental role in the control of eye
morphogenesis and terms such as 'the master control gene' are frequently used
(Quiring et al. 1994; Haider et al. 1995). PAX6 gene function (normal and mutant
genes) can be studied in great detail by looking at its expression in various tissues
(which implies function of some sort) in relation to different stages of development
(Walther and Gruss, 1991; Nishina et al. 1999). The gene can be manipulated in
Drosophila (Haider et al. 1995) or mice (Schedl et al. 1996); the production of
model mutants or 'knockouts' furthers understanding of gene and protein function.
However, one must be aware of the limits of the conclusions that can be drawn from
such experiments (see earlier discussion in this chapter).
■ 93 -
Therefore, the genes conserved in Drosophila and vertebrates such as mice are likely
to be of great importance in human eye development. One then hopes to find or
demonstrate naturally occurring eye mutations with a phenotype that is recognisable.
Not all eye development genes fit these criteria, as the human gene may not have been
discovered or recognised, but those that do are most amenable to intense study. Such
genes are the first to become candidates for human eye conditions. It is likely that
humans and mice have many important eye development genes that have not been
found, or which are involved in other aspects of development e.g. Rx in Drosophila
(see below).
There is a huge number of developmental genes recognised in Drosophila, mice and
other vertebrates, whose function in humans has yet to be fully elucidated and which
are the subject of intense interest and speculation. Examples are Six3, a murine
homolog of the Drosophila sine oculis gene (Oliver et al. 1995), the Rx homeobox
gene which is conserved in Xenopus and mice (Mathers et al. 1997), and mouse Hox-
7.1 and Hox 8.1 which are related to the Drosophila Msh-like family (Monaghan et al.
1991). The Soxl gene is important in lens development, partly through its action on y-
crystallin gene expression. When homozygous mice have been targeted with
mutations they are microphthalmic with abnormal and opaque lenses (Nishiguchi et al.
1998), yet another example of what is primarily a lens problem manifesting as the
'microphthalmos' phenotype.
Therefore, the first group of candidates are those mouse eye development genes in
which naturally occurring eye mutations occur with a recognisable phenotype, and in
which the orthologous human gene is known and mutations may have been identified
(Table 3.1).
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In the second group (Table 3.2) one can include mouse and vertebrate eye
development genes in which the orthologous human gene is not yet known or in
which human mutations have not been described. This table excludes several mouse
mutants (described earlier, page 84) with no gene identified e.g. myelencephalic
blebs. Listed in Table 3.2 are the strong candidate genes.
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Table 3.2: Eye development genes with mutations in mouse but no human
mutation or phenotype



























Not known Not known
Anterior Segment Dysgeneses
The embryology of the anterior segment was described in chapter one. Anterior
segment dysgenesis (mesenchymal dysgenesis) is a group of closely related
developmental eye disorders, with some overlap of phenotypic features (Churchill and
Booth, 1996). Axenfeld, Peters' anomaly, Rieger's anomaly, and sclerocornea are all
thought to be due to faulty migration or function of neural crest cells. Peters' anomaly
is characterised by congenital corneal opacity with underlying defects in the posterior
corneal stroma, Descemet's membrane, and endothelium. Iris synechiae are frequently
present, passing from the collarette to the periphery of the corneal opacity, as well as
keratolenticular strands. Half of patients with Peters' anomaly develop early onset
glaucoma. Rieger's syndrome consists of Rieger's anomaly plus facial and systemic
abnormalities: maxillary hypoplasia, hypodontia and peg shaped teeth, and
periumbilical hernia.
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The genes for anterior segment dysgenesis are autosomal dominant, fully penetrant,
and variable in expressivity. All four anterior segment iris-hypoplasia disorders result
in glaucoma in over half the cases.
The nomenclature and terminology used in describing the various anterior segment
dysgeneses is (understandably) confusing. This stems from the fact that there is
extensive phenotypic overlap (Shields et al. 1985). To further complicate the picture,
genetic heterogeneity is now becoming apparent as more genes are identified and
implicated as the cause underlying these eye defects.
Whilst the genes PITX2, PITX3 and FKHL7 may not be the cause of anophthalmos or
microphthalmos, the extensive phenotypic overlap and variable expression of this
group of developmental eye anomalies and the complexity of their genetics is well
documented. Some of the findings are summarised below, with abbreviations in Box
3.2.





Both IGDA and ARA map to the same chromosomal location, 6p25, and are
therefore possibly allelic (Gould et al. 1997). There is also the possibility that two or
more genes are located at 6p25 and that mutations of the different genes underlie the
related ARA and IGDA phenotypes. A major locus for development of the anterior
segment of the eye, IRID1, is therefore located at 6p25. FKHL7 (FOXC1), a member
of the evolutionarily conserved forkhead/winged helix transcription factor gene
family, has been mapped to 6p25. Mutations of this gene have been identified in some,
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but not all, patients with Axenfeld-Rieger Anomaly. An additional locus involved in
eye development is probably located at 6p25 (Mears et al. 1998).
The ARS gene has been mapped by linkage to 4q25 and mutations of this gene,
PITX2 (RIEG), a homeobox transcription factor gene, underlie the phenotype
(Semina et al. 1996). IGDS has been mapped to 4q25 so this again raises the
possibility that ARS and IGDS are allelic variants of the same disorder (Walter et al.
1996). A second locus for ARS has been mapped to 13q 14 (Phillips et al. 1996).
PITX3 is a human homeobox gene and is the human homologue of the mouse Pitx3
gene (Semina et al. 1998). It is a member of the RIEG/PITX homeobox gene family,
and mutations have been found in families with anterior segment dysgenesis.
It is worth remembering here that the genetic aetiology of the anterior segment
dysgeneses is not so straightforward, as PAX6 mutations have been identified in some
cases of Peters' anomaly (Hanson et al. 1994) (see chapter nine, PAX6).
Summary, chapter three
• Several different approaches to finding a genetic cause of eye malformations have
been introduced. The reasons why these have not been fruitful or applicable to
anophthalmos, microphthalmos and coloboma have been discussed.
• There is some overlap and misuse of terms used to describe different ocular
phenotypes in mouse developmental eye disorders. This can make comparisons
with the homologous human eye condition difficult.
• Some mouse eye anomalies and the associated gene have been described.
• Homeobox genes and the PAX6 gene have been introduced.
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• The candidate gene approach has been introduced. Some of the eye development
genes with (natural) mutations in mouse and humans that could be investigated in
this way have been listed. An important point is the similarity between an animal
(usually mouse) phenotype and a human eye disorder.
This chapter has been an introduction. In the second half of this thesis, the practical
application of the candidate gene approach on a phenotypically well-defined
population is described is (chapter nine). The next chapter describes the methods used
to obtain such a population.
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CHAPTER FOUR
MATERIALS AND METHODS: OVERVIEW
'Mystery ofbabies with no eyes'
The Observer, January 1993 (Paduano et al. 1993)
In the introductory section, chapters 1-3, four key points were raised which form the
main arguments of this thesis. In this second part, divided into six chapters consisting
of four parallel studies, the data collected will be examined with reference to the four
arguments. Each chapter and study is distinctive enough to stand alone with its own
background, methods, results and discussion.
The introductory arguments in chapters 1-3 were:
1. Anophthahnos/microphthalmos have not been defined adequately (chapter
one). The case was argued that there is no satisfactory definition. Data presented in
chapter seven, the classification of the eye defects, and chapter eight, the study on
axial length and corneal diameter, will demonstrate this.
2. Anophthalmos/microphthalmos and coloboma have features that suggest
both genetic and environmental aetiology (chapter two). Data presented in
chapter six (description and classification of eye defects) and chapter eight
(systemic abnormalities, family history, recurrence risk) will reinforce this
argument.
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3. The correct investigation for any cause rests on establishing a
structural/phenotypic definition (chapter two). A classification based on a
phenotypic definition is described in chapter six.
4. The candidate gene approach can be used to consider the genetic aetiology of
anophthalmos/microphthalmos and coloboma (chapter 3). These investigations
are described in chapter nine for PAX6 and CHX10.
Background and history
In 1996 the Scottish Office Department of Health (Chief Scientist's Office) provided
the funding for a two-year study into anophthalmos and microphthalmos in Scotland,
The Scottish Microphthalmia Study. The chief investigator and grant holder is Dr
Harry Campbell (Grant number K/OPR/2/2/D303).
The origins of the study date back to 1985, when the Scottish Home and Health
Department produced the Bonnybridge/Denny Morbidity Review (Lenihan, 1985). In
1983, a farmer living near Denny (north west of Glasgow) reported unusual morbidity
in his herd of dairy cattle. The farmer attributed this problem to atmospheric emission
from a nearby chemical waste incineration plant (Re-Chem International Ltd). The
chemical incineration plant was disposing of polychlorinated biphenyls (PCBs). In
1984, there were complaints by the public about the emissions having an adverse
effect on their health. In May 1984 the figures for cancer registrations in the area of
Stirlingshire covering the towns of Bonnybridge, Denny and Larbert were published in
the press, showing an apparently greater rate of increase of cancer in this area (1977-
81) than in Scotland as a whole. It was later in 1984 that two babies were reported as
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being born within four weeks of each other, to parents living within a mile of each
other, with similar but rare congenital eye defects.
In view of the public concern about these reports, on 26 June 1984 the Secretary of
State for Scotland (House of Commons, 1984) set up an independent review of
morbidity in the Bonnybridge/Denny area under the chairmanship of Professor John
Lenihan:
To review any unusual features of morbidity recorded in the Bonnybridge/Denny
area and in the surrounding district; to take full account of other available studies
of statistical variations in morbidity in areas of comparable size; to report on the
significance of any abnormal findings and on any other relevant information that is
available; and to advise whether further studies are required.
From 1976-1983 in the area studied (population 38,000) there was one reported case
of microphthalmos, which was not particularly unusual, plus two recent cases of
microphthalmos/anophthalmos in 1984. Three further cases were outside the study
area but within the Forth Valley Health Board area between 1981 and 1984.
Comparing this data with a 79% sample of Scotland as a whole, it was considered that
the number of cases was 'sufficiently striking to merit further investigation' and that
'in view of the absence of an established cause in most cases ofmicrophthalmos which
have been reported in the literature, we suggest the possibility of hitherto
unrecognised environmental factors should also be examined by comparing the
incidence ofmicrophthalmos in the Forth Valley Health Board area with the incidence
in other areas where similar environmental conditions are likely to exist.' Although
hospital consultants and general practitioners did not report unusual morbidity other
than the incidence in 1984 of microphthalmos, it was advised that the full data for
1983 onwards should be monitored (Lenihan, 1985).
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In 1984 in South Wales there was similar public concern about the Re-Chem
industrial waste plant at Pontypool. The Secretary of State for Wales immediately
instructed Welsh Office officials to examine health data for the Torfaen area, which
lies within Gwent, similar to that which had been examined and published by the
Scottish Office for the Denny/Bonnybridge area. The recorded incidence of
anophthalmos and microphthalmos (1974-83), derived from OPCS notifications and
Welsh Hospital Activity Analysis system (HAA), was lower than that for Wales as a
whole. No cases were revealed for Torfaen (Welsh Office, 1985).
In response to the recommendations of the Lenihan report, in 1988 the Scottish Home
and Health Department reported on microphthalmos in the Forth Valley Health Board
Area (Scottish Home and Health Department, 1988). This was a working party under
the chairmanship of Professor J. Strong. Prevalence data in the Forth Valley for
microphthalmos, congenital cataract and coloboma were compared with five other
health board areas. The data was obtained from several sources to maximise case
ascertainment (Busby et al. 1998). The prevalence rate for microphthalmos in the
Forth Valley (1971-1985) was comparable to the other areas. No clustering of cases
was observed in the area of the chemical incineration plant. The highest prevalence
rate occurred in Greater Glasgow, an area with the most highly organised recording
system. The study concluded that the available data did not allow a firm conclusion to
be drawn about the occurrence of microphthalmos in Forth Valley compared with
other areas of Scotland. Of equal significance in the conclusion was that the
difficulties of collecting sound information on a relatively rare and untreatable
congenital abnormality affecting a small but very visible organ were clearly
demonstrated. The present surveillance system in the neonatal period identified less
- 105 -
than a third of cases of microphthalmos and there was no national system for the
consistent reporting of congenital abnormalities recognised after the neonatal period.
In 1993, newspaper reports (Paduano et al. 1993) of an apparent cluster of children
with anophthalmos/microphthalmos or coloboma in North East Fife prompted an
investigation by the Fife Health Board (Rowarth, 1995). The birth prevalence, using a
variety of information sources, was relatively high, there being 22 cases observed
against the 15 expected for the period studied (1981-1993). This report
recommended further local study and continued monitoring of the birth prevalence of
coloboma and/or microphthalmos in Fife.
The study on which some of this thesis is based came about as a result of continued
public anxiety and some of the recommendations of the Forth Valley Area and Fife
Health Board Reports (Scottish Home and Health Department, 1988; Rowarth,
1995). It was recommended that there should be continued monitoring of the birth
prevalence of anophthalmos/microphthalmos and coloboma, and that data be recorded
in such a way as to allow identification of cases notified from more than one source.
The Scottish Microphthalmia Study was the name chosen for this project, which was
approved by all the relevant local research ethics committees and health boards. The
Scottish Microphthalmia Study set out to achieve a number of objectives:
1. To identify all the cases of microphthalmos, anophthalmos, and coloboma (MAC)
in Scotland from 1/1/81 to 31/12/96, using multiple sources of information. This
was to include live births and stillbirths. The result would allow calculation of the
birth prevalence.
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2. It was hoped that if sufficient cases were identified, that the data would provide the
basis of a future case control study into environmental aetiology (principal
investigator and grant holder Dr Harry Campbell, University ofEdinburgh).
3. To develop a simple case definition for registration purposes, applicable and
understandable by non-specialists.
4. To consider the validity of defining microphthalmos based on axial length of the
eye.
5. To produce a case register and get it established and running.
6. To examine clinically as many cases as possible and confirm or make an accurate
ocular diagnosis, as well as documenting any systemic anomalies.
7. Where clinical examination is not possible, to confirm the ocular diagnosis as
accurately as possible using case records and notes.
8. To examine the distribution of MAC in Scotland for the period 1981-1996
inclusive.
9. Where possible, to extract DNA from blood samples or mouthwashes, and to
examine this DNA for mutations in the PAX6 gene. In selected cases, to establish
lymphoblastoid cell lines in Edinburgh or at the European Collection of Animal and
Cell Cultures (ECACC) in Wiltshire, England for storage and transformation.
10.To calculate the recurrence risks for inheritance of anophthalmos, microphthalmos,
or coloboma, for the purpose of counselling.
11.Collaborative studies: to examine selected DNA samples for CHX10 mutations
(Professor R. Mclnnes, Toronto, Canada). Other candidate genes identified by
laboratories willing to undertake the analysis would also be considered.
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Multiple sources of information were used for a number of reasons, the primary aim
being to capture the entire population. This method provided data for further studies:
(i) To compare the accuracy and completeness of ascertainment for the different
sources, and the completeness and quality of data held at the Information and
Statistics Department (ISD) Scotland. Comparisons would also be made against the
data from local registers, when permissible, such as the Glasgow Eurocat register.
(ii) To estimate by capture-recapture analysis the total population ofMAC.
The following sources of information were used:
1 The Scottish Morbidity Record (SMR1, SMR10 and SMR11)
The data was provided with the permission of ISD Scotland, consisting of a list of
263 names. The SMR11 is the neonatal discharge record, SMR1 the hospital inpatient
statistic, and SMR10 is the school health service medical record. This data was
provided by ISD. Eye disorders are coded according to the World Health
Organisation (WHO) International Classification of Diseases (ICD) 9. A search was
made under the three codes: 743.0, 743.1 and 743.4 (Table 4.1). The search could
have been extended to include 743.5 (congenital anomalies of the posterior segment)
but the likelihood of this diagnostic code picking up any additional cases of true
fundus coloboma would be almost nil (see chapter six results, eye findings), the more
likely outcome being a huge number of 'false positives' from other unrelated
conditions. Some of the conditions confused with fundus coloboma of the uveal tract
were discussed in the three introductory chapters of part 1. Some of the conditions
causing false positives are listed in the results section, chapter six.
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Data from ISD Scotland included the following:
Case ID number
Surname
Case reference number: a code unique to hospital's record system
Sex (1 for male, 2 for female, 9 for unspecified)
Date of birth
Outcome description: alive, died 1-23 hours, died 1-6 days, died 1-3 weeks, stillbirth
Postcode
Hospital code
Area of residence (health board)
Diagnostic code (ICD-9): up to 12 codes listed
Contact with all children and their parents was always with the consent of the General
Practitioner. This was important for several reasons, since the GP would be in a
position to confirm that the child's date of birth and address were correct, that the
child was still alive, and also make us aware if there were any special circumstances
which might prevent the child taking part in the study, e.g. social or multiple health
problems. The GP would also, from their records, confirm the ocular diagnosis. The
child's address and the GP's name and address were identified by contacting the
relevant health board. Letters to GPs were sent with reply-paid envelopes.
Individual children were traced systematically by a number of different methods.
Closer inspection of the ISD tables and subsequent letters showed that errors in the
recording of data, e.g. incorrect date of birth, misspelling of surname and duplicate
entries, had occurred. This did create major problems in some cases. Other difficulties
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were changes of surname, such as the child being recorded under the mother's maiden
name rather than her married name.
Following a reply from the patient's GP, a letter was sent to the child's parents
inviting them to take part in the study, with written consent forms for both parents
and the child. All letters included reply-paid envelopes.
An appointment letter was then sent to the parents and child for examination at their
local or nearest ophthalmology department, or at home in some cases. Use of
ophthalmic outpatient clinics all over Scotland was by permission of the local hospital
consultants and NHS trusts management.
Non-responders
All non-responders were sent a second letter by recorded delivery.
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It is apparent that no specific code exists for every eye condition, and that the same
condition may be coded differently. However, the search is wide enough to cover all
the conditions in which the malformations of anophthalmos, microphthalmos or uveal
coloboma might be the diagnosis.
ICD-10 (Table 4.2) is now in use (since April 1996) (World Health Organisation,
1977) and whilst this represents an improvement in terms of diagnostic specificity and
more detailed coding (e.g. coloboma of iris has its own unique code), there is still
overlap between the different codes.
Ill •
Tab e 4.2: Classification of congenital eye anomalies (reproduced from ICD-10)












Excludes: macrophlhalmos in congenital glaucoma
Q13 Congenital malformations of anterior segment of eye
Q13.0 Coloboma of iris
Coloboma not otherwise specified
Q13.1 Absence of iris
Aniridia
Q13.2 Other congenital malformations of iris
Anisocoria, congenital
Atresia of pupil
Congenital malformation of iris not otherwise specified
Corectopia
Q13.3 Congenital corneal opacity
Q13.4 Other congenital corneal malformations




Q13.8 Other congenital malformations of the anterior segment of eye
Rieger's anomaly
Q13.9 Congenital malformation of the anterior segment of eye,
unspecified
Q14 Congen ital malformations of posterior segment of eye
Q14.0 Congenital malformation of vitreous humour
Congenital vitreous opacity
Q14.1 Congenital malformation of retina
Congenital retinal aneurysm
Q14.2 Congenital malformation of optic disc
Coloboma of optic disc
Q14.3 Congenital malformation of choroid
Q14.8 Other congenital malformations of posterior segment of eye
Coloboma of fundus
Q14.9 Congenital malformation of posterior segment of eye, unspecified
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2. Ophthalmologists
A letter was written to each of the 75 consultant ophthalmologists in Scotland. The
list was obtained from ISD Scotland.
3. Paediatricians
A letter was written to each of the 138 consultant paediatricians in Scotland. The list
was obtained from ISD Scotland.
4. Clinical geneticists
A letter was written to each of the eight consultant and senior registrar clinical
geneticists in Scotland.
5. Pathologists
A letter was written to each of the consultant pathologists in Scotland. The list was
obtained from ISD Scotland.
6. Publicity campaign
A press release was issued in February 1997 via the University of Edinburgh to
publicise the research. Dr Harry Campbell was interviewed on the two main Scottish
evening news terrestrial TV channels, as well as on Radio Scotland. Articles appeared
in the Herald and the Edinburgh Evening News (Robertson, 1997).
7. Micro and Anophthalmic Children's Society (MACS)
This national support group was written to and informed of the study. Parents and
children who contacted us were volunteers with fully informed consent.
8. Directors of education of special schools
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For each health board, the directors of education of all special schools for all the
Scottish local education authorities were contacted. The 34 head teachers and/or
official correspondents of the grant-aided special needs schools were contacted.
9. Blind registration data (BP1)
Record cards were searched by hand for two health boards (Lothian and Borders).
10. Glasgow ophthalmology outpatients
Permission was granted from the Sick Children's Hospital in Glasgow to search the
diagnostic codes (ICD-9) for the outpatient clinics.
11. Glasgow Department of Clinical Genetics
Access was granted to search the computerised database and examine records of
patients seen with eye complaints within this department.
12. Royal Blind School, Edinburgh
With permission, the records were searched of Scotland's only blind school, with
further assistance from the medical (Dr Brian Fleck, Consultant Ophthalmologist,
Royal Infirmary of Edinburgh) and nursing staff. Subjects were contacted via their
GP
13. School clinical medical officers
A total of 59 school clinical medical officers were written to.
Data Collection
Data collection form
Because of the wide brief of the study, the data collection forms had to be developed
to serve many purposes. The forms were also to be used in cases where information
may have been extracted from medical case notes, such as in neonatal deaths.
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Therefore, some of the questions asked may at first glance seem irrelevant (some
examples are given below). A copy of the 17-page data collection form is in the
Appendix.
Features of note on the data collection form:
Page 1: The study was on children born in Scotland. Both the address at birth
registration and the hospital of birth were included (page 3).
Page 3: Mothers were specifically not asked about illnesses before or during
pregnancy or medications taken in order not to prejudice the validity of the
questionnaire for the future case control study into environmental factors.
Study identification number
All children notified to the study were assigned a unique identification (ID) number.
Photographs
Where possible, and with written consent, each child had a basic set of photographs
taken: eyes, face, profile, hands and feet. Additional photographs were of any
congenital anomalies noted and to confirm/make any difficult diagnoses or
dysmorphological comments (Dr David FitzPatrick, Clinical Geneticist).
Blood samples and mouthwashes
Where possible, and with written consent, a sample of venous blood was withdrawn
for DNA extraction and/or to create a lymphoblastoid cell line (see chapter nine). In
some cases, blood was also sent for chromosome analysis. Alternatively, a mouthwash
was obtained for DNA extraction from buccal mucosal cells (see chapter 9).
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Ultrasound scans
Where possible, an ultrasound B scan was done to determine the axial length of both
eyes. The measurements were taken as part of an investigation into eye size and the
definition ofmicrophthalmos (chapter seven).
Not all hospitals or clinics had ultrasound B scanners available; scans were done in
Edinburgh (Princess Alexandra Eye Pavilion), Dunfermline (Queen Margaret's
Hospital), Glasgow (Yorkhill), Dundee (Ninewells), Aberdeen (Royal Infirmary). In
Glasgow, the late Dr Anne Hollman, Consultant Radiologist, did B scans in the X-ray
department.
Ocular diagnosis
Children were recruited into the study based on a prior medical diagnosis of
anophthalmos, microphthalmos, or coloboma. On completion of the eye examination
or review of medical notes, an accurate phenotypic clinical diagnosis was made if
possible. In some cases, this meant excluding the child from the study on the basis of
the eye abnormality not being clinical anophthalmos, microphthalmos, or coloboma.
The colobomas did include both uveal and optic nerve 'colobomas' (see chapter one).
Based on knowledge before the start of the study, the following congenital eye
conditions were excluded (Box 4.3):
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Box 4.3: Congenital ocular malformations associated with microphthalmos (see










The ocular diagnosis and reasons for exclusion were documented. The collected data
is summarised in the next chapter (results, chapter five).
DISCUSSION
The methods used to collect the data were as comprehensive as possible, from as
many sources as could be identified. Blind registration data was searched through for
only two health boards. These records had to be searched manually and the pick up
from this source is extremely low since only bilaterally affected cases with low vision
are listed (see chapter two) (Evans, 1995). Additional cooperation from some regions
or departments (e.g. Glasgow) did not necessarily produce further cases.
There are difficulties with using different sources, some of which are national and
some local. Not all sources have an equal chance of identifying an affected individual.
The clinical examination and review of medical records ensured that duplicate dates of
birth or errors resulting from changes of name were eliminated, thus avoiding multiple
inclusion of the same individual. Some of these issues are considered in a separate
publication (Campbell et al. 2002).
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Summary, chapter four
• There have been major concerns about chemical hazards being a possible
cause of congenital eye anomalies in Scotland since 1983 when a farmer in
Bonnybridge noticed some increased morbidity in his cattle.
• The Scottish Microphthalmia Study arose from continued public anxiety and
some of the recommendations of the Forth Valley Area Report and Fife Health
Board Report, which recommended that there should be continued monitoring
of the birth prevalence of anophthalmos/microphthalmos and coloboma.
• The multidisciplinary nature of the study is emphasised.
• An outline of the methods of case ascertainment is described, followed by the
methods of data collection and documentation.




'Future epidemiological studies on anophthalmia and microphthalmia should
include the detailed ophthalmological and dysmorphological assessment of affected
patients and their families to define cases accurately and identify those of known
cause. Such assessment would also provide the opportunity to investigate
chromosomal and genetic factors, with potential benefitsfor genetic counselling and
antenatal diagnosis.'
(Gilbert, 1993)
This thesis was the first national clinical population study of
anophthalmos/microphthalmos and coloboma.
Summary
A total of 152 Scottish children were clinically examined. Of these, 122 were included
in the study and this group formed the subset for detailed analysis. A further 61
children are believed to be affected, based on examination of clinical records.
The total number of children affected is believed to be 183.
135 children were excluded from the study, based on clinical examination or detailed
review of records.
The combined minimum birth prevalence of anophthalmos, coloboma and
microphthalmos in Scotland for the period 1981-1996 was 1.19 per 10,000 live
births. This birth prevalence increases to 1.98 per 10,000 if the cases not clinically
confirmed are included.
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There were seven children with clinical anophthalmos. The birth prevalence of
anophthalmos for the period 1981-1996 was 0.68 per 100,000 live births.
Birth prevalence was highest in the health board region ofFife (2.59 per 10,000).
Birth prevalence was lowest in the Western Isles (0 per 10,000).
28% of children were registered as blind. More than half of the children aged three or
over had special educational needs.
RESULTS
The study continues to add names to the database. The database is continuous and
allows diagnoses to be verified clinically and not to be based solely on medical notes
(general or ophthalmic records).
At the end of February 1999, 338 ID notifications of possible cases were in the
database (Table 5.1). The total number of affected children assigned an ID number by
the end of February 1999 was 203. The total number excluded from the study by the
end of February 1999 was 135. All children were born between 1 January 1981 and
31 December 1996. The breakdown was as follows and is summarised in Figure 5.1.
Table 5.1: Status of 338 notifications to study in February 1999
Total mm
Excluded from study 135
Clinically examined 122
Medical records only, not clinically
confirmed
61
SMR coding only 11
Insufficient records/uncertain diagnosis 8
Born 1997 1
120
Figure 5.1: Status of 338 notifications to study in February 1999
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□ Excluded
□ Clinically verified cases
□ Medical records only, not
clinically verified





123 cases were examined in detail by the author. One child, ID 271, was bom in 1997
and was examined because the referring consultant was particularly interested in the
study. This child is included in the table but not in any analysis of prevalence. Some
clinical information is used from this case.
The 122 children form the subset that was subjected to detailed analysis.
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In another 61 cases in which only records were available, the notes were examined by
the author (DM) (Table 5.2).
Table 5.2: Ocular diagnosis by records only
ill Oate of birth Ocular diagnosis from records; comments
2 22 September 1983 right iris coloboma
10 17 December 1988 optic disc coloboma
12 26 October 1990 bilateral iris coloboma/cataracts; Patau's syndrome
(trisomy 13)
13 22 January 1992 left ocular malformation and retinal atrophy
21 28 July 1991 bilateral iris/fundus colobomas; microcephaly,
phenylketonuria
25 26 July 1991 right iris and simple retinal coloboma
27 04 July 1985 bilateral iris and simple retinal colobomas; multiple
congenital anomalies
28 23 June 1990 coloboma left iris, sib affected (ID 32)
31 31 August 1987 bilateral microcornea/microphthalmos, corneal opacities,
7PHPV
32 08 November 1985 bilateral uveal coloboma, right microphthalmos; sib
affected (ID 28)
46 28 September 1993 optic disc colobomas; CHARGE association
49 29 October 1991 right cataract/microphthalmos, retinal pigment/scar;
foetal varicella
56 12 May 1989 left iris and retinal coloboma
68 09 April 1994 right iris coloboma, bilateral retino-choroidal coloboma;
microcephaly
71 26 November 1985 bilateral iris and right retinal coloboma
72 29 December 1987 bilateral anophthalmia; delayed development
74 03 July 1989 right cataract with microphthalmos, squint
78 16 April 1994 bilateral uveal/fundus colobomas/microphthalmos;
CHARGE association
82 25 May 1990 right microcornea/microphthalmos, detached retina
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(}) Date of birth Ocular diagnosis from records; comments
88 09 July 1995 right iris coloboma
95 18 February 1994 small right eye, no vision right eye, cataract
103 02 January 1987 microphthalmos (congenital toxoplasmosis)
108 14 November 1991 bilateral colobomas/microphthalmos, right enucleation
112 14 November 1992 bilateral optic nerve head colobomas
116 07 February 1984 right microphthalmos
118 17 May 1988 right chorioretinal scarring and inferior coloboma
128 10 January 1996 bilateral uveal coloboma, microphthalmos;
CHARGE/VATER association
130 29 May 1983 bilateral iris colobomas only.
136 23 November 1984 right microphthalmos
139 04 August 1996 complicated microphthalmos
149 28 February 1990 left iris/fundus coloboma
154 01 May 1994 right iris and fundus coloboma; spina bifida
157 29 March 1981 a 'degree' ofmicrophthalmos, fetal alcohol syndrome
160 03 August 1982 left microphthalmos
161 05 May 1983 bilateral iris and fundus colobomas, detached retina
163 29 July 1996 microphthalmos
173 16 May 1991 bilateral microphthalmos; bilateral acetabular dysplasia
176 28 March 1992 bilateral aphakia, right squint, microphthalmos
184 10 July 1995 left coloboma
191 15 October 1994 right microphthalmos
193 08 May 1981 small right eye, coloboma
195 14 March 1983 left iris/fundus coloboma; delayed development,
dysmorphic
196 07 December 1983 bilateral fundus coloboma/microphthalmos; patent
ductus arteriosus, delayed development
198 07 July 1983 coloboma right eye
207 25 June 1996 left iris coloboma
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ID Date of birth Ocular diagnosis from records; comments
208 25 February 1982 cataract, superior left iris coloboma, microphthalmos
211 11 July 1981 microphthalmos; ventriculoseptal defect
227 17 January 1984 bilateral retinal dysplasia; microcephaly
229 09 February 1987 left microphthalmos 7PHPV
231 10 August 1985 right retinal coloboma, left microphthalmos
248 16 July 1994 bilateral optic disc coloboma
266 21 October 1992 left eye coloboma
278 23 August 1991 right microphthalmos
281 27 July 1996 left iris/fundus coloboma; congenital heart disease
289 06 April 1993 left squint, microphthalmos
291 03 December 1995 bilateral iris/chorioretinal coloboma
341 08 July 1993 right iris/optic disc coloboma. left hypoplastic disc
343 25 March 1995 small retinal coloboma left eye
344 13 July 1995 left inferior chorioretinal coloboma
348 03 July 1996 iris coloboma; Noonan's syndrome
352 07 July 1989 right retinal dystrophy, microphthalmos
In 11 more cases, the diagnosis was derived only from the diagnostic coding, and was
not verified clinically or from records.
A further 8 cases were referred from other sources, or the GP replied but with
insufficient or no clinical data.
Total 122 + 61 +11+ 8= 202
Six deceased individuals are amongst the two groups (four from the SMR and two
from the other sources.
Therefore, of the 202 subjects, 122 are definitely affected as these have been clinically
verified. This proportion increases by 61 to 183 of the 202, if the diagnostic records
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examined are accurate. These 61 records were only included because there was little
doubt that the diagnosis was correct. In nearly all cases the information was obtained
from the comments and notes based on examination by a consultant ophthalmologist.
There were several reasons why it was not possible for some children to be examined,
and these ranged from subjects not giving consent, which was rare, to failure to attend
an appointment on more than one occasion (Table 5.3). In some cases, although
consent for a clinical examination was not given, permission was granted for access to
medical records.
Table 5.3: Reasons for children not having a clinical examination (total 81)
28 No reply to letter
11 Untraced (from SMR)
10 Refusal
6 Resident in England (no consent to contact)
6 Untraced
6 Did not attend appointment
6 Deceased
3 GP refusal to approach patient
3 Refusal but with permission to examine records
2 Search still in progress
81 Total not clinically examined
A number of children are in Table 5.1 on the basis of the SMR coding only, no other
information having been obtained. The SMR diagnostic codings are unreliable in both
quality and quantity (see comments below on ascertainment). The majority of the
exclusions (Table 5 .4) were obtained from the SMR data from ISD Scotland, and the
actual ocular diagnosis can differ quite significantly from the SMR coding.
In addition to the above, 135 names were excluded from the study on the basis of the
ocular diagnosis not being microphthalmos, anophthalmos or coloboma (definition
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below). These are listed in Table 5.4. Of the 135 exclusions, the author clinically
examined 29. In 24 cases both eyes were normal with no congenital abnormality. A
further 9 children were born and registered outside Scotland, usually in England.
Table 5.4: Exclusions from study
Examined
by DM
ID Date of birth Ocular diagnosis; comment
Normal eye
examination
7 October 27, 1992 blepharophimosis, myopia
Examined by
DM
9 February 4, 1992 corectopia and posteriorembryotoxon
Examined by
DM
11 September 18, 1983 born in England
14 August 9, 1993
Peters' plus: multiple and severe
congenital abnormalities
16 January 26, 1992 Rieger's syndrome and congenitalglaucoma; mother also affected
22 November 10, 1984 born in England
23 August 12, 1985 retinopathy of prematurity, born 26weeks, both eyes small
24 May 31, 1986 retinopathy of prematurity, born 25weeks, is blind
36 January 20, 1993 aniridia
41 August 31, 1994 bilateral corneal opacities
Examined by
DM
42 August 12, 1991 congenital glaucoma
43 July 24, 1996 normal eyes normal eyes
44 October 20, 1990 optic nerve hypoplasia, septo-optic
dysplasia
52 July 20, 1993 narrow palpebral apertures normal eyes
54 August 21, 1986 anterior segment dysgenesis, familial
57 June 6, 1988
anterior segment dysgenesis (Rieger's- Examined by
like), congenital glaucoma DM
59 May 15, 1982 left congenital cataract
Examined by
DM
65 January 22, 1993 born in England
69 March 19, 1988
no eye problems at all; brother has
Rieger's normal eyes
73 August 21, 1986 anterior segment dysgenesis, familial
80 January 4, 1993 Rieger's anomaly
81 March 17, 1993 corneal ulcer/anterior segment dysgenesis Examined DM









87 January 13, 1984 Peters' anomaly
Examined by
DM
92 November 15, 1992 septo-optic dysplasia; hypothalamic
hypopituitarism
98 December 6, 1994 squint
99 August 19, 1994
facial asymmetry, body asymmetry,
toe abnormalities normal eyes
Examined by
DM





105 March 1, 1994 optic nerve hypoplasia, septo-optic
dysplasia
110 October 31, 1993 pale optic discs, unusual choroidalvessels
114 March 15, 1986 retinopathy of prematurity, born 26weeks
119 July 7, 1984
bilateral corneal scarring and
maculopathy
120 September 16, 1982 born in England
123 March 27, 1983 nystagmus, optic nerve hypoplasia,
squint
124 June 15, 1990 Rieger's anomaly
125 June 9, 1990 not born in Scotland
127 August 28, 1982 unilateral Peters' anomaly
Examined by
DM
131 January 8, 1984 blue sclera; osteogenesis imperfecta normal eyes
Examined by
DM
133 March 12, 1984 Peters' anomaly, left eye enucleated
135 December 7, 1984 epibulbar dermoid; Goldenhar's
137 March 5, 1985 left convergent squint
Examined by
DM
141 March 20, 1986 no eye abnormality normal eyes
143 May 1, 1986
whites of eyes were greyish at birth
only normal eyes
144 July 8, 1986 Norries syndrome
146 November 26, 1986
right cataract, probably mild form of
persistent hyperplastic primary
vitreous
147 August 30, 1988 anterior segment dysgenesis
148 February 24, 1988 had cyst on left eyeball at birth normal eyes Examined DM
151 January 9, 1993 optic nerve hypoplasia
Examined by
DM
152 February 8, 1993 aniridia bilaterally Examined by
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156 September 6, 1990 right vitreous opacity and right squint
158 November 12, 1981
no eye abnormality; Robinow's
syndrome normal eyes
164 November 22, 1984 cortical blindness
165 March 8, 1985 retinopathy of prematurity
167 January 8, 1985 corneal opacity
168 November 21, 1985 anisocoria, anisometropia, ptosis
169 August 23, 1986 born in England
171 October 1, 1987 optic nerve hypoplasia
177 December 3, 1992 congenital glaucoma,
Axenfeld/Rieger's
178 March 17, 1994 retinopathy of prematurity, high
myopia
179 January 7, 1994 aniridia
180 September 29, 1995 no eye problem normal eyes






194 May 5, 1982 familial aniridia (sib ID 197)
197 December 31, 1983 familial aniridia (sib ID 194)
201 December 30, 1985 anterior segment dysgenesis
202 February 3, 1987 sporadic aniridia
Examined by
DM
203 March 25, 1987 nystagmus, squint
205 March 16, 1990 sporadic aniridia
Examined by
DM
209 January 21,1994 optic nerve hypoplasia, right
convergent squint.
212 October 13, 1986 anterior corneal staphyloma
215 December 13, 1989
Axenfeld's anomaly, congenital
glaucoma
218 September 29, 1990 corneal dystrophy
221 October 6, 1991 congenital glaucoma
223 January 20, 1993 right third cranial nerve palsy
225 February 26, 1994 eyelid coloboma and angular dermoid
226 May 18, 1983 left eyelid ptosis
235 April 7, 1987 aniridia
237 September 20, 1986 Rieger's anomaly; Hirschprung's,chromosome translocation (4, 13).
Examined by
DM









245 July 16. 1987 blepharophimosis syndrome
246 June 9, 1988 aniridia (familial)
247 October 15, 1994 optic nerve hypoplasia, septo-opticdysplasia
250 November 21, 1988 born in England
Examined by
DM
255 February 28, 1992 not born or conceived in Scotland
256 December 6, 1982 optic nerve hypoplasia, septo-optic
dysplasia
257 September 8, 1990 corectopia
259 August 27, 1985
bilateral optic atrophy, multiple
congenital abnormalities
260 September 16, 1982 septo-optic dysplasia
265 February 20, 1981 septo-optic dysplasia
270 April 28, 1988 cortical blindness
273 July 14, 1987




274 February 23, 1988 unilateral congenital cataract
279 June 8, 1985 retinopathy of prematurity, born 28
weeks, left cataract, detached retina
Examined by
DM
280 January 18, 1985 no eye abnormality normal eyes
283 November 29, 1989 retinopathy of prematurity
285 April 22, 1991 retinopathy of prematurity left eye
286 November 20, 1993 prematurity, born 26 weeks
288 December 1, 1992 retinopathy of prematurity, born 28
weeks, myopia and astigmatism
Examined by
DM
292 August 30, 1992 astigmatism and refractive ambylopialeft eye
298 July 6, 1982




300 December 24, 1985 aniridia (familial)
301 August 22, 1987 no eye abnormality normal eyes
302 February 16, 1993 optic nerve hypoplasia,
holoprosencephaly, micropcephaly
303 May 27, 1992 Rieger's anomaly
304 October 23, 1982 no eye abnormality normal eyes
305 September 25, 1986 no eye abnormality normal eyes
306 October 15, 1981 no eye abnormality normal eyes
307 March 12, 1984
no eye abnormality, had a sticky eye
at birth normal eyes
308 August 10, 1989 no eye abnormality normal eyes
309 February 25, 1993 optic nerve hypoplasia, cerebral palsy
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310 February 13, 1995 no eye abnormality normal eyes
311 October 30, 1995 not affected
312 November 28, 1987 narrowed palpebral aperture
313 September 12, 1995 limbal dermoid cyst
314 December 7, 1984 no eye abnormality normal eyes
315 March 30, 1990 no eye abnormality normal eyes
316 August 25, 1985 not affected
317 November 21, 1984 aniridia (familial)
319 September 17, 1985 premature, born 28 weeks, has
cataracts
320 July 7, 1983 premature, no ocular abnormality
321 June 22, 1987 septo-optic dysplasia;
holoprosencephaly
322 October 28, 1985 no eye abnormality normal eyes
323 October 2, 1981 iris heterochromia
336 June 26, 1989 aniridia
339 December 6, 1982 Rieger's/glaucoma (familial)
340 June 6, 1988 no eye abnormality normal eyes
342 September 21, 1986
born in England, bilateral iris
coloboma, brother affected (ID 267)
345 July 21, 1988 aniridia
346 March 14, 1996 no eye abnormality normal eyes
347 May 24, 1996 aniridia
349 September 9, 1996 Peter's anomaly
350 November 11, 1996 no eye abnormality
351 July 31, 1996 aniridia/glaucoma
353 December 9, 1984 anterior segment dysgenesis, familial
356 August 29, 1985
born in England, optic disc coloboma,
familial, sister of ID 102
Examined by
DM
Common diagnoses in those excluded from the study included aniridia, anterior
segment dysgenesis (Peters' or Rieger's anomaly), retinopathy of prematurity and
strabismus (squint). Corectopia is illustrated in Figure 5.2.
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Figure 5.2: Corectopia left pupil (ID 9, excluded from study)
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pP^fW
It will be recalled from the last chapter that SMR diagnostic codes were used to
search for these eye conditions and that in the case of coloboma, a search was made
under ICD9 743.4. This includes 'Coloboma and other anomalies of the anterior
segments'. It is therefore not surprising that so many major and minor disorders
affecting the front of the eye are included in the exclusions (Table 5.4). Another
notable feature which is not surprising is the number of rare and unusual congenital
abnormalities affecting the retina or optic nerve and therefore only visible with an
ophthalmoscope. An example of this is that there were more than a dozen cases of
optic nerve hypoplasia. It is reasonable to expect that at the time these abnormalities
in very young babies were first suspected and the names placed on diagnostic
registers, to make a more precise clinical diagnosis without detailed specialist opinion
would have been difficult. In clinical practice, an examination under anaesthesia is
sometimes required.
Ascertainment of cases and sources of information (chapter four)
The levels of case ascertainment and the effectiveness of the different sources are
beyond the scope of this thesis and will form the basis of a separate publication. Cases
were obtained from all sources. Most of the cases were obtained from the SMR data,
ophthalmologists and paediatricians. There was considerable overlap between
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sources. It should also be noted that some sources were more reliable than others in
the quality or accuracy of the data obtained, and this is not surprising. Also, not all
sources have an equal chance of capturing a case. Blind registration data can only
yield those children with bilateral and significant visual impairment. These points have
been considered in a publication on capture-recapture (Campbell et. al, 2002).
The birth prevalence is similar to that obtained in previous studies and suggests that
case ascertainment was extremely high.
Birth prevalence ofmicrophthalmos, anophthalmos and coloboma (MAC)
This was estimated for Scotland as a whole and for each of the 15 health boards. The
total number of live births (all genders) in Scotland from 1981-1996 was 1 023 027.
Based on the lower figure of clinically validated diagnoses (122), the minimum birth
prevalence of MAC in Scotland over this period is 1.19 per 10,000. The birth
prevalence of anophthalmos (n=7) was 0.68 per 100,000 live births. The figures are
comparable with other studies (chapter two, Table 2.1 page 46). (Data for live births
from ISD, Scotland). No corrections have been made for births within the same
family.
If the higher figure of 202 cases is used the birth prevalence is 1.98 per 10,000 live
births. Based on 183 validated diagnoses, including 61 records (but excluding those
with only SMR codes), birth prevalence overall is 1.78 per 10,000 live births.
Further analysis of 122 cases examined clinically
The minimum birth prevalence based on 122 is 1.19 per 10,000, The birth prevalence
for each of the 15 health boards ranged from 0.74 to 8.02 per 10,000 live births
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(Table 5.5). The unusually high figure in the Shetland Isles, where the total number of
live births was 4,982, is accounted for by 3 of the 4 affected children being siblings. In
Fife, the health board region that has attracted so much attention, the overall birth
prevalence was 2.58 per 10,000 live births. The figure is reduced to 2.44 per 10,000
when the two affected sibs are counted as one, reducing the number of confirmed
affected children from 18 to 17. In view of such intense publicity and attention in this
area, it is no surprise that a high number of cases were found.
No affected children were reported or found in the Western Isles (total number of
births 4,909). Study questionnaires and letters were returned from this region. The
small population of this region is the most likely explanation for the complete absence
of cases.
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Table 5.5: Birth prevalence ofmicrophthalmos, anophthalmos, and coloboma in
Scotland 1981-1996, by health board
Health board ai-ca Number of Number of live Prevalence per
clinically verified
cases
births % 10,000 live births
(95% confidence
interval)
Argyll and Clyde 9 88 812 1.01 (0.35-1.67)
Ayrshire and Arran 11 73 724 1.49 (0.61-2.37)
Borders 2 17 844 1.12 (0.00-2.67)
Dumfries and 6 26 956 2.23 (0.45-4.01)
Galloway
Fife 18 69 531 2.59 (1.40-3.78)
Forth Valley 9 52 782 1.71 (0.60-2.28)
Grampian 9 103 007 0.87 (0.30-1.44)
Greater Glasgow 16 196 027 0.81 (0.42-1.20)
Highland 3 40 653 0.74 (0.00-1.58)
Lanarkshire 9 116 920 0.77 (0.27-1.27)
Lothian 11 147 642 0.75 (0.31-1.19)
Orkney 1 3 745 2.67 (0.00-7.90)
Shetland 4 4 982 8.03 (0.16-15.90)
Tayside 14 74 461 1.88 (0.90-2.86)
Western Isles 0 4 909 0
Scotland 122 1 023 307 :: 1.19(0.98-1.40)
Distribution ofMAC births by year (Table 5.6 and Figure 5.3)
There are about 60,000 live births each year in Scotland, the numbers having fallen
slightly since 1981 (source: Registrar General's Office, Scotland). In this study, the
birth prevalence ofMAC was lowest in 1988 and highest in 1993 (0.60 and 2.23 per
10,000 live births respectively).
The distribution of births by year is shown in Table 5.6. A significant number of cases
was ascertained from every year back to 1981 and the maximum number from 1993,
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the year in which news of anophthalmos and microphthalmos hit the national papers
(Paduano et al. 1993).
Table 5.6: Birth prevalence ofmicrophthalmos, anophthalmos, and coloboma in
Scotland 1981-1996, by year




1981 6 68 055 0.88 (0.17-1.59)
1982 5 65 197 0.77 (0.10-1.44)
1983 6 64 232 0.93 (0.19-1.67)
1984 7 64 512 1.09 (0.28-1.90)
1985 11 65 281 1.69 (0.70-2.68)
1986 7 65 038 1.08 (0.18-1.88)
1987 6 65 307 0.92 (0.18-1.66)
1988 4 65 799 0.61 (0.01-1.21)
1989 7 63 347 1.11 (0.29-1.93)
1990 4 64 963 0.62 (0.02-1.22)
1991 9 66 371 1.36 (0.47-2.25)
1992 11 64 671 1.70 (0.69-2.71)
1993 14 62 732 2.23 (1.06-3.40)
1994 10 60 911 1.64 (0.62-2.66)
1995 8 59 485 1.34 (0.41-2.27)
1996 7 57 406 1.22 (0.32-2.12)
Scotland
1981-1996
122 1 023 307 1.19 (0.98-1.40)




A similar number of male and female cases were found. Of the 122 clinically verified
cases, 67 (55%) were male and 55 (45%) were female. The difference is statistically
significant (chi-square test 0.50 > probability > 0.10).
Clinical anophthalmos data
The data obtained from the national register for congenital anomalies held at ISD
Scotland is currently the only source from which any estimate of the birth prevalence
of anophthalmos can be made. To illustrate some of the difficulties (small numbers,
rare condition) in using this data to draw conclusions, a closer inspection of the
number of cases of anophthalmos follows. The findings of the 13 names coded as
ICD9 7430 (anophthalmos) are listed in Table 5.7. Of these 13, 10 were traced and
examined. In only six was the actual diagnosis (anophthalmos) correct. Two children
died within the first six days of life and one was stillborn. Two children had
colobomatous microphthalmos. In one case examined there was no structural eye
abnormality at all (see table of exclusions). Included in the table (ID 47) is a child with
anophthalmos coded as microphthalmos at birth. Even for a condition as apparently
obvious as anophthalmos, the accuracy of 7/13 (54%) with no guarantee of complete
ascertainment has implications. Conclusions about data drawn from the congenital
anomalies register need to be interpreted with great caution.
In Fife health board region only one confirmed case of anophthalmos (ID 166) was
found over a 16-year period. Two children were incorrectly coded on the SMR
register as 743.0 (anophthalmos).
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Table 5.7: New cases of anophthalmos in Scotland, 1981-1996, based on SMR
data








166 F 20.4.85 Alive 7430 Left anophthalmos
F 1985 Died 1-23
hrs
7430 ?
280 M 18.1.85 Alive 7430 No eye abnormality
306 F 15.10.81 Alive 7430 No eye abnormality
72 F 29.12.87 Alive 7430 Bilateral anophthalmos
51 M 17.11.89 Alive 7430 Coloboma, microphthalmos
204 M 24.3.89 Alive 7430 Left anophthalmos
M 1990 Died 1-6
days
7430 ?
117 F 31.10.90 Alive 7430 Anophthalmos
/microphthalmos
M 1991 Still birth 7430 ?
62 F 10.5.92 Alive 7430 Coloboma, microphthalmos
47 M 3.9.93 Alive 7431* Left anophthalmos
67 F 4.7.94 Alive 7430 Left anophthalmos
239 F 19.6.94 Alive 7430 Left anophthalmos
*7431 is microphthalmos. This case included in table for completeness since all other
known cases of anophthalmos are included.
Unilateral or bilateral eye defects
69 (57%) children had a unilateral eye defect and 53 (43%) were bilaterally affected.
Fife health board report 1995
This 1995 report is a further illustration of the limitations of data based on reporting
without clinical examination or uniformity of definition. An investigation was carried
out into the apparent clusters of microphthalmos/anophthalmos/coloboma in North
East Fife (Rowarth, 1995). After exclusion of children with chromosomal
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abnormalities or an obvious family history link (see discussion below as to the logic
and validity of doing this), 22 cases ofMAC were observed in the study period 1981-
1993. Multiple sources of ascertainment were used. It was concluded that the birth
prevalence of MAC in Fife was relatively high. Inspection of the tables of 27 cases
listed in the report, most of whom were traced and clinically examined during the
Scottish Microphthalmia Study, reveals that the data obtained is mostly accurate, but
with some errors which are significant when dealing with such small numbers. One
child had a rare congenital iris anomaly (corectopia), one pair of twins had partial
aniridia, another child had Peters' anomaly, and another had normal eyes. Of the 27,
only two children were not traced in this study, which again confirms the likely high
degree of case ascertainment achieved for this region. That the prevalence was highest
in the health board region of Fife (2.59 per 10,000) is partly explained by the
particular attention drawn to this condition in the area.
Vision and registration
Out of 122 examined, 34 (28%) were registered as blind (less than 3/60 best corrected
Snellen acuity for distance).
Seven children on the blind/partially-sighted register had a unilateral eye defect with a
normal fellow eye. There is no simple explanation for this. One would expect a
population such as this, which was not selected based on vision, to express the full
range of visual potential. Studies on populations selected from hospital clinics or blind
registration data will yield a different clinical spectrum.
Education and social needs
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There were 106 children aged 3 or over, and over half of them received help with
special educational needs: 23 (22%) attended a special school and a further 31 (29%)
received special assistance within a mainstream school. However, the reasons for
being in a special school may not be based solely on vision, but on the presence of
other congenital anomalies. Some form of disability living allowance was received by
46 children (38%).
Ocular phenotype
A summary of the ocular phenotypes in each of the 122 clinical examinations is listed
in Table 5.8. A total of 72 children were classified as having clinical microphthalmos
in either eye (94 eyes). Clinical microphthalmos was defined as the clinical impression
of a small eye. All colobomas (iris, fundus and optic nerve) were included, a total of
130 eyes. Colobomatous microphthalmos (eyes with coloboma which were classified
as microphthalmic) was present in 53 eyes. Six children had clinical anophthalmos in
at least one eye.




bilateral extreme microphthalmos, right corneal opacification, iris
abnormalities
3
bilateral atypical iris 'colobomas', 'aniridia-like', bilateral anterior subcapsular
cataracts
4 right iris coloboma only, left minor pupil margin abnormality
5 bilateral iris and fundus colobomas, bilateral microphthalmos
6 left iris and fundus coloboma, microphthalmos, iris heterochromia
8 left iris coloboma, corneal opacity, microphthalmos
15 right optic disc coloboma, right ptosis, blepharophimosis
17 bilateral iris colobomas, bilateral fundus colobomas, right lens opacities, high
myopia
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IB Ocular phenotvpic diagnosis
myopia
18 bilateral iris colobomas, right simple retinal coloboma
19 left microcornea/cataract, retinal pigmentation, microphthalmos
20 right microphthalmos, right ptosis, possible retinal dysplasia
26 bilateral iris and fundus colobomas, microphthalmos, affected sib ID 106
29 left optic disc coloboma and simple retinal coloboma
30 right iris coloboma and simple retinal coloboma
33 right iris and fundus coloboma, bilateral microphthalmos
34 bilateral iris, lens, and fundus colobomas
35 right fundus coloboma/ microphthalmos, left optic disc coloboma and thin
vessels, affected twin ID 96
39
bilateral iris and simple retinal colobomas, bilateral cataracts (lensectomies)
bilateral microphthalmos
40 bilateral iris and fundus colobomas, left microphthalmos
45 bilateral iris colobomas, ptosis
47
left anophthalmos, right iris 'coloboma' nasally (atypical and atrophic),
'aniridia-like', dysplastic retina, optic disc hypoplasia
48 left extreme microphthalmos
50
left extreme microphthalmos, right nystagmus, right optic nerve head/disc
'coloboma'
51
bilateral iris and fundus colobomas/microphthalmos, iris heterochromia, left
post subcapsular cataract
53 right sclerocornea, left cataract, bilateral microphthalmos
55 bilateral iris colobomas/microphthalmos, left cataract, right fundus coloboma
58 left iris coloboma, bilateral fundus colobomas/microphthalmos
60
bilateral nanophthalmos/microphthalmos, high hypermetropia, left divergent
squint, Schwartz-Jampel syndrome, has twin
61 left iris and fundus coloboma, detached retina, left microphthalmos
62 left microphthalmos, right optic disc/macular coloboma, abnormal right retina
63
bilateral iris and fundus colobomas, left microphthalmos, right cataract, right
mucocele nasolacrimal duct
64 right iris abnormal/dysplastic, left iris coloboma
66




ID Ocular phenotypic diagnosis
70 right iris coloboma
75
bilateral iris colobomas, right iris fissure/cleft, right disc/macular coloboma,
left microphthalmos, left fundus coloboma
76 bilateral iris and fundus colobomas
77 left microcornea, cornea opaque, extreme microphthalmos
79
bilateral iris and fundus colobomas, bilateral microphthalmos, iris
heterochromia, right cataract, high myopia
83 right iris fissure-like 'coloboma', left iris coloboma, bilateral fundus
colobomas, iris heterochromia, left microphthalmos
84 right cataract, extreme microphthalmos
85 right iris and simple retinal coloboma, microphthalmos, iris heterochromia
89
bilateral iris colobomas, left iris fissure-like 'coloboma', right simple retina
coloboma
90 bilateral iris and colobomas/microphthalmos
93
bilateral complicated microphthalmos, vitreous and retina disorganised,
bilateral lensectomies
94
bilateral extreme microphthalmos, corneal opacification, right iris coloboma
(right lensectomy/vitrectomy, retinal detachment failed surgery)
96 bilateral fundus colobomas, affected twin ID 35
97 left iris coloboma, left retina abnormal, bilateral extreme microphthalmos
100 right cataract and severe microphthalmos, possibly complicated by
prematurity, born at 30 weeks
101 right cataract and corneal scar, right microphthalmos, simple retinal
coloboma, anterior scleral staphyloma
102 bilateral optic disc colobomas, mum and sister affected
106 right iris and fundus coloboma, iris heterochromia, affected sib ID 26
107 right lens opacity, complex optic disc/macular coloboma, microphthalmos
109
bilateral cataracts (lensectomies), bilateral optic disc colobomas, right
microphthalmos
111 left iris coloboma, left retina detached, microphthalmos
113
bilateral iris colobomas, right simple retinal coloboma, left fundus
coloboma/microphthalmos
115
left microphthalmos, possible persistent hyperplastic primary vitreous
(PHPV), left lensectomy/vitrectomy, blocked left nasolacrimal duct
117 left anophthalmos, right extreme microphthalmos
121 bilateral iris 'colobomas', aniridia-like
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ID Ocular phenotypic diagnosis
122 bilateral iris colobomas, bilateral optic nerve hypoplasia (from records)
129 right iris and fundus coloboma, right microphthalmos
132 right iris and fundus coloboma, iris heterochromia, right microphthalmos,
affected sibs ID 216, ID 299
138
bilateral iris and Hindus colobomas, bilateral cataract, right microphthalmos,
high myopia
140 left iris coloboma, lens coloboma, iris heterochromia
142 left iris stromal coloboma/'furrow'
145 bilateral iris colobomas, left cataract, lens 'notches'/colobomas
150 right iris coloboma and simple retinal coloboma
153 left iris coloboma
159 bilateral iris coloboma, cortical lens opacities, affected sib ID 297
162
left atypical superior iris coloboma, left cataract and lens coloboma, left
simple retinal coloboma (atypical position)
166 right anophthalmos, left nystagmus
172 right cataract and extreme microphthalmos
174 left iris coloboma
181 bilateral iris fissure/coloboma, bilateral microphthalmos
187 bilateral and unusual iris 'colobomas', 'aniridia-like', small right lens opacity
188
left iris pupillary membrane remnant, left cataract, bilateral fundus
colobomas, left microphthalmos
189 bilateral sclerocornea, bilateral microphthalmos
192
bilateral iris and fundus colobomas/microphthalmos, bilateral small corneal
opacities
199 bilateral corneal opacification, bilateral cataracts, extreme microphthalmos
200 right iris coloboma
204 right anophthalmos
210 right corneal scar, absent pupil, right microphthalmos
213
left microcornea and corneal opacification, retinal dysplasia/coloboma (eye
enucleated: records)
216 right iris coloboma and simple retinal coloboma, affected sibs ID 132, ID 299
217 bilateral iris colobomas, bilateral simple retinal colobomas
219 left cataract and microphthalmos, possibly PHPV
222 right iris coloboma, bilateral simple retinal colobomas
224 right optic disc coloboma/dysplasia, right microphthalmos
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ID Octtlar phenotypic diagnosis
228 bilateral iris and fundus colobomas
232 left cataract, iris and fundus colobomas
234 bilateral iris colobomas/simple retinal colobomas
236
right iris coloboma, right minor lens opacities, right fundus
coloboma/detached retina, right microphthalmos , left simple retinal
coloboma
238
left iris and fundus coloboma, left cataract, microphthalmos, iris
heterochromia
239 left anophthalmos, right nystagmus
241 right iris stromal coloboma/'furrow'
242 right iris coloboma and simple retinal coloboma
243 left iris coloboma/fissure
244
left iris atrophy, pupillary membrane, microphthalmos, pigmentary
retinopathy, probably inflammatory/infective
251 right atypical superior iris coloboma, right simple retinal coloboma
252 right iris coloboma, cataract, extreme microphthalmos, probable detached
retina
253 left extreme microphthalmos
254 right cataract (aphakic) and microphthalmos, possibly PHPV
258 right iris and fundus coloboma, right microphthalmos, iris heterochromia
261
left corneal opacity and cataract, left extreme microphthalmos, possibly
PHPV
263 left iris coloboma and simple retinal coloboma
264 right iris and fundus coloboma, left optic disc abnormally shaped, iris
heterochromia
267 right iris coloboma and microphthalmos, left sclerocornea and
microphthalmos
268 right iris and fundus coloboma, microphthalmos, affected twin ID 269
269 left iris and fundus coloboma, microphthalmos, affected twin ID 268
272 left iris and fundus coloboma, left microphthalmos
275 right atypical superior iris and fundus coloboma (in typical position) right
limbal dermoid excised
276 left cataract and microphthalmos
277 left persistent pupil membrane, iris heterochromia, microphthalmos
284 right corectopia, left anterior segment malformed, bilateral microphthalmos
287 bilateral iris coloboma, left iris 'fissure-like' defect
290 left iris coloboma, left simple retina coloboma
296 left optic disc coloboma affected sib ID 66
297 left iris fissure/coloboma, affected sib ID 159
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ID Ocular plienotypic diagnosis
299
bilateral cataracts and retinal colobomas (?) and microphthalmos, abnormal
anterior segments, affected sibs ID 132, ID 216
324 right iris and fundus coloboma, right microphthalmos
335 right iris coloboma and simple retinal coloboma
337 left iris and fundus coloboma, iris heterochromia
Extraocular congenital malformations
These are discussed in more detail in chapter nine. There was significant
developmental delay in 23 children (19%), 40 children were considered to be facially
dysmorphic (Dr David FitzPatrick, Consultant Clinical Geneticist), 11 children had
significant congenital heart disease, and a total of 45 had another (extraocular)
congenital anomaly. In 13 children there was a recognised clinical genetic syndrome,
including 3 with the CHARGE association. Seven children had a positive family
history of a related eye defect and this data is considered further in chapter eight.
DISCUSSION
Data for this study was collected retrospectively, using multiple sources of
ascertainment. The birth prevalence is therefore a minimum value. Ascertainment
levels were probably very high and there appears to be consistency, since similar
numbers were obtained for each of the 16 years back to 1981. The study continues to
add to the database, although very few 'new' cases continue to be added.
Some sources of ascertainment were not fully explored, although this may have had
little or no effect on the outcome, since not every source has the same chance of
identifying a case. Blind registration data was used for only two health board areas.
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Cases in which the eye abnormality was minor with no effect on vision may not have
come to the attention of any medical service.
An individual ophthalmologist rarely sees these eye conditions in clinical practice, and
it is likely that most cases will be remembered and the notes or details would be
retrievable. Most departments did not have a formal method of retrieving cases.
In children with multiple congenital anomalies, it is understandable that there may be a
failure to document an eye abnormality, either because of time constraints, ill health
due to a life-threatening malformation, or there not being sufficient space to log all
abnormalities on the recording form (there is space for eight diagnoses on the SMR11
neonatal discharge record). With multiple malformations, it may be assumed that the
eye anomaly is present as part of a clinical syndrome e.g. trisomy 13, so the eye defect
is not documented. Conversely, there may be an excess of ocular diagnoses made in
children with multiple congenital anomalies.
The large number of exclusions and incorrect diagnoses illustrates some of the
difficulties of relying on registers for data analysis. Some of the lack of specificity of
the ICD-9 codes will be improved by ICD-10 (see chapter four).
In England, the combined prevalence of anophthalmos and microphthalmos has been
estimated as 1.0 per 10,000 births (Dolk et al. 1998). The prevalence of clinical
anophthalmos in this study is less than that found in an Italian study of 0.60 per
10,000 births (Clementi et al. 1992).
It is difficult to compare the findings of this study with other work, as each case was
clinically validated. A recent study in England (Dolk et al. 1998) was based on a
postal survey and questionnaire. A period of just six years was covered (1988-1994).
Problems with this approach included the failure to use a definition that could be
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applied consistently and the confusion of case ascertainment by excluding cases of
'mild' microphthalmos or where the 'severity' of microphthalmos was unknown,
whatever these incompletely defined terms may be. In the English study, cases of
assumed aetiology based on clinical appearance in combination with other congenital
abnormalities, or maternal infection, were excluded. That 'genetic' and
'environmental' cases cannot easily be distinguished has been made clear in chapter
two.
This study included all cases, which were selected based on the presence of an eye
abnormality without reference to vision, other congenital anomalies, or cause. Cases
with chromosome abnormalities and multiple malformations have been excluded in
some studies (Kallen et al. 1996).
The question of clustering has not been considered since the small numbers involved
in each health board region would not stand up to detailed analysis, and it is not
within the scope of this thesis. Only a small change in the numbers would have a
marked effect on prevalence, and the data is not sufficiently complete to allow useful
conclusions to be drawn on these matters. Furthermore, the place of birth has been
used for geographical location, but this may not be the most significant factor, as
prenatal development and factors back to at least the point of conception need to be
considered.
The evaluation of clustering itself does not add much towards our understanding of
the aetiology of these eye defects (Rothman, 1990). An investigation into
geographical variation and clustering of anophthalmos and microphthalmos in
England did not find any evidence of clusters in babies born between 1988 and 1994
(Dolk et al. 1998). The prevalence was higher in rural and low-density population
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areas compared to urban areas. Despite the shortcomings of the study, the
observation of an almost twofold excess risk in rural areas does warrant further
investigation and confirmation.
Summary, chapter five
• The co-operation from GPs, specialists and other health professionals was
extremely good. Very few patients refused consent for the clinical aspects of the
study, once contacted.
• Case ascertainment in this study used a wide variety of sources. The overall
prevalence suggests that ascertainment levels were high.
• A significant number of children were excluded from the study after being found
not to have any congenital eye defect.
• Birth prevalence was highest in the Fife health board area, an area which has
received the most attention and which was the subject of a previous report.
• Birth prevalence in the Western Isles was nil. This health board region has one of
the smallest populations and very few births. This is interesting in the light of
suggested clusters in rural and low-density population areas.




CONGENITAL OCULAR MALFORMATIONS: CLASSIFICATION AND
OTHER NEW FINDINGS
Summary
Eye defects were classified into three groups according to the presence or absence of
a defect related to optic fissure closure, with a third category comprising eye defects
without a recognisable phenotype. The term microphthalmos does not feature in the
new classification, which is based on ocular phenotype.
A classification of coloboma is presented which highlights some of the difficulties in
defining this condition and the limitations of our understanding. Some forms of
coloboma are best described by the term 'optic nerve head disruption'.
Most of the eye defects were related to defects of optic fissure closure. All the
bilateral defects were consistent with the new classification.
Eye pathology in bilaterally affected individuals was usually asymmetrical.
The pathophysiology of superior (atypical) iris coloboma is poorly understood.
A number of ocular phenotypes were seen which do not fall easily into any
classification system.
The iris coloboma-heterochromia association has been characterised and is not
uncommon (Morrison et al. 2000).
The prevalence of retinal detachment in chorioretinal coloboma has been estimated
(Morrison and Fleck, 1999).
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BACKGROUND AND METHODS
The reason for first grouping the eye defects into clinical anophthalmos,
microphthalmos and coloboma at the outset of this study was to make the data
comparable to previous studies. These diagnoses are the terms by which cases could
be searched for on registers and when communicating with clinicians. The categories
of coloboma and clinical microphthalmos (the latter often with coloboma) were
predicted to overlap, and this also occurred to some extent with anophthalmos and
microphthalmos (chapter one). As each of the terms was applied to the various
structural ocular abnormalities, it became apparent that greater specificity and
diagnostic (phenotypic) information was required, and this exposed the limitations and
shortcomings of current terminology. Also, problems with definition arose as there is
no accepted or applicable definition of microphthalmos (chapter one).
The different eye anomalies needed to be distinguished in order to make more detailed
comparisons, e.g. of family history and recurrence risk (chapter eight), extraocular
abnormalities (chapter eight), and mutation screening for candidate genes (chapter
nine). The limitations and lack of precision of the term coloboma and its different
varieties, the wide range of microphthalmic phenotypes, and the inability to
characterise anophthalmos beyond clinical anophthalmos, all needed to be addressed.
An attempt was made to unify and classify the conditions of anophthalmos, coloboma,
colobomatous microphthalmos and microphthalmos.
A new classification system would need to be simple, reliable, repeatable, and ideally
would be based on development with respect to timings and structural abnormalities.
It would also need to be clinically applicable. Classification based on a description of
the anatomical site affected is over-complicated and not easily applied in practice.
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This type of classification may not bear any relationship to the cause (Warburg,
1993). A classification related to genetic mutations is also a possibility, but the role
and contribution of genetic factors is poorly understood. Ideally, future genetic
studies (family history and pedigree analysis, clinical genetic syndromes, recurrence
risk, mutation screening) would be consistent with the classification system.
Observations resulting from the ultrasound study of axial length made it clear that
microphthalmos could not be defined on the basis of axial length (chapter seven).
Making the diagnosis of microphthalmos based on appearance is easy for extreme
microphthalmos but with 'mild' or 'moderate' degrees of microphthalmos it is
problematic. For unilateral cases it is possible to comment on the relative difference
on the assumption, possibly incorrectly, that the structurally normal fellow eye is
indeed normal, but for bilateral cases the task is even more difficult.
The most common structural abnormality found in all cases was a uveal coloboma,
and this is relatively easy to distinguish. The timing of the insult to the eye can also be
narrowed down to a relatively short period of development (chapter one).
This created the first two categories, fissure (OFD) or non-fissure (non-OFD). The
third category relates to those cases in which it could not be said with any certainty
that a fissure defect was present or not. In such cases, there was no view of the iris or
posterior segment, or no discernible eye structures due to an extremely small eye or
remnant being present (clinical anophthalmos). This third group was unclassifiable
(U). It should be noted that unclassifiable could mean an underlying OFD or non-
OFD, but this can only be based on the status of the fellow eye.
An attempt was made to make a simple classification of coloboma based on the
anatomical site, taking into account the present knowledge about formation of the
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optic fissure (chapter one). Ideally, the new classification would be consistent with
some of the understanding of the expression/involvement of developmental genes in
different parts of the eye. However, abnormalities within different genes could cause a
similar defect, or the same gene could be responsible for several different types of
defect. A decision had to be made, based on the appearance of the optic disc, as to
whether or not the defect was likely to be fissure-related.
The first step was to classify the eye as OFD or non-OFD. Only one eye needed to be
a fissure defect to classify the individual as belonging to this category.
Any case of clinical anophthalmos or bilateral extreme clinical microphthalmos was
unclassifiable. These unclassifiable cases cannot be phenotyped, unless the fellow eye
expresses a defect.
The non-fissure defects were expected to be heterogeneous, and the small numbers
involved would not allow further classification.
For a classification system to work, agreement would be expected between the two
eyes of the same individual. Also, if the condition were thought to be inherited, the
same basic structural defect would be present within any family or pedigree. The
expected combinations would be OFD/OFD, OFD/U, non-OFD/non-OFD, U/U,
U/non-OFD. The combination ofOFD/non-OFD would not be predicted.
The above classification is not entirely 'new' in the sense that colobomatous and non-
colobomatous microphthalmos has long been recognised (Bateman, 1984; Tucker et
al. 1996). Non-colobomatous microphthalmos has been called 'complicated'
microphthalmos due to its heterogeneous nature (Goldberg and McKusick, 1971).
The key difference with the proposed classification is that defects are not classified
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according to apparent or actual eye size (axial length), but according to phenotypic
abnormality.
Microphthalmos is not a phenotypic diagnosis and does not feature in this
classification. What was previously non-colobomatous microphthalmos is either not
an optic fissure defect (non-OFD) or an unclassifiable eye malformation (U).
Optic nerve head coloboma and fissure defects
In chapter one, the term coloboma (literally, a defect) was shown to be an inadequate
term for describing the poorly understood underlying processes. Optic nerve head
colobomas have a highly variable clinical appearance (Olsen et al. 1996).
The origin of certain types of optic disc (optic nerve head) colobomas is not
understood. It is possible that some types are related to closure of the optic fissure.
Other unknown mechanisms related to optic nerve formation may be involved.
Optic nerve head 'colobomas' suffer from being assigned this limited term, since
assumptions are made about the causative mechanism being related to fissure closure,
being lumped together with iris or chorioretinal colobomas (Daufenbach et al. 1998).
A separation or distinction would be helpful, with the word coloboma dropped. 'Optic
nerve head closure disruption', 'optic stalk/groove head closure disruption', or 'optic
nerve head disruption' would be more helpful to distinguish this group of
abnormalities. From here on, the term 'optic nerve head disruption' will be used to
describe these defects. It is important to emphasise that although the probable
embryological mechanism is a defect of optic fissure closure, the genetic influences
may be different, possibly due to the different anatomical location - the optic
stalk/groove - as well as the timing.
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RESULTS
Tables 6.1, 6.2 and 6.3 lists the ocular diagnoses along with the designated
classification into one of the three categories OFD, non-OFD and unclassifiable.
There were 85 individuals with an optic fissure defect, 12 non-optic fissure defect,
and 25 unclassifiable (Table 6.4). This breakdown is represented in Figure 6.1.











Table 6.1: Ocular phenotypes classified as left or right optic fissure defect (OFD)
11) Ocular phenotypic diagnosis
4 right iris coloboma only, left minor pupil margin abnormality
5 bilateral iris and fundus colobomas, bilateral microphthalmos
6 left iris and fundus coloboma, microphthalmos, iris heterochromia
8 left iris coloboma, corneal opacity, microphthalmos
15 right optic disc coloboma, right ptosis, blepharophimosis
17
bilateral iris colobomas, bilateral fundus colobomas, right lens opacities, high
myopia
18 bilateral iris colobomas, right simple retinal coloboma
26 bilateral iris and fundus colobomas, microphthalmos, affected sib ID 106
29 left optic disc coloboma and simple retinal coloboma
30 right iris coloboma and simple retinal coloboma
33 right iris and fundus coloboma, bilateral microphthalmos
34 bilateral iris, lens, and fundus colobomas
35 right fundus coloboma/ microphthalmos, left optic disc coloboma and thin
vessels, affected twin 96
39
bilateral iris and simple retinal colobomas, bilateral cataracts (lensectomies)
bilateral microphthalmos
40 bilateral iris and fundus colobomas, left microphthalmos
45 bilateral iris colobomas, ptosis
51
bilateral iris and fundus colobomas/microphthalmos, iris heterochromia, left
post subcapsular cataract
55 bilateral iris colobomas/microphthalmos, left cataract, right fundus coloboma
58 left iris coloboma, bilateral fundus colobomas/microphthalmos
61 left iris and fundus coloboma, detached retina, left microphthalmos
62 left microphthalmos, right optic disc/macular coloboma, abnormal right retina
63
bilateral iris and fundus colobomas, left microphthalmos, right cataract, right
mucocele nasolacrimal duct
64 right iris abnormal/dysplastic, left iris coloboma
66
bilateral fundus colobomas/microphthalmos, left iris coloboma, affected sib
ID 296
70 right iris coloboma
75
bilateral iris colobomas, right iris fissure/cleft, right disc/macular coloboma,
left microphthalmos, left fundus coloboma
76 bilateral iris and fundus colobomas
79
bilateral iris and fundus colobomas, bilateral microphthalmos, iris
heterochromia, right cataract, high myopia
83 right iris fissure-like 'coloboma', left iris coloboma, bilateral fundus colobomas,
iris heterochromia, left microphthalmos
85 right iris and simple retinal coloboma, microphthalmos, iris heterochromia
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!D Ocular pheitotypic diagnosis
89
bilateral iris colobomas, left iris fissure-like 'coloboma', right simple retina
coloboma
90 bilateral iris and colobomas/microphthalmos
94
bilateral extreme microphthalmos, corneal opacification, right iris coloboma
(right lensectomy/vitrectomy, retinal detachment failed surgery)
96 bilateral fundus colobomas, affected twin ID 35
97 left iris coloboma, left retina abnormal, bilateral extreme microphthalmos
101 right cataract and corneal scar, right microphthalmos, simple retinal coloboma,
anterior scleral staphyloma
102 bilateral optic disc colobomas, mum and sister affected
106 right iris and fundus coloboma, iris heterochromia, affected sib ID 26
107 right lens opacity, complex optic disc/macular coloboma, microphthalmos
109
bilateral cataracts (lensectomies), bilateral optic disc colobomas, right
microphthalmos
111 left iris coloboma, left retina detached, microphthalmos
113
bilateral iris colobomas, right simple retinal coloboma, left fundus
coloboma/microphthalmos
122 bilateral iris colobomas, bilateral optic nerve hypoplasia (from records)
129 right iris and fundus coloboma, right microphthalmos
132 right iris and fundus coloboma, iris heterochromia, right microphthalmos,
affected sibs ID 216, ID 299
138
bilateral iris and fundus colobomas, bilateral cataract, right microphthalmos,
high myopia
140 left iris coloboma, lens coloboma, iris heterochromia
142 left iris stromal coloboma/'furrow'
145 bilateral iris colobomas, left cataract, lens 'notches'/colobomas
150 right iris coloboma and simple retinal coloboma
153 left iris coloboma
159 bilateral iris coloboma, cortical lens opacities, affected sib ID 297
162
left atypical superior iris coloboma, left cataract and lens coloboma, left simple
retinal coloboma (atypical position)
174 left iris coloboma
181 bilateral iris fissure/coloboma, bilateral microphthalmos
188
left iris pupillary membrane remnant, left cataract, bilateral fundus colobomas,
left microphthalmos
192
bilateral iris and fundus colobomas/microphthalmos, bilateral small corneal
opacities
200 right iris coloboma
216 right iris coloboma and simple retinal coloboma, affected sibs ID 132, ID 299
217 bilateral iris colobomas, bilateral simple retinal colobomas
222 right iris coloboma, bilateral simple retinal colobomas
224 right optic disc coloboma/dysplasia, right microphthalmos
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ID Ocular phenotypic diagnosis
228 bilateral iris and fundus colobomas
232 left cataract, iris and fundus colobomas
234 bilateral iris colobomas/simple retinal colobomas
236 right iris coloboma, right minor lens opacities, right fundus
coloboma/detached retina, right microphthalmos , left simple retinal coloboma
238
left iris and fundus coloboma, left cataract, microphthalmos, iris
heterochromia
241 right iris stromal coloboma/'furrow'
242 right iris coloboma and simple retinal coloboma
243 left iris coloboma/fissure
252 right iris coloboma, cataract, extreme microphthalmos, probable detached
retina
258 right iris and fundus coloboma, right microphthalmos, iris heterochromia
263 left iris coloboma and simple retinal coloboma
264 right iris and fundus coloboma, left optic disc abnormally shaped, iris
heterochromia
267 right iris coloboma and microphthalmos, left sclerocornea and microphthalmos
268 right iris and fundus coloboma, microphthalmos, affected twin ID 269
269 left iris and fundus coloboma, microphthalmos, affected twin ID 268
272 left iris and fundus coloboma, left microphthalmos
275 right atypical superior iris and fundus coloboma (in typical position) right
limbal dermoid excised
287 bilateral iris coloboma, left iris 'fissure-like' defect
290 left iris coloboma, left simple retina coloboma
296 left optic disc coloboma affected sib ID 66
297 left iris fissure/coloboma, affected sib ID 159
324 right iris and fundus coloboma, right microphthalmos
335 right iris coloboma and simple retinal coloboma
337 left iris and fundus coloboma, iris heterochromia
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Table 6.2: Ocular phenotypes classified as left or right non-optic fissure defect
(non-OFD)
ll> Ocular phenotypic diagnosis
-i
bilateral atypical iris 'colobomas', 'aniridia-like1, bilateral anterior subcapsular
cataracts
20 right microphthalmos, right ptosis, possible retinal dysplasia
60
bilateral nanophthalmos/microphthalmos, high hypermetropia, left divergent
squint, Schwartz-Jampel syndrome, has twin
93
bilateral complicated microphthalmos, vitreous and retina disorganised,
bilateral lensectomies
115
left microphthalmos, possible PHPV, left lensectomy/vitrectomy, blocked left
nasolacrimal duct
121 bilateral iris 'colobomas', aniridia-like
187 bilateral and unusual iris 'colobomas', 'aniridia-like', small right lens opacity
244
left iris atrophy, pupillary membrane, microphthalmos, pigmentary retinopathy,
probably inflammatory/infective
254 right cataract (aphakic) and microphthalmos, possibly PHPV
277 left persistent pupil membrane, iris heterochromia, microphthalmos
284 right corectopia, left anterior segment malformed, bilateral microphthalmos
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Table 6.3: Ocular phenotypes classified as left or right unclassifiable (U)
ID Ocular phenotypic diagnosis
1
bilateral extreme microphthalmos, right corneal opacification, iris
abnormalities
19 left microcornea/cataract, retinal pigmentation, microphthalmos
47
left anophthalmos, right iris 'coloboma' nasally (atypical and atrophic),
'aniridia-like1, dysplastic retina, optic disc hypoplasia
48 left extreme microphthalmos
50
left extreme microphthalmos, right nystagmus, right optic nerve head/disc
'coloboma1
53 right sclerocornea, left cataract, bilateral microphthalmos
67 left anophthalmos
77 left microcornea, cornea opaque, extreme microphthalmos
84 right cataract, extreme microphthalmos
100 right cataract and severe microphthalmos, possibly complicated by
prematurity, born at 30 wks
117 left anophthalmos, right extreme microphthalmos
166 right anophthalmos, left nystagmus
172 right cataract and extreme microphthalmos
189 bilateral sclerocornea, bilateral microphthalmos
199 bilateral corneal opacification, bilateral cataracts, extreme microphthalmos
204 right anophthalmos
210 right corneal scar, absent pupil, right microphthalmos
213
left microcornea and corneal opacification, retinal dysplasia/coloboma (eye
enucleated: records)
219 left cataract and microphthalmos, possibly PHPV
239 left anophthalmos, right nystagmus
251 right atypical superior iris coloboma, right simple retinal coloboma
253 left extreme microphthalmos
261 left corneal opacity and cataract, left extreme microphthalmos, possibly PHPV
276 left cataract and microphthalmos
299
bilateral cataracts and retinal colobomas (?) and microphthalmos, abnormal
anterior segments, affected sibs ID 132, ID 216
As predicted, the categories of non-OFD and unclassifiable defects were both very
heterogeneous. Some of the suggested phenotypic diagnoses are listed in Tables 6.4
and 6.5. Many of these diagnoses are extremely rare and a much larger population
would need to be studied to yield sufficient numbers to form subgroups. It is hoped
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that some of these conditions will eventually be distinguished genetically (chapter
three).
Table 6.4: Phenotypic diagnoses of non-OFD group
Phenotypic Diagnosis ID
Possible aniridia 3, 121, 187
Retinal and/or vitreous dysplasia 20, 93
Nanophthalmos 60
Persistent hyperplastic primary vitreous 115,254
Prenatal inflammation or infection 244
Persistent pupillary membrane 277
Corectopia 284
Figure 6.1: Possible aniridia, non-OFD. This subject also has a left esotropia (ID
121)
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Table 6.5: Unclassifiable (no clear phenotype)
Diagnosis (no clear phenotype) ID
Absent pupil 210
Anophthalmos 47, 67, 117, 166, 204, 239
Atypical (superior) iris coloboma 162,251
Corneal opacification 1,77, 199,210,213, 261
Cataract (no view of posterior pole) 19, 53, 84, 100, 162, 172, 199, 219, 261,
299
Extreme microphthalmos 48, 50, 77, 84, 100, 117, 172, 189, 199,
210, 219, 261
Iris abnormalities 1
Microcornea 19, 77, 213
Retinopathy ofprematurity (suspected) 100
Sclerocomea 53, 189
Figure 6.2: Left extreme clinical microphthalmos (ID 48)
There were several other external eye abnormalities and defects noted (Table 6.6).
Some of these could be described as secondary i.e. a consequence of the visual
problem (e.g. strabismus). In many cases, they must be regarded as another
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pathology. That other abnormalities coexist is not surprising and is a reminder of the
complex aetiology (chapters one and two).
Table 6.6: External eye abnormalities noted
External Eye abnormality ID
Blepharophimosis 20
Blocked nasolacrimal duct 115
Limbal dermoid 275
Mucocele 299
Nystagmus 50, 166, 239
Ptosis 15, 20, 45
Strabismus 60, 45
Lens coloboma
This was recognised in four cases (IDs 34, 140, 145, 162), all of whom had iris
coloboma. The abnormality is subtle and appears as a small defect/impression in the
lens, often with disruption of the adjacent zonular fibres (Pagon, 1981; Hornby et al.
2000).
Cataract
Lens opacities were seen in a significant number of cases,
not usually visually significant. (ID 159) (Pagon, 1981;
children had had cataract surgery (lensectomies).
Iris heterochromia-iris coloboma
This is described in a published paper. Nearly 20% of cases are affected (Morrison et
al. 2000). Figure 7.8 page 193 and Figure 7.12 page 197.
In many the opacities were
Hornby et al. 2000). Six
- 163 -
Retinal detachment
There were several cases in which this occurred (IDs 94, 111, 236, 252). A letter has
been published on this topic in which the prevalence was estimated at 3.76% (4 out of
101 affected eyes) (Morrison and Fleck, 1999).
Clinical anophthalmos (Figure 6.3)
This occurred in 7 cases (IDs 47, 67, 72, 117, 166, 204, 239). The cases had little in
common and in none of them was there a family history of anophthalmos or
coloboma. The systemic abnormalities present are discussed in chapter eight. Only
one case was bilateral (ID 77). In ID 117 a very small ocular remnant could be seen in
the fellow orbit by careful examination of a child documented as being bilateral
anophthalmos. The distinction is academic (chapter one).
Figure 6.3: Left clinical anophthalmos
ID 47 is very unusual since the fellow eye has an atrophic iris with a defect nasally.
The retina is whitish and dysplastic with a hypoplastic abnormal disc. This could well
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have been a case of atypical aniridia or coloboma with anophthalmos affecting the
other side. Blood was tested for PAX6 and CHX10 gene mutations and none were
found (chapter nine). This boy was born with hydrocephalus (detected at 27 weeks of
gestation) and cerebral atrophy and has developmental delay.
IDs 67 and 204 were the only cases of anophthalmos with a completely normal fellow
eye.
The author did not examine ID 72 but the documentation and clinical records were
accurate enough to be certain of the diagnosis. This included discussion with the
child's artificial eye fitter.
ID 117 was the child born within a consanguineous marriage. Parents are first cousins
(chapter two) and the mother had already had three miscarriages. This girl had
microcephaly and developmental delay.
In ID 166 the fellow eye had reduced vision with nystagmus. Developmental delay
and brain abnormalities meant that a more detailed assessment of vision was not
possible.
ID 239: This three-year-old child also had nystagmus in the apparently normal fellow
eye but was too young for a more detailed visual assessment.
Cases with a family history (IDs 26, 35, 66, 96, 102, 106, 132, 159, 216, 268, 269,
276, 296, 297, 299)
These are discussed from the combined systemic and ocular aspects in chapter eight.
IDs 26 and 106 are brothers with iris and fundus colobomas. The degree of
involvement is different and one of the brothers is only affected unilaterally.
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IDs 35 and 96 are identical twins. They are affected bilaterally but to different degrees
with iris or fundus coloboma.
IDs 66 and 296: A girl with iris and fundus colobomas has a brother with normal
vision and a retinal abnormality best described as a coloboma. Retinal architecture
was normal. This would be classified as type 1 (see below). This coloboma would
have remained undetected without fundus examination (see earlier comment).
ID 102: One of two sisters (the other was born in England) who come from a large
family and are the third generation affected by an optic nerve abnormality best
described as a coloboma. These have been classified in this study as being due to
defects in optic fissure closure. This point is debatable. The optic nerve abnormality
would be described as an 'optic nerve head disruption' (type 5, see below).
IDs 132, 216, 299: These three brothers are affected differently with defects of optic
fissure closure. IDs 132 and 216 are unilaterally affected, but the vision of ID 216 is
not impaired as the retina is involved to a lesser degree. ID 299 has a phenotype that
could not readily be distinguished. This child is severely affected and is blind in both
eyes.
ID 159 and 297: One brother is bilaterally affected with iris colobomas. The other (ID
297) has only a deep vertical fissure in the iris at the six o'clock position. This mild
manifestation of an optic fissure defect has already been discussed above.
ID 268 and 269: These girls, the second pair of identical twins in the study, are
affected symmetrically but on opposite sides. They are affected unilaterally. The
ocular defect is therefore mirrored. The paternal grandmother has a well-documented
iris coloboma.
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ID 276: This girl has a unilateral cataract as the primary diagnosis and clinical
microphthalmos. No view of the Hindus was possible but detailed records from an
examination at Great Ormond Street Hospital and from relatives confirmed that a first
cousin born in England is affected unilaterally with the same condition.
With the exception of ID 276, all of the other seven cases above with a family history
have an underlying defect of optic fissure closure.
Consanguinity
This was present in the parents of one child with bilateral clinical
anophthalmos/extreme microphthalmos (ID 117, first cousins) and in the grandparents
(suspected/complex?) of another (ID 109). ID 60 Schwartz-Jampel syndrome was a
twin resulting from a consanguineous union. This condition is autosomal recessive
(Pinto-Escalante et al. 1997).
DISCUSSION
Difficulties identifying fissure defects
IDs 15 and 102: Right optic disc coloboma refers to the 'optic nerve head disruption'
(see above comments) and these were considered to be due to defects of optic fissure
closure.
IDs 142, 181, 241: Iris fissure/grooves. These fissures or grooves also appeared in
positions on the iris consistent with the location of the optic fissure in the fellow eye
of classical coloboma (ID 64, 287) or in a sibling (ID 297, 159). For this reason they
were judged to be optic fissure closure defects. However, in ID 243, discussed in
more detail in chapter ten, a PAX6 gene mutation was found.
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ID 296 has a left optic nerve head disruption. This was classified as a fissure defect
since an affected sibling ( ID 66) had classical iris and fundus coloboma.
Difficulties identifying and classifying non-fissure defects
ID 3: The appearance was highly suggestive of aniridia. An ophthalmologist first saw
this toddler when she was a small baby, and detailed examination was not possible due
to the lack of cooperation in such a small child. The external appearance without the
aid of a slit lamp makes it difficult to distinguish a coloboma from some forms of
aniridia. It was hoped that the PAX6 mutation study (chapter nine) would clarify this.
A similar situation also applied to IDs 121 and 187.
Difficulties identifying and classifying unclassifiable defects
Most of these cases were clinically anophthalmic or had extreme microphthalmos with
sclerocornea. No view of the iris or fundus was possible, e.g. ID 67, 84.
Fundus coloboma has a variable clinical appearance (Pagon, 1981; Gopal et al.
1996), and clinical classifications have been attempted before (Gopal et al. 1996),
using the appearance of the optic disc and whether or not it is involved within the
retinal coloboma. Their results did bear some relationship to visual function.
However, more relevant to this study (aetiology, recurrence risk, molecular genetic
studies) was that the defects all had the same underlying mechanism.
Classification of coloboma
Five types of uveal coloboma were recognised in this study. The five types were
classified as being due to an underlying defect of optic fissure formation or closure.
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The numbers of cases assigned to each group are listed in Table 6.7. The first three
categories have iris involvement (iris coloboma).
1. Iris coloboma only.
2. Simple fundus coloboma. E.g. ID 18, ID 30. The iris was (nearly) always
involved. The anatomy of the posterior segment of the eye was normal in terms of
the vessel pattern and position of the optic disc. The disc was usually not affected
and the eye not clinically microphthalmic. Many of these subjects had near normal
visual acuity.
3. Complex fundus coloboma. Figures 6.4 and 6.5. The iris was nearly always
involved, the anatomy of the posterior pole of the eye is indistinct, the vessel
pattern is abnormal, the macula is indistinct or involved, and the optic disc is often
involved within the coloboma. Staphyloma was common. Many of these eyes were
clinically microphthalmic. Vision was usually poor, but often much better than the
appearance suggested (see discussion below on visual acuity, extrafoveal function,
and near visual acuity (Olsen et al. 1996)). These complex fundus colobomas may
be a more extensive form of optic nerve head disruption, e.g. IDs 33, 51, 66.
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Figure 6.4: Complex left fundus coloboma, type 3. The edge of the coloboma
traverses the nasal region of the macula adjacent to the poorly defined fovea
(arrow) (ID 51)
Figure 6.5: Right complex fundus coloboma involving the optic nerve and lower
half of the retina, type 3. Note the irregular pattern of the blood vessels in the
superior (uninvolved) retina (ID 26)
4. Irregular fundus/posterior pole coloboma. Figure 6.6. The iris was not involved.
The coloboma affects the anatomy of the posterior pole, there being no
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recognisable optic disc or macula. Clinical microphthalmos was sometimes present.
IDs 66, 96, 35, 188, 107.
Figure 6.6: Right irregular fundus coloboma (ID 107)
5. Optic nerve head disruption. Figure 6.7. The iris was not involved. Here, the disc
is the only part of the eye involved (see above). The anatomy of the blood vessels
and macula appears normal. Clinical microphthalmos was almost never present e.g.
ID 15, 102.
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Figure 6.7: Right optic nerve head disruption (ID 102)
Table 6.7: Classification of colobomas: distribution amongst study group
Coloboma type Number of eyes
I. Iris coloboma only 29
II. Simple fundus coloboma 22
III. Complex fundus coloboma 58
IV. Irregular fundus/posterior pole coloboma 7
V. Optic nerve head disruption 11
The coloboma types were identical in most bilaterally affected cases, although the
symmetry of clinical appearance differed in most cases of bilateral eye pathology. In
only four cases was there a difference in coloboma type. In ID 264, the types were
type 3 (complex fundus coloboma) and type 5 (optic nerve head disruption) in each
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eye. This does suggest that the underlying cause of some optic nerve head
abnormalities is a defect of optic fissure formation or closure.
It is apparent that a simple classification of coloboma is not easy, and that the protean
nature of this structural eye anomaly has made it difficult to apply any rules which do
not have an exception.
The main difference between types 3 and 4 was whether the iris was involved or not.
One important consideration is whether or not 'asymptomatic' retinal colobomas
exist, and how common they are. The situation can exist where no iris coloboma is
manifest and the vision is not significantly affected, and a retinal coloboma is present.
This applies only to types 2 and 5 above. In only one case was this found, in the
brother of a girl affected with classical coloboma (ID 66, 296). Therefore, it is highly
unlikely that a significant number of cases were missed.
This reclassification of eye defects has deliberately moved away from classifying
microphthalmos to classifying a group of structural defects. This recognises that
microphthalmos is not a phenotypic diagnosis. Classification ofmicrophthalmos in the
past has not been easy or productive, and has done little to further our understanding
of the causes (Bateman, 1984; Warburg, 1993).
The malformations that are not classifiable still present a problem. Because of the
small numbers and rarity, it is difficult to recognise individual phenotypes. This should
not deter us from sub-classifying each defect into a further category, though this
would be on the basis that each category could later merge or disappear as more
similar cases are found or patterns emerge. The key element here is adequate




Coloboma has a wide and complex variety of clinical presentation (Steahly, 1990;
Daufenbach et al. 1998). There have been several recent attempts to classify
coloboma, based on the effect on vision and fundus appearance (Gopal et al. 1996;
Olsen et al. 1996), or anatomy (Warburg, 1993). These classifications have all been
excessively complicated, and are not easily applied in clinical practice. Gopal's
classification concentrated on the variable appearance of the optic disc in fundus
coloboma (based on photographs) and the author makes some correlation between
disc appearance and visual acuity. Examination of fundus photographs by Olsen
correlated normal foveal anatomy with improved visual acuity.
In this study, fundus photographs were not taken due to practical constraints.
Drawings were made in the records ofmost cases, but these would not yield the detail
required for the studies based on photographic evaluation.
Visual function
Observations in this study and recently published work (Olsen et al. 1996; Hornby et
al. 2000) have made it clear that visual acuity is difficult to correlate with the
structural eye abnormality seen. This is important since being able to predict the vision
in a small baby or child is relevant to later development and education. The vision is
also affected by factors other than the coloboma, such as corneal astigmatism and
high refractive error and lens opacity. The reading and navigational vision can be
surprisingly good, especially after optical correction with low vision aids (Hornby et
al. 2000). In II) 51, for example, this boy has extensive left iris and fundus coloboma
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(type 2) with optic disc involvement. Distance acuity is 6/18 but he is able to read
small print (N5) with a spectacle correction of -2.00/+1.50 x 90.
A recent study proposed a phenotypic classification of coloboma, which correlated
the groups with visual acuity, reading and navigational vision (Hornby et al. 2000).
This study included diagnostic groups based on microcornea, which was defined
(incorrectly) as being less than 10 mm horizontal corneal diameter, regardless of the
patient's age. Microphthalmos was a further diagnostic category, and this was
inappropriately defined based on axial length. These aspects are dealt with again in the
next chapter (seven).
The above classification may require modification as not all the ocular phenotypes fit
easily into it, and it is difficult to apply without having a photographic record. This
makes application into clinical practice difficult. However, it is simple with just four
categories. It is more easily understood and applicable than other classifications, and
is not based upon the use of the terms microphthalmos or microcornea.
The classification will only have real importance if visual outcome or prognosis, or
association with a specific genetic abnormality can distinguish the four groups.
As has already been stated, visual outcome in coloboma depends on factors in
addition to anatomy, such as refractive error, strabismus, cataract, and extraocular
problems such as developmental delay. This makes assessment extremely difficult.
Although an attempt was made to document these factors, there are not sufficient
numbers in this study with a complete data set for a valid comparison to be made.
Data was collected on both near and distance vision of nearly 70 eyes affected with
coloboma, but details of spectacle prescription or refraction were available in only 12
cases. None of the subjects were refracted due to time and equipment constraints.
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Accurate vision assessment takes longer and detailed assessment needs orthoptic skill
in younger children, when the most appropriate tests, e.g. Sheridan-Gardiner or Kay's
pictures, can be used.
Asymmetry
Asymmetry was very common for fissure defects. Of 45 individuals bilaterally
affected, 12 had symmetrical eye pathology. Also, all the individuals with a family
history demonstrated asymmetry and variable ocular phenotypic expression (see
above). There is no simple explanation for asymmetry. Each individual has two
genetically identical eyes but because of stochastic factors (i.e. chance) the genetic
defect, if it is indeed genetic, is expressed differently in the two eyes. This may be a
result of critical gene dosage and effects of their protein products. If the eye defects
were entirely environmental in aetiology then variable effects of toxins on the
developing eye could explain the asymmetry. The alternative explanation is that genes
and the environment are acting together (see chapter two). The gene(s) responsible
for these eye malformations are known to have a very variable phenotypic expression.
The varied expression does give clues as to the timing of gene expression during eye
development (chapter three).
Fundamental to the classification of fissure and non-fissure defects is that no
individual should have an eye defect in one eye not consistent with the same
aetiology, i.e. there were no cases of OFD/non-OFD occurring together.
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Atypical colobomas
In a few individuals, a 'coloboma' of the iris was seen in a position not usually
recognised, that is, a typical coloboma of the iris is usually seen inferiorly (6 o'clock
position) or inferonasally, consistent with the position of the optic fissure. In IDs 251
and 275, iris colobomas were atypical in position. There is no complete explanation
for this but there are several possibilities:
The iris defect may not be a coloboma, but an anterior segment dysgenesis with a
'coloboma', or variant of aniridia. These would not be expected to have retinal or
optic disc colobomas in the eye or fellow eye.
It may be the case that in some individuals the position of the optic fissure is different,
or that an accessory fissure is present. In ID 251, the retina was affected in a position
corresponding to the iris coloboma, and in ID 275 the fundus coloboma was in a
typical (inferior) position away from the (superior) iris coloboma. Brodsky has
described a unilateral superotemporal coloboma of the iris, ciliary body and choroid
(Brodsky et al. 1988). The retina, macula and optic disc were normal.
ID 162, atypical superior iris coloboma with lens coloboma/notch and simple retinal
coloboma, was unclassifiable (debatable).
This study has confirmed the highly variable appearance of ocular coloboma. Also,
asymmetry of ocular pathology in bilaterally affected individuals was present in 33 of
the 45 cases. Within individuals from affected pedigrees, there was asymmetry of eye
pathology and cases with unilateral eye defects. This highlights the phenotypic
variability and variable penetrance and expression of possible genes involved. Patterns
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of inheritance suggested both autosomal dominant and autosomal recessive
inheritance.
Non-OFD covers a number of different ocular phenotypes.
It is not possible to say whether any of those phenotypes grouped as unclassifiable
had an underlying optic fissure defect and this group would need to be larger to sub-
classify if further studies were undertaken.
Summary, chapter six
• A database and research resource of well phenotyped and clinically verified
congenital eye malformations has been set up.
• Eye malformations previously described as coloboma and anophthalmos have been
reclassified according to phenotype, based on the presence or absence of an optic
fissure closure defect.
• A classification of coloboma is suggested, based on the assumption that some optic
nerve head abnormalities are due to underlying defects of optic fissure closure.
Difficulties remain with categorisation of optic nerve head abnormalities, which
have been named 'optic nerve head disruption'.
• In 12 cases, external eye and lid abnormalities were present.
• There were eight cases with a family history confirmed by examination, and in
seven of these the underlying eye malformation was a defect of optic fissure
closure.
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The structural eye anomalies in this study occurred not only as isolated eye defects,
but also in individuals often with other systemic congenital anomalies. These are the
subject of chapter eight.
The need for a new classification came about partly as a result of the findings in the




AN ULTRASOUND STUDY ON THE AXIAL LENGTH OF THE EYE IN
CLINICAL MICROPHTHALMOS
'The diagnosis [of microphthalmos] frequently can be made by inspection alone.
However, as microcornea may occur without microphthalmos and, conversely,
microphthalmos may occur with a normal-sized cornea, a clinical diagnosis may be
inaccurate. Ultrasonography, with precise measurement of the anteroposterior axis,
now permits, and is in fact essentialfor, a biometric diagnosis in vivo. '
(Bateman, 1984).
This chapter will show that the latter part of the above statement is incorrect, since
microphthalmos cannot be defined by the proposed methods.
Summary
Axial length of the eye is not a useful definition ofmicrophthalmos.
More than half of all congenitally microphthalmic eyes have an axial length within or
significantly beyond the normal range when corrected for age.
Most (not all) clinically small eyes have normal sized globes.
Some congenitally colobomatous eyes with microphthalmos are bigger than normal:
congenital colobomatous macrophthalmos with microcornea.
Less than half of clinically microphthalmic eyes fulfil the commonly accepted
definition of microphthalmos, which is based on an axial length of less than two
standard deviations below the mean.
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Reduced horizontal corneal diameter is found in most cases of clinical
microphthalmos.
Reduced palpebral fissure length is found in most cases of clinical microphthalmos.
Ocular ultrasound B-scan seems to be well tolerated by children. Unlike CT or MRI, a
general anaesthetic is not required for small children.
Ultrasound B-scan can yield additional clinical information by imaging the posterior
segment in the presence of a lens or corneal opacity: microphthalmos with cyst,
posterior staphyloma and retinal detachment. However, useful images are not always
obtained with B-scans.
BACKGROUND
Making the diagnosis of clinical microphthalmos based on appearance is relatively
easy for extreme microphthalmos but with mild/moderate microphthalmos it is
problematic. For unilateral cases it is possible to comment on the relative difference
on the assumption, possibly incorrectly, that the structurally normal fellow eye is
indeed normal, but for bilateral cases the task is not so easy.
The current accepted definition of microphthalmos is based on the axial length of the
globe being below the fifth centile (more than 2 standard deviations below the mean)
when corrected for age, (Weiss et al. 1989b) (chapter one).
The aim of this study was to show that microphthalmos cannot be defined based on
the axial length of the globe and that the current definition is not satisfactory (chapter




Eyes were judged as clinically microphthalmic or non-microphthalmic according to
the records and diagnosis from the referring consultant ophthalmologist.
Microphthalmos therefore included all apparently small eyes. An ultrasound B-scan
was done on both eyes. All the eyes had an ocular phenotypic diagnosis, which
included coloboma and clinical anophthalmos. Clinically anophthalmic eyes were not
included in this part of the study for measurement.
Ultrasounds were done with a hand-held probe against the eyelid using contact gel.
This does not require corneal anaesthesia or contact, making the procedure pain free
and tolerable to young children. It was felt that other diagnostic information might be
obtained by using ultrasound B-scan in preference to A-scans (Fledelius, 1996;
Isenberg and Fishman, 1996). It is easier to obtain an axial length or a useful image in
colobomatous eyes (often with staphylomas), eyes with cysts, dense lens opacities or
vitreous abnormalities. Both eyes were measured where possible, including the normal
fellow eye in unilaterally affected children.
Not all centres or clinics had ultrasound B-scanners available, so scans were only
performed at the centres listed below.
A contact gel was applied to the outside of the upper eyelid, the scan performed, and
an image printed. At least five different machines were used in different departments:
Edinburgh (Princess Alexandra Eye Pavilion), Dunfermline (Queen Margaret's
Hospital), Glasgow (Yorkhill), Dundee (Ninewells), Aberdeen (Royal Infirmary), and
in each case it was the same operator (DM). The 14 ultrasound scans in Glasgow
were done in the X-ray department of the Royal Hospital for Sick Children, Yorkhill.
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These scans were performed under the supervision of the late Dr Anne Hollman,
Consultant Radiologist.
Scans were assessed by Dr Brian Fleck, consultant ophthalmologist, who was
unaware of the clinical diagnosis. The axial length of the eye was estimated from the
printed image to the nearest 0.5 mm, using a calliper and the printed scale below each
image.
All children had measurement of horizontal corneal diameter (HCD) and eyelid
palpebral fissure length (PFL), where possible. These measurements were taken using
a straight rule held as close to the eye and lids as possible.
Axial length (AL) was compared to the age-corrected mean for sex (Larsen, 1971).
HCD was compared to age-corrected mean for sex (Hymes, 1929).
Palpebral fissure length was compared to the age-corrected mean (Hall et al. 1989).
RESULTS
Clinical microphthalmos was judged by the referring consultant ophthalmologists to
be present in 56 eyes (42 subjects), and 30 eyes (22 subjects) were judged not to have
microphthalmos (Tables 7.1 and 7.2). Both groups of eyes had structural
abnormalities and the ocular phenotypes are listed in Table 7.3. The commonest
phenotypic eye abnormality was uveal coloboma. A third group consisted of 21 eyes
that were completely normal on examination and with normal vision. These 21
measurements were on the fellow eye of unilaterally affected individuals. The ID
numbers are listed in Table 7.4.
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Table 7.1: Clinically microphthalmic eyes: axial length (AL), horizontal corneal
diameter and palpebral fissure length. Grey boxes represent eyes with an AL
more than 2 SDs below the mean (matched for age and sex), blue boxes
represent eyes with an AL more than 2 SDs above the mean, and the plain boxes


























1 05-Sep-1984 1 13 1 6.0 17.0 26.0
6 28-Jun-1984 1 13 1 9.0 22.0 21.0
8 29-Nov-1992 1 5 1 9.5 22.0 21.0
20 19-Dec-1993 4 r 6.0 18.5 21.0
33 22-May-1985 1 12 r 5.6 22.0 24.0
33 22-May-1985 1 12 1 3.0 12.0 21.5
35 28-Feb-1993 4 r 9.5 21.0 18.0
39 06-Jun-1992 1 5 r 9.0 21.0 19.0
39 06-Jun-1992 1 5 1 8.0 20.5 19.0
48 29-Mar-1984 13 1 5.0 16.0 22.0
50 23-Jun-1996 1 1 1 3.0 13.0 18.0
51 17-Nov-l 989 1 8 r 5.8 16.0 22.0
51 17-Nov-1989 1 8 1 10.5 18.0 26.0
55 17-Aug-1984 2 13 r 7.5 24.0 24.0
55 17-Aug-1984 2 13 1 8.0 23.0 24.0
61 05-Sep-1991 2 6 1 7.0 22.0 21.0
62 10-May-1992 2 5 1 8.0 15.0 22.0
66 19-Feb-1989 2 8 r 10.0 25.0 22.0
66 19-Feb-1989 2 8 1 6.5 21.0 22.0
75 01-Feb-1988 1 9 1 9.5 26.0 23.0
79 17-Jul-1991 1 6 r 9.5 32.0 21.5
79 17-Jul-1991 1 6 1 7.0 22.0 17.0
83 28-Feb-1982 2 15 1 10.5 24.0 26.0
84 15-Oct-1981 2 16 r 8.0 11.0 24.0
90 15-Oct-1993 1 4 r 9.5 22.0 22.0
90 15-Oct-1993 1 4 1 7.0 17.5 20.5
93 20-Aug-1981 2 16 r 10.0 13.0 24.0
93 20-Aug-1981 2 16 1 13.0 15.0 24.0
94 27-Aug-l 987 1 10 r 7.0 13.0 19.0
94 27-Aug-1987 1 10 1 4.0 13.0 18.0
97 22-M-1982 2 15 r 1.0 14.0 23.0
97 22-Jul-1982 2 15 1 2.8 14.0 25.0
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100 23-Aug-I992 2 5 r 5.0 not recordable 21.0
101 14-Dec-1985 1 12 r 10.0 22.5 26.5
107 23-Feb-1984 1 13 r 9.5 25.0 25.0
109 08-Mar-1987 1 10 r 9.5 26.0 23.0
111 22-Jun-1992 2 5 1 10.0 22.0 20.0
113 21-Jun-1995 1 2 8.0 22.5 20.0
129 27-Dec-1982 2 15 r 10.5 23.0 25.0
138 30-Jan-1982 2 15 r 11.0 24.5 28.0
172 07-Apr-1987 1 10 r 4.0 9.0 24.0
181 27-Dec-1995 1 2 r 8.5 22.0 not recorded
181 27-Dec-1995 1 2 1 8.0 24.0 not recorded
189 01-Jul-1992 2 5 r not recorded 20.0 17.0
189 01-Jul-1992 2 5 not recorded 16.0 17.0
192 17-Nov-1989 2 8 r 7.0 22.0 18.0
192 17-Nov-1989 2 8 8.5 24.0 22.0
224 04-Aug-1993 1 4 r 9.0 22.0 16.0
252 24-Jan-1982 2 15 r 7.0 16.0 25.5
258 14-Nov-1990 1 7 r 9.0 24.0 21.0
261 26-Jul-1987 2 10 1 5.0 12.0 21.0
268 16-Feb-1996 2 1 r 7.0 20.0 not recorded
269 16-Feb-1996 2 1 1 7.0 20.0 not recorded
272 19-Aug-1991 2 6 1 8.0 23.0 not recorded
276 07-Nov-1991 2 6 1 9.5 21.5 20.5
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Table 7.2: Clinically non-microphthalmic eyes: axial length, horizontal corneal
diameter and palpebral fissure length. Grey boxes represent eyes with an AL
more than 2 SDs below the mean (matched for age and sex), blue boxes
represent eyes with an AL more than 2 SDs above the mean, and the plain boxes
represent eyes within the normal range
















18 04-Aug-1995 2 2 r 11.0 22.5 21.0
18 04-Aug-1995 2 2 1 11.0 21.0 21.0
34 27-May-1993 1 4 r 11.0 23.5 24.0
34 27-May-1993 1 4 1 11.0 24.5 24.0
35 28-Feb-1993 2 4 1 11.0 21.5 19.0
50 23-Jun-1996 1 1 r 11.0 20.0 21.0
62 10-May-1992 2 5 r 11.0 24.5 22.0
75 01-Feb-1988 1 9 r 11.5 22.0 23.0
76 31-Oct-1989 2 8 r 9.0 24.5 23.0
76 31-Oct-1989 2 8 1 10.0 27.5 23.0
83 28-Feb-1982 2 15 r 11.0 24.0 26.0
96 28-Feb-1993 2 4 r not recorded 22.0 not recorded
96 28-Feb-1993 2 4 1 not recorded 19.5 not recorded
109 08-Mar-1987 1 10 1 10.0 26.0 23.0
113 21-Jun-1995 1 2 r 10.5 25.0 20.0
138 30-Jan-1982 15 1 11.5 29.0 28.0
140 25-Nov-1985 1 12 1 11.0 23.5 26.0
150 13-Jul-1992 1 5 r 12.0 20.0 22.0
153 09-Mar-1994 1 3 1 11.5 22.0 23.0
159 12-Dec-1981 1 16 r 11.0 21.0 26.0
159 12-Dec-1981 1 16 1 11.0 22.0 26.0
166 20-Apr-1985 12 1 not recorded 24.0 0.0
187 16-Dec-1996 1 1 r 12.5 20.0 18.0
187 16-Dec-1996 1 1 1 12.5 20.0 18.0
228 05-Apr-1994 2 3 r 9.0 26.0 22.0
228 05-Apr-1994 2 3 1 9.0 22.0 22.0
234 12-Nov-1991 2 6 r 11.0 24.0 22.0
234 12-Nov-1991 2 6 1 11.0 22.0 22.0
241 22-Nov-1981 2 16 r 12.0 24.5 28.0
275 29-May-1993 2 4 r 10.5 24.0 21.5
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Table 7.4: Clinically normal eyes: axial length, horizontal corneal diameter and
palpebral fissure length Grey boxes represent eyes with an AL more than 2 SDs
below the mean (matched for age and sex), grey boxes represent eyes with an
AL more than 2 SDs above the mean. The plain boxes represent eyes within the
normal range

















6 28-Jun-1984 1 13 r 11.00 23.0 23.0
8 29-Nov-1992 1 5 r 11.50 21.0 23.0
20 19-Dec-1993 2 4 1 11.50 18.0 21.0
48 29-Mar-1984 2 13 r 12.00 25.0 26.0
61 05-Sep-1991 2 6 r not recorded 22.0 21.0
84 15-Oct-1981 2 16 1 12.00 24.0 26.0
101 14-Dec-1985 1 12 1 12.50 23.0 26.5
107 23-Feb-1984 1 13 1 12.50 24.0 26.5
111 22-Jun-1992 2 5 r 11.50 22.0 20.0
129 27-Dec-1982 2 15 1 12.00 22.0 25.0
140 25-Nov-1985 1 12 r 11.50 24.0 26.0
153 09-Mar-1994 1 3 r 11.50 22.0 23.0
224 04-Aug-1993 1 4 1 11.50 20.0 18.0
241 22-Nov-1981 2 16 1 12.00 24.0 27.0
252 24-Jan-1982 2 15 1 12.00 26.0 27.0
258 14-Nov-1990 1 7 I 12.00 21.0 24.0
261 26-Jul-1987 2 10 r 11.00 22.5 24.0
268 16-Feb-1996 2 1 1 10.00 20.5 not recorded
269 16-Feb-1996 2 1 r 10.00 21.5 not recorded
272 19-Aug-1991 2 6 r 11.00 23.0 not recorded
275 29-May-1993 2 4 1 10.75 23.0 21.5
Axial length (AL)
Table 7.1 lists the AL of 55 of the 56 clinically microphthalmic eyes. ID 100 had
severe clinical microphthalmos with a clinically apparent globe and an ocular
phenotype that included cataract and corneal scarring. The corneal opacification and
density of the ocular media meant that no measurable ultrasound image was obtained.
Only 20/55 (36%) clinically microphthalmic eyes fulfilled the proposed definition
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criteria for microphthalmos. Almost half (42%) of the clinically microphthalmic eyes
(23/55) had AL within the normal range when corrected for age and sex. Twelve eyes
(22%) had AL more than 2 SDs above the normal range. Results are illustrated in
Figure 7.1.
Figure 7.1: Axial length of 55 clinically microphthalmic eyes, showing number of
eyes within two standard deviations of the age-corrected mean
Microphthalmos as Axial length within Bigger than normal axial










Axial length within normal
range
Bigger than normal axial
length (macrophthalmos)
Table 7.2 lists the AL of 30 clinically non-microphthalmic eyes. Only 4 (13%) were
below 2 SDs of AL when corrected for age and sex. Thirteen eyes (43%) were within
normal range and 13 were above the normal range for AL.
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Figure 7.1: Axial length of 30 clinically non-microphthalmic eyes with structural
abnormality, showing number of eyes within two standard deviations of the age-
corrected mean
Microphthalmos as Axial length within Bigger than normal axial






Microphthalmos as Axial length within Bigger than normal
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(macrophthalmos)
Table 7.3 lists the AL of 21 normal eyes. Two eyes (9.5%) fulfilled the definition of
microphthalmos and 3 eyes were bigger than normal. Most of the normal eyes
(16/21=76%) fell within the normal range of size.
Microphthalmos as Axial length within Bigger than normal axial












Figure 7.3: Axial length of 21 clinically normal eyes showing number of eyes
within two standard deviations of the age-corrected mean
The B-scan ultrasounds confirmed many of the clinical findings. Other features noted
were: staphyloma ID 76, 138, 258 (Figure 7.13, page 199), detached retina ID 94, 33
(Figure 7.15) (Morrison and Fleck, 1999), microphthalmos with cyst ID 50.
The cases in which the eye was clinically microphthalmic but which on measurement
had AL more than 2 SDs above the normal range are colobomatous macrophthalmos
with microcornea ID 55, 76, 79, 83, 192, 258. The increased AL in some cases may
explain the presence ofhigh myopia (ID 138).
Horizontal corneal diameter (HCD)
Horizontal Corneal Diameter (HCD) was measured in 53 clinically microphthalmic
eyes (Table 7.1) and in 50/53 cases (94.3%) was more than 2 SDs below the mean,
when corrected for age and sex. Only 3 eyes had a HCD within the normal range. In
X 71
Microphthalmos as defined by Axial length within normal Bigger than normal axial
axial length range length (macrophthalmos)
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the non-microphthalmic eyes (Table 7.2), HCD was measured in 27 cases and 9/27
(33.3%) were below the normal range with 16/27 within normal range. Two eyes had
a HCD bigger than normal range. In the group of 20 normal eyes measured, HCD was
within 2 SDs of the age-corrected mean in 90% of cases (18/20). In two cases with
normal eyes, HCD was just below the normal age-corrected range (Table 7.3).
Eyelid palpebral fissure length (PFL)
The palpebral fissure length (PFL) of the eyelid was measured in 50 clinically
microphthalmic eyes and was more than 2 SDs below the mean in 48 (96%) when
corrected for age (Table 7.1). In 27 non-microphthalmic eyes measured, PFL was 2
SDs below the mean in 22/27 (81.5%) cases, with 5 cases within the normal range
Table 7.2). Of 18 normal eyes measured, PFL was below the normal range in 13
(72.2%), Table 7.3.
To highlight some of the AL findings, several cases are discussed and illustrated in
more detail:
Clinical microphthalmos: small eye measured on ultrasound
(i) Bilateral iris and fundus coloboma, ID 51 (Figure 7.4) Both eyes are clinically
microphthalmic and have significantly shorter than normal axial lengths: right AL 16
mm, left AL 18 mm, right HCD 5.8 mm, left HCD 10.5mm
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Figure 7.4: Bilateral iris and fundus coloboma with clinical microphthalmos (ID
51)
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(ii) Bilateral extreme clinical microphthalmos and left iris coloboma, ID 97 (Figure
7.5). ALs measured as small (14 mm). Right HCD 1 mm, left HCD 2.8 mm An
ultrasound B-scan of the left globe is shown in Figure 7.6.
Figure 7.5: Bilateral extreme clinical microphthalmos and left iris coloboma
Figure 7.6: Ultrasound B-scan of left globe, ID 97. AL is 14 mm. The subject is
pictured in Figure 7.5
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Clinical microphthalmos: normal eye measured on ultrasound
(i) Bilateral clinical colobomatous microphthalmos ID 79 Figure 7.7. Right AL 32
mm, left AL 22 mm.
Figure 7.7: Bilateral clinical colobomatous microphthalmos. The left AL of 22
mm is within the normal range. Right AL of 32 mm is big (ID 79)
(ii) Left clinical colobomatous microphthalmos ID 272, Figure 7.8. AL 23 mm.
Figure 7.8: Left clinical colobomatous microphthalmos and iris heterochromia.
The AL of 23 mm is within the normal range (ID 272)
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(iii) Left iris and fundus coloboma with clinical microphthalmos, normal right eye. ID
269. Right AL 21.5 mm, left AL 20 mm, left HCD 7.0 mm, Figure 7.9.
Figure 7.9: Ultrasound B-scan of left globe with left iris and fundus coloboma
with clinical microphthalmos. The anterior corneal surface and the retina are
indicated with crosses (ID 269)
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(iv) Bilateral iris/fundus colobomas and bilateral clinical microphthalmos ID 90 Figure
7.10. Right AL 22 mm (normal), left AL 17 mm (small). Right HCD 9.5 mm, left
HCD 7.0 mm.
Figure 7.10: Bilateral iris and fundus colobomas and bilateral clinical
microphthalmos, Ultrasound B-scan of right eye. The anterior corneal surface
and retina are marked with crosses (ID 90)
Clinical microphthalmos: big eye measured on ultrasound scan = colobomatous
macrophthalmos with microcornea
(i) Right iris and fundus coloboma, clinical microphthalmos: ID 79 (Figure 7.7 page
193) Right AL 32 mm, right HCD 9.5 mm.
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(ii) Bilateral iris and fundus colobomas, bilateral clinical microphthalmos: ID 192
(Figure 7.11). Left AL 24.0 mm, left HCD 8.5 mm.
Figure 7.11: Bilateral iris and fundus colobomas, bilateral clinical
microphthalmos. The left AL of 24 mm is bigger than normal. The ultrasound
B-scan is also shown (ID 192)
Ultrasound B-scan of left eye, ID 192. The axial length is 24.0 mm
6.HOME! 7.DRTE!e-0-6
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(iii) Right iris and fundus coloboma, right clinical microphthalmos: ID 258 Figure
Right Eye, ultrasound B-scan (ID 258)
7.12. Right AL 24.0 mm, HCD 9.0 mm.
Figure 7.12: Right iris and fundus coloboma, right clinical microphthalmos, iris
heterochromia. Ultrasound B-scan of right eye shows irregular post pole. The B-
scan of the normal left eye is shown at the bottom. AL right 24 mm (big), left 21
mm (normal eye in length and phenotype), HCD right 9.0 mm. (ID 258)
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Left eye, ultrasound B-scan (ID 258)
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Posterior staphyloma with or without macrophthalmos
(i) Bilateral iris and fundus colobomas, clinically non-microphthalmic Figure 7.13. The
subject is an 8-year old girl. Right AL 24.0 mm (big), left AL 28.0 mm (big). Right
HCD 9.0 mm left 10.0 mm (small). The symmetry of corneal size and the eyelid
position makes the eyes appear to be normal size.
Figure 7.13: Ultrasound B-scan of left globe with iris and fundus coloboma,
clinically non-microphthalmic. Note the ectatic and distorted posterior pole,
typical of a staphyloma (ID 76)
(ii) Bilateral clinical colobomatous microphthalmos ID 79 (see Figure 7.7). Right AL
32 mm, left AL 22 mm. The diagnosis is right colobomatous macrophthalmos with
microcornea.
(iii) Bilateral iris and fundus colobomas, right clinical microphthalmos, ID 138
ultrasound B-scan shows staphyloma Figure 7.14, AL 24.5 mm.
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Diagnosis right colobomatous macrophthalmos with microcornea. Note that the left
clinically non-microphthalmic eye has a staphyloma and AL 29.0 mm. Right HCD
11.0 mm (lower end of normal range), left HCD 11.5 mm. The bigger left cornea has
made the right eye look small.
Figure 7.14A and 7.14B: Ultrasound B-scan of right and left globes. Bilateral
iris and fundus colobomas, right clinical microphthalmos, left clinically non-




(iv) Bilateral iris coloboma, bilateral clinical microphthalmos, right fundus coloboma,
left cataract ID 55 kimberley black. Right HCD 7.5 mm, left HCD 8.0 mm. Right AL
24 mm (big), left AL 23 mm (normal). Diagnosis: right colobomatous
macrophthalmos with microcornea.
(v) Bilateral iris/fundus colobomas, left clinical microphthalmos: ID 83. Left AL 24
mm (big), right AL 24 mm (big).
Diagnosis: colobomatous macrophthalmos with microcornea. A staphyloma is
present in left eye. Right HCD 11.00 mm, left HCD 10.5 mm. The difference in HCD
has accentuated the appearance of left small eye. Both HCDs are just within normal
range.
Retinal detachment
Right extreme clinical microphthalmos, bilateral corneal opacification and iris
coloboma, Figure 7.15 (ID 94).
Figure 7.15: Ultrasound B-scan of globe with left extreme clinical
microphthalmos, bilateral corneal opacification and iris coloboma. A retinal
detachment is shown with an arrow (ID 94)
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DISCUSSION
Not all eyes that look small are small when measured. The reasons for this were
discussed in chapter one and several examples are illustrated in this study: reduced
corneal diameter, reduced palpebral fissure length, ptosis and cataract, can all lead to
the false conclusion of the eye being small.
This study has looked at a group of eyes that appear to be small and measured the AL
with ultrasound B-scan. Only 36% of these clinically microphthalmic eyes fulfilled the
definition criterion of having an AL more than 2 SDs below the age- and sex-
corrected mean. Almost half of the eyes had normal ALs and a significant number had
longer than normal axial lengths (colobomatous macrophthalmos with microcornea).
In the group of 30 eyes with structural abnormalities but without the appearance of
microphthalmos, only 4 were below the normal range of globe size, the rest being
within or above the normal range. Therefore, some eyes that appear to be of normal
size are small when measured. In the group of 21 normal eyes, the majority (72%) had
eye sizes within 2 SDs of the mean.
For the definition of microphthalmos based on axial length to be useful, all eyes
considered to be clinically microphthalmic would have to fulfil the criterion.
Alternatively, the definition could be based on measurement and then to include only
those eyes that fall below the normal range. But this would leave a group of eyes
which look small but when measured are not. This is the case in 35/55 (64%) of the
microphthalmic eyes in this study. It is neither practical nor useful in clinical practice
to require measurement of AL, which is not necessarily indicated or relevant (see
below).
- 203 -
In some of the colobomatous eyes with clinical microphthalmos, the AL was above
the mean by more than 2 SDs. This colobomatous macrophthalmos with microcornea
has already been described in the literature (Bateman and Maumenee, 1984; Pallotta
et al. 1998), but in both papers was considered only to be part of an autosomal
dominant familial trait. Only one of the cases in this study had any family history (ID
66) and the large number of cases (Table 7.1, ID 55, 75, 79, 107, 109, 113, 181, 192,
258) suggests that colobomatous macrophthalmos with microcornea is more common
than previously recognised. The big eye explains the presence of high myopia in some
cases, although hypermetropia is often found too (Olsen et al. 1996). Interestingly,
microcornea (defined by the authors as HCD less than 11 mm) was not present in all
of the cases described and was not always considered essential to make the diagnosis
(Bateman and Maumenee, 1984). Bateman and Pallotta (Pallotta et al. 1998) found
the eye anomaly of colobomatous macrophthalmos with microcornea in individuals
with no systemic anomalies. In this study, colobomatous macrophthalmos with
microcornea was found in individuals with (ID 55, 75, 109, 181, 192) and without
(ID 66, 79, 107, 113, 258) systemic congenital anomalies, many of which are
discussed in more detail in the next chapter (eight). The discussions by Bateman and
Pallotta recognise the complex interrelationship between coloboma, corneal diameter,
size of the globe and refractive error but, in an admirable attempt to categorise,
simplify and define a 'new' clinical entity, they fail to realise that this cannot be
achieved because of limitations in our understanding of why some of these structural
abnormalities arise. Reasons for an overlong axial length include staphyloma and the
ectatic distorted sclera that occurs in uveal colobomas affecting the posterior pole
(See Figures 6.4, 6.5, 6.6, 7.13, and 7.14.)
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The ultrasound B-scans confirmed some of the clinical abnormalities in cases such as
retinal detachment and microphthalmos with cyst (Fisher, 1978; Weiss et al. 1985).
The scans were well tolerated by all children but require a good degree of co¬
operation and patience on the part of the child. The ability to print an image is
advantageous. The B-scan does not require clear media in order to obtain an image of
the globe. In only one case where there was a clinically visible globe did the
ultrasound machine fail to produce a useful image of the globe (ID 100 had a small
cornea, cataract, vitreous opacification and extreme clinical microphthalmos, all of
which probably contributed to the failure to obtain an image).
There are several disadvantages of this method of imaging when used to measure AL.
A co-operative child is essential. To avoid corneal contact which would have required
topical anaesthesia and since this might have caused corneal abrasion or trauma,
ultrasounds were taken through the closed lid (Fledelius, 1996; Isenberg and Fishman,
1996). This makes it more difficult to align the probe with the visual axis, as there is
no fixation target. All the scans were performed by the author and considerable care
was taken not to indent the globe whilst performing the B-scans. The scans were
measured independently by an observer (Dr Brian Fleck), who was not aware of the
clinical diagnosis. Axial lengths were estimated by subtracting the thickness of the
closed eyelid on the ultrasound, so there may have been errors in over- or under¬
estimation of eyelid thickness in the image. It is difficult to know how accurate the
technique is, but it is unlikely to be as accurate as an ultrasound A-scan, most
commonly used for biometry prior to cataract surgery. The A-scan requires the
subject to fixate on a target or corneal contact, as well as relatively clear media so was
not considered suitable for this study. The irregular posterior pole in many cases of
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fundus coloboma would almost certainly have presented problems for an A-scanner,
and pathology such as microphthalmos with cyst or retinal detachment would not
have been detected. The A-scan also requires still more concentration and co¬
operation from the subject than the B-scan, and is therefore not suitable for smaller
children.
The technical difficulties of measuring axial length of a globe with a large fundus
coloboma or possible staphyloma include ensuring that the measurement of AL is
along the visual axis, i.e. central corneal surface to fovea, which is not necessarily the
longest axis of these eyes. Measuring the distance to the optic nerve head is not
identical to the visual axis and, in the absence of a large coloboma or staphyloma
affecting the optic nerve head, is only an approximation.
Many of the questions about the accuracy of measurements are dealt with by looking
at the results from the group of 'normal' eyes, which is almost a type of 'control'
group. There was no true control group as it was felt to be impractical to recruit
children with no eye abnormalities from outside the hospital service to avoid any bias.
The 'normal' group therefore consisted of the unaffected fellow eyes of children in the
study with a unilateral abnormality. The results on AL suggest that the methods of
measurement used in this study were accurate and repeatable, since the majority
(72%) of these eyes had normal AL measurements.
The definition of microphthalmos based on AL arose as an attempt to reduce the
confusion that exists about what microphthalmos is and how to discuss it within the
context of various epidemiological or genetic studies. It has been made clear in the
first chapter of this thesis and the previous chapter (six) that the term microphthalmos
has very limited use. Instead, emphasis should be placed on the structural
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(phenotypic) eye abnormality present. Intentionally therefore, no 'new' definition of
microphthalmos based on AL will be proposed here. In theory, one could try and
define microphthalmos clinically by looking independently at the HCD or eyelid PFL.
The HCD, when reduced, certainly gives the impression of a small eye but, as this
study shows, not all of the clinically microphthalmic eyes have a corneal diameter
which is 2 or more SDs below the normal range. Unlike some recent publications
(Hornby et al. 2000), this study has recognised that corneal growth and increase in
HCD occurs mainly in the first few years, and that 'microcornea' does not represent a
phenotypic abnormality. Like microphthalmos, microcornea is a descriptive term that
applies to many structural eye abnormalities. HCD was therefore compared to age-
and sex-matched tables. Not all eyes with reduced HCD have a reduced AL
(Warburg, 1993). The measurements in this study, taken with a rule (not callipers,
which more than likely would have been too difficult with small children), would
appear to be accurate since nearly all (95%) of the HCDs were normal in the 'normal'
group.
The palpebral fissure length results are interesting, since in many cases of clinical
microphthalmos PFL is reduced. Also, the relationship between size of the globe and
orbital growth is not entirely clear, although it is well recognised that the absence of a
globe or a small globe probably inhibits eyelid growth (Lamb, 1970; Dunaway and
David, 1996). A high proportion of all three groups studied (microphthalmos, non-
microphthalmos and normal eyes) had eyelid PFLs that were more than 2 SDs below
the normal range. It may be that in this particular group of children this was the case,
and that the presence of a normal fellow eye did not prevent the eyelids, which are
derived from different tissues in the embryo, from developing abnormally.
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Alternatively, the measurements may have been underestimated as they were taken
with a straight plastic rule, which may not have been held near enough to the face.
The reasons for not having the HCD and PFL measurements in a few cases (Tables
7.1-7.3) include lack of co-operation or not having consent, or difficulty in clearly
defining the limbus for HCD measurements.
An ultrasound scan or image of the eye is not indicated in all cases of structural eye
abnormality but, like all investigations, the decision is made based on the clinical
findings and by considering many factors. In clinical anophthalmos, it is important to
confirm the suspected diagnosis (Hodes and Snyder, 1978). Indeed, it may not be
possible to open the eyelids easily in a very small baby when the condition is first
suspected. Imaging may also reveal other pathology such as congenital cystic eye. A
CT or MRI may provide even more information, including images of the brain and
optic nerves (Albernaz et al. 1997). In an eye that appears to be smaller than normal,
provided there is a good view of the vitreous and retina through a clear cornea and
lens, imaging is unlikely to add further useful information. However, a detailed eye
examination and refraction in a baby or small child will require a general anaesthetic.
It is neither practical nor necessary for all eyes that appear to be small to have the
axial length measured. If a diagnosis such as nanophthalmos is suspected (reduced
HCD, high hypermetropia), an ultrasound A-scan may be more appropriate for
measurement for the AL.
Clinically anophthalmic eyes were not included in this part of the study, since the
primary concern was AL measurement. Ultrasound B-scan would only confirm the
absence of a globe and not add significantly to whatever detail was already known.
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An eye can appear to be small for several reasons, all of which contribute to the
appearance: eyelid PFL and palpebral aperture, facial asymmetry, reduced HCD, any
ocular asymmetry, abnormalities of the cornea or pupil or lens opacity.
Although AL of the eye cannot and should not be used to make a clinical diagnosis of
microphthalmos, the size of the eye as determined by ultrasound may have some use
in predicting visual function. Hornby et al looked at visual acuity in a large series of
eyes with coloboma (Hornby et al. 2000). Sub-classification included the categories
of microcornea with and without microphthalmos. Microphthalmos was defined using
the definition of an eye smaller than 2 SDs below the mean, which is less than 18.5
mm AL in an adult. Such eyes tend to have extensive chorioretinal malformations,
retinal detachment and vitreous opacification (IDs 93, 94, 97). In addition,
microcornea (defined in Hornby's study as less than 10 mm HCD), was found to be a
predictor of poor visual acuity when HCD was less than 6 mm. Neither of these two
findings based on HCD or AL are at all surprising since the eyes with smaller anterior
segments are more likely to be the most severely malformed and have posterior
segment involvement. By arbitrarily defining microcornea as less than 10 mm HCD,
many eyes with the appearance of clinical microphthalmos would be inappropriately
excluded from further investigation, especially as they will have had structural
abnormalities such as coloboma. The study by Hornby, in a worthy attempt to simplify
a complex eye malformation, has created many artificial categories that overlap and
cannot readily be distinguished (e.g. coloboma with microphthalmos, coloboma with
microcornea). This approach also requires measurement of AL of every case of
coloboma.
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It is important to emphasise that a very small cornea often means a small eye
(Bateman, 1984) but that there is no consistent relationship between corneal diameter
and size of the globe. The results of this study make it quite clear that in many cases
of small cornea, the size of the eye is normal, or even bigger than normal.
Summary, chapter seven
• Axial length of the eye is not a useful definition ofmicrophthalmos.
• Axial length of the eye is very variable in the group of congenital eye defects
studied, most ofwhich had a uveal coloboma.
• Ultrasound B-scan is useful for visualising and confirming intra- and extraocular
abnormalities, although there are limitations as to what can be seen.
• More than 42% of clinically microphthalmic eyes have an axial length within the
normal range when corrected for age and sex.
• Some clinically microphthalmic eyes are bigger than normal: colobomatous
microcornea with macrophthalmos.
• Colobomatous microcornea with macrophthalmos is not just an autosomal
dominant familial eye condition, and occurs in individuals with systemic anomalies.
• Reduced eyelid palpebral fissure length and reduced horizontal corneal diameter
are both common in clinical microphthalmos, but are not consistent findings.
• Not all structurally abnormal eyes need imaging: a specific indication should be
sought.
Up to this point, the structural eye anomalies have been discussed as eye conditions
only, with minimal reference to the individual in whom they occur. As described in the
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introduction to this thesis (chapter two), no description of these eye anomalies would
be complete without examining the possible relationship between the eye
abnormalities and the many congenital systemic anomalies, clinical genetic syndromes
and associations. This is the subject of the next chapter.
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CHAPTER EIGHT
THE ASSOCIATED SYSTEMIC ANOMALIES, PATTERNS OF
INHERITANCE AND RECURRENCE RISK
A prospective study that ascertains individuals with the entire spectrum of
colobomatous defects from cystic eye to iris coloboma is needed to derive these types
of empirical recurrence risks that exist for many other common congenital
malformations. (Pagon, 1981).
Summary
121 children were examined for non-ocular congenital anomalies.
The colobomatous and non-colobomatous eye defects and the clinical anophthalmos
studied were frequently associated with extraocular congenital anomalies.
Some previously recognised clinical genetic syndromes and associations were
identified.
Many children were identified with multiple congenital anomalies that did not fit any
previously described pattern or syndrome.
Mendelian patterns of inheritance were recognised in some individuals belonging to
families with other affected members, with apparent autosomal dominant and
recessive inheritance.




The classification system proposed in chapter six when applied to the 121 cases
appears to be robust and consistent.
Recurrence risk estimates have been calculated for anophthalmos/microphthalmos and
coloboma (Morrison et al. 2002).
It has not been possible to distinguish cases having a genetic aetiology from
environmental/sporadic causes, based on examination.
ASSOCIATED SYSTEMIC ANOMALIES
BACKGROUND
Chapter two described how in previous studies involving clinical
anophthalmos/microphthalmos and coloboma, a significant number of the affected
individuals are reported to have systemic congenital malformations in addition to the
eye anomaly (Pagon, 1981; Bateman, 1984; Maumenee and Mitchell, 1990; Clementi
et al. 1992; Warburg, 1993; Leppig and Pagon, 1993; Kallen et al. 1996; Tucker et
al. 1996; Daufenbach et al. 1998). These associated anomalies have been considered
in various categories, some of which overlap extensively: clinical genetic
(malformation) syndromes, multiple malformations but without a recognised
syndrome, associations, chromosomal defects and single gene autosomal dominant,
recessive or X-linked syndromes. (Pagon, 1981; Daufenbach et al. 1998). Some
authors have listed the extraocular abnormalities as 'midline', 'limb' or 'digital'
defects (Maumenee and Mitchell, 1990). In other reports, the anomalies are listed
according to the organ system affected. (Kallen et al. 1996). Maumenee looked at 82
patients with colobomatous defects of the eye and identified a malformation syndrome
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in 28 cases (34%) (Maumenee and Mitchell, 1990). Daufenbach studied associated
anomalies in 48 children with chorioretinal coloboma and 18 (38%) had systemic
abnormalities (Daufenbach et al. 1998). Because of problems with definition of these
eye conditions and the differing primary aim of each of these studies (Clementi et al.
1992; Kallen et al. 1996), there is a huge variation in the percentage reported with
extraocular systemic anomalies. The difficulties with definition are not confined only
to the eye defects, as some systemic anomalies may be considered too minor to report
or document (Leppig and Pagon, 1993).
In this study, a number of different approaches were used to document and to try and
make sense of the systemic anomalies detected. It was hoped that the presentation of
the raw data, without prior assumption of a 'genetic' or 'environmental' cause, might
reveal new patterns or trends.
Classification system (chapter six)
As was made clear in the previous chapters, the term microphthalmos was not used as
a diagnosis; instead, the phenotypic eye classification (described in chapter six) was
employed. A further aim was to validate the classification system by seeing if the OFD
was different in any way from non-OFD with respect to extraocular malformations.
Isolated eye anomalies
This is one of the most interesting concepts and various terms have been employed by
other authors in an attempt to understand the aetiology of this entity more completely.
Leppig refers to 'ocular coloboma without known cause', excluding subjects with an
autosomal dominant condition, a known syndrome or chromosomal abnormality
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(Leppig and Pagon, 1993). They did include patients with mental retardation and
other malformations.
'Isolated' usually meant that the eye anomaly occurred without systemic anomaly and
with no positive family history. An individual case like this can be considered to be
'sporadic' in aetiology. To some authors, this implies that the cause is 'non-genetic',
but there is no evidence for this. As shown in chapter two, abnormalities may be
confined to the eye in an individual with a positive family history.
METHODS
A total of 121 children were examined in detail and the ocular diagnoses are listed in
Table 5.8, page 142). Systemic congenital anomalies were defined as any major
deformity requiring treatment or surgical correction or causing morbidity or mortality,
including significant developmental delay (Leppig and Pagon, 1993).
All previously documented congenital abnormalities and any named syndromes or
provisional diagnoses used in the past in reference to the child were recorded. A full
general examination of every child was done, including height, weight and head
circumference. Photographs were taken of face, hands and feet. Additional
photographs were taken of any anomalies seen. Supplementary information and
previous investigations were confirmed by contacting general practitioners or by
review of hospital medical records, with the parents' written informed consent.
The file, medical records and photographs of each child were reviewed with Dr David
FitzPatrick, Consultant Clinical Geneticist. Any dysmorphological features were
noted. In all cases with an extraocular congenital abnormality, a search for an
identifiable syndrome or association was made on the London Dysmorphology
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Database (LDDB) (Baraitser and Winter, 2000). A systemic clinical diagnosis was
made wherever possible, and all cases were classified as isolated (i.e. eye anomaly
only) or non-isolated (extraocular anomaly present).
All cases where there was a positive family history were recorded, including full
details of the pedigree.
RESULTS
121 children were examined and included in this part of the study. The eye defects
were divided into three groups: optic fissure defect, non-optic fissure defect, and
unclassifiable (chapter 6, Tables 6.1, 6.2 and 6.3).
Extraocular (systemic) congenital anomalies
These covered the entire range of organs and systems. The individual results are
summarised in Table 8.1, and the range of anomalies are listed in Table 8.2. Those
abnormalities that occurred in significant numbers are discussed separately below.
Extraocular malformations can be grouped into those affecting the brain, head and
neck, chest, abdomen, and limbs. Most of the congenital anomalies were previously
documented and investigated and treated as clinically indicated. For the brain defects
described, reference was made to CT scan reports.
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Table 8.1: Associated systemic congenital anomalies
ID
Sex
l=male Systemic (extraocular) congenital anomalies
2=female
15 2 nasogastric feeding, congenital heart disease (VSD, PDA), trisomy 18
26 1 learning difficulties
33 1 postaxial Polydactyly, proximal set thumbs
35 9




left Vllth nerve palsy, choanal atresia, laryngomalacia, congenital heart
disease (PDA), overriding toes 2/3
45 l
feet 4/5 toe syndactyly, cleft palate, micrognathia, inguinal hernias,
horseshoe kidney
47 I
severe developmental delay, cerebral cortical atrophy, low set ears, doll-like
facies
50 l
cerebellar cyst, left ear tag, left facial/scalp capillary haemangioma,
scoliosis
53 l microcephaly, right inguinal hernia
55 2 congenital heart disease (VSD), unilateral deafness, toes 2/3 syndactyly,
22q 11 microdeletion
58 2 microcephaly
60 1 postaxial Polydactyly R hand and both feet, psoriasis
62 2 agenesis of corpus callosum, ptosis, 4/5 hand syndactyly, broad toes
63 2 heminasal aplasia, pyloric stenosis, congenital heart disease (VSD)
67 2 hydrocephalus, bilateral radial aplasia, congenital dislocation of the hip
75 1 congenital heart disease (PDA), digitalised thumbs, maxillary hypoplasia
76 2 broad nasal tip, unusual facies (Kabuki-like)
90 1 congenital heart disease (PDA), low set lop ear
93 2
2/3 syndactyly left toes, high nasal root with broad tip, low set ears, short
tented philtrum
94 1 congenital myopathy
96 2 tracheo-oesophageal fistula
97 2 hypotonia, ataxia, pharyngoplasty, 4/5 brachydactyly, deafness
109 1 bilateral cryptorchidism, low set posteriorly rotated ears
117 2 microcephaly
145 2 significant developmental delay
162 1 congenital heart disease (hole in heart), extra bones in feet
166 2 cleft palate, right deafness, notched alae nasi
181 1 hypotonia, right low set posteriorly rotated ear
192 2 abnormal vertebrae (C6/7), heart murmour
199 1 right hip subluxation, pyloric stenosis, cong heart disease (PDA)
204 1 heminasal hypoplasia





11) Systemic (extraocular) congenital anomalies
213 2 seizures, heminasal aplasia with proboscis (surgery) ophthalmic
encephalocele
216 1 bilateral cleft lip and palate, glomerulonephritis
224 1 prominent ear lobes, small mouth, chest wall unusual shape
232 1 cleft plate, left inguinal hernia, cryptorchidism
238 1 congenital heart disease (Fallot's), nasal speech
239 2 hydrocephalus, abnormal premaxilla, lowset rotated left ear
253 1 osteogenesis imperfecta, umbilical hernia, camptodactyly
284 1 severe learning difficulties
299 1 severe learning difficulties, bilateral cleft lip and palate
324 1 congenital heart disease, developmental delay
Table 8.2: Extraocular (systemic) congenital anomalies
Head and
neck
seventh cranial nerve palsy, laryngomalacia, unilateral deafness,
cleft palate, cleft lip and palate, capillary haemangioma, nasal
hypoplasia (Figure 8.1), choanal atresia.
Brain ... cortical atrophy, microcephaly, cerebellar cyst, agenesis of corpus
callosum, hydrocephalus, seizures, sleep apnoea, absences, petit
III : mal.
Chest !§!!!! ventriculoseptal defect (VSD), patent ductus arteriosus (PDA),
lllll Fallot's tetralogy.
Abdomen lllf! umbilical hernia, inguinal hernia, inguinal hernia with
cryptorchidism, cryptorchidism, glomerulonephritis, horseshoe
kidney, pyloric stenosis, hypospadias.
Limbs 4/5 syndactyly of hand, bilateral radial aplasia, congenital
dislocation of the hip, extra bones in feet, hypotonia, Polydactyly
f| hand and feet, post axial hand Polydactyly, 4/5 syndactyly of feet,
I h congenital hip subluxation, congenital myopathy, 2/3 toe
:|1| syndactyly (Figure 8.2), scoliosis
Skid eczema, psoriasis, capillary malformation over lumbar spine.
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Figure 8.1: (Right) nasal hypoplasia and clinical anophthaimos (prosthetic eye
in place) (ID 204)
Figure 8.2: Bilateral toe syndactyly, toes 2 and 3 (ID 55)
Dysmorphic features
These are soft variations in morphogenesis and are not easy to categorise, and there is
some justification to not including them in any analysis. In some cases they can be
confirmed by measurement and rigid adherence to diagnostic criteria. It is not within
the scope of this thesis to describe the art and science of dysmorphology as it applies
to clinical genetics.
Several dysmorphisms were noted (Table 8.3), mostly affecting the head and neck. At
least 40 children were judged to be facially dysmorphic. As already stated, there was
■ 219 -
no control group and 'soft' dysmorphic features were noted in nearly every child. Ear
abnormalities were documented in 20 cases.
Table 8.3: Dysmorphic features
Ears posteriorly rotated ears, low-set, simple, cleft ear lobe (Figure 8.3),
prominent, large, preauricular pit, lop ear, ear tag.
up-slanting palpebral fissures, down-slanting palpebral fissures,
epicanthus.
broad nasal root, high nasal root, notched alae nasi, nasal hypoplasia,
small nose.
Lips Cupid's bow upper lip, long philtrum, thick lips, thin upper lip, short-
tented philtrum, smooth philtrum.
Teeth Crowded.
Mouth small, carp-shaped, Cupid's bow mouth.
Face tall forehead, maxillary hypoplasia, facial asymmetry, hypertelorism
Digits broad thumbs, camptodactyly, 4/5 brachydactyly, tapering fingers, 4/5
finger clinodactyly, arachnodactyly, short 4/5 metatarsals, proximal set
thumbs, digitalised thumbs (Figure 8.4), short hallux bilaterally, saddle-
gap toes, overriding toes 2/3.
Height short stature.
Figure 8.3: Cleft earlobe (ID 187)
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Figure 8.4: Digitalised left thumb (indicated with arrow) (ID 75)
A previously recognised clinical genetic syndrome or association or chromosomal
syndrome was identified in 13 children (Table 8.3). Three of these had the CHARGE
association (Pagon et al. 1981a).
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Congenital heart disease
Congenital heart disease was present in 11 individuals (9%). Six of these had a patent
ductus arteriosus (PDA), two a ventriculoseptal defect (VSD), and one tetralogy of
Fallot, (see Table 8.6).
Significant developmental delay
This was the commonest congenital anomaly present, affecting 23 children (19%),
most of these severely (Table 8.6).
Karyotyping: chromosomal abnormality on G-banding
Not all children in the study had karyotyping. In those cases where chromosomes had
not been previously tested, G-banding was done on a blood sample. In 35 cases,
chromosomes were tested. The indications for testing included any child with
significant developmental delay and at least one congenital anomaly or growth failure
or multiple craniofacial dysmorphisms. One case of trisomy 18 (47 XX, +18) was
confirmed.
One child (ID 20) was noted to have increased chromosome fragility. This girl did not
have developmental delay or any systemic congenital anomaly.
Several other individuals were strongly suspected of having chromosomal
abnormalities, but none were detected on G-banding or when specific microdeletions
were sought. For example, ID 166: severe developmental delay, cleft palate, unilateral
deafness, dysmorphic (notched alae nasi, smooth philtrum).
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Chromosome deletions and microdeletions
The second child with a significant chromosome abnormality was a girl with a 22ql 1
microdeletion (Table 8.4, ID 55). Chromosomes were normal on G-banding. Two
other individuals (ID 97, 238) strongly suspected of having a 22q 11 microdeletion
were tested and no deletion was found:
ID 97: mild developmental delay, deaf, hypotonia, pharyngoplasty, hand (4/5)
brachydactyly.
ID 238: Fallot's tetralogy, nasal speech, mild developmental delay.
A chromosome 4p deletion was suspected in ID 228 (Shapira, 1998). Ocular features
were bilateral iris and fundus colobomas. Dysmorphic features included a broad nasal
root and low-set ears. No 4p deletion was found on testing.
'Syndromic' but not recognised
Many of these were unusual combinations of congenital birth defects not previously
described or readily explained. In this study, this group comprised those children in
whom the clinical features strongly suggested a clinical genetic syndrome or
association or that a chromosomal abnormality might be found. In none of these cases
was a search on the London Dysmorphology Database productive (Baraitser and
Winter, 2000).
ID 253: Male, age 8. Unilateral clinical anophthalmos (extreme microphthalmos) with
osteogenesis imperfecta and umbilical hernia. Camptodactyly of fingers. No
developmental delay.
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ID 50: Male, age 4. Severe developmental delay, cerebellar cyst, left ear tag,
preauricular pit, capillary haemangioma on scalp, scoliosis.
Several children were suspected of having a particular clinical genetic syndrome but
when investigated none of these were proven, e.g. ID 45 suspected Rubinstein-Taybi
syndrome but no 16p 13 deletion detected (Hennekam et al. 1993).
Systemic congenital anomalies and clinical anophthalmos
As defined by the classification system, clinical anophthalmos was included in the
category of unclassifiable defects i.e. it is not possible to know with certainty whether
the defect has arisen due to an event occurring at the time of optic fissure formation.
One would expect the range of systemic anomalies to be very different if the
aetiologies were different. The systemic anomalies in the seven cases of anophthalmos
are listed in Table 8.4. Although the range of extraocular congenital anomalies listed
is diverse, in all cases the anomalies are of craniofacial origin and all but one child has
severe developmental delay.











































The majority (62.8%) of individuals examined were considered to have a congenital
eye abnormality only (Table 8.6). This was defined as having no systemic congenital
anomaly or developmental delay, no chromosomal abnormality, and not being
significantly dysmorphic. This isolated group also included those with a confirmed
family history (see below). There is an argument to exclude those with a family
history as not being truly 'isolated' since a 'genetic' cause is strongly suggested. It is
these apparently isolated eye abnormalities that cause some of the greatest difficulty in
genetic counselling. (See recurrence risk below and discussion.)
Positive family history
Those individuals with a confirmed family history of an eye defect were identified in
chapter six. Eight different family pedigrees were affected, one of these having
identical twins (ID 268 and 269). The presumed or most likely pattern of inheritance
is listed in Table 8.5 along with the clinical details. Seven of the eight affected
pedigrees had defects related to closure of the optic fissure (Table 8.6). Both
autosomal dominant and recessive patterns of inheritance are suggested. Within these
affected pedigrees both unilateral and bilateral ocular pathology was found, e.g. IDs
26 and 106. Some affected members had congenital anomalies isolated to the eye and
others did not, e.g. IDs 216 and 132.






















































ID132unilateral irisandfundus coloboma ID216unilateral irisandretinal coloboma ID299 unclassifiable.
ID132isolated ID216 glomeruloneph ritis,cleftlip andpalate ID299severe developmental delay
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Table 8.6: Systemic examinations of 121 individuals with congenital eye
anomalies in relation to type of eye defect
Ocular Optic fissure Noil-optic Uuclassiilabic TOTAL
developmental defect (OLD) fissure
pathogenesis defect (non-
OFD)
iMiiii 86 11 24 121
Bilateral eye :• 45 6 10 61 (50.4%)
pathology
Discordance of 11 o 0 0 0
pathogenesis in
bilaterals
Isolated (ocular 111 58 8 10 76 (62.8%)
anomaly only)
Positive family *| 7 1 0 8
history
Other congenital SI 27(31%) 2(18%) 16 (66%) 45
anomaly
(% of subgroup)






Congenital heart HI 9(10.5%) 0 (0%) 2 (8.3%) 11
disease
(% of subgroup)
Developmental >.. 13(15%) 2 (18%) 8 (33.3%) 23
delay
(% of subgroup)





In this study, 37% (45/121) of children had an extraocular congenital anomaly and the
findings are consistent with other studies. Previous studies have been at major referral
centres or estimates from congenital anomaly registers (Maumenee and Mitchell,
1990; Leppig and Pagon, 1993; Kallen et al. 1996; Tucker et al. 1996; Daufenbach
et al. 1998). Such studies tend to include the more severely affected individuals as far
as the eye abnormalities are concerned. This study was based on an entire population
and selection bias is therefore minimal.
The data from a large epidemiological study in Europe and California using congenital
anomaly registers estimated that non-eye malformations were present in 73% of
children with anophthalmos or microphthalmos after excluding all cases with a known
chromosomal abnormality (Kallen et al. 1996). A review of the records of48 patients
found that 18 (38%) had other systemic anomalies (Daufenbach et al. 1998). In one
retrospective study of the records of 82 patients in whom there was a colobomatous
malformation, 27% had a 'midline' defect (clefting, cardiovascular, urogenital and
intracranial malformations), 13% had digital anomalies, and between 15% and 24%
had mental retardation. An identifiable syndrome was present in 28 patients, the
CHARGE association being the commonest (Maumenee and Mitchell, 1990). In a
retrospective review of ocular coloboma without known cause, defined as coloboma
not occurring as part of a known syndrome or as autosomal dominant condition, 58
patients were examined for coexisting malformations. Mental retardation was present
in 14/42 (33% ) of those more than one year old. Other congenital malformations
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were present in 43% of the patients. Of these 25 patients, 10 had anomalies of the
heart or great vessels and 18 had skeletal anomalies (Leppig and Pagon, 1993). A
review of the medical records of 77 patients with anophthalmos or microphthalmos
referred to Moorfields Eye Hospital found a 50% association with systemic anomalies
in patients with congenital unilateral or bilateral anophthalmos and congenital
unilateral or bilateral 'remnant only' microphthalmos. The percentages were lower in
unilateral and bilateral non-colobomatous microphthalmic groups (30% and 0%
respectively) and unilateral and bilateral coloboma microphthalmic groups (11% and
0% respectively) (Tucker et al. 1996).
Clinical genetic syndromes, associations and one case of a chromosomal malformation
syndrome were identified in this population. In several children, the pattern of
malformations was not previously described or recognised. Is this evidence of a
genetic or environmental cause? It can be taken as evidence of either or both. Many
clinical genetic syndromes have variable expression of the systemic features, and some
sporadic (environmental) conditions are suspected and characterised by their random
nature with respect to almost any organs or system being involved (see chapter two).
In this study, care has been taken to avoid ascribing a 'cause' or aetiology to any of
the eye or systemic malformations described. Whilst it is important to recognise
congenital malformation syndromes, such an exercise may detract from the search for
a cause. This study avoided the temptation to describe new syndromes or fit those
children into a previously recognised category. New combinations of congenital eye
and systemic anomalies can lead to the recognition of a syndrome, but is only likely to
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when such a combination occurs within a well-phenotyped pedigree, as opposed to
the sporadic (isolated) cases seen in this study.
None of the parents in this study were questioned about the details of the pregnancy
such as medications taken, diet, place of conception, and unusual events happening in
early pregnancy. This information, whilst being of great interest, would not establish a
causal role for the eye defects in any individual affected child. Mrs Sheena Macdonald
at the University of Edinburgh is currently investigating these aspects in an
environmental case-control study.
Family history
The affected individuals with family histories confirm that pedigrees with autosomal
dominant and recessive inheritance exist, and X-linked inheritance has been described
(chapter two).
Chromosomes
This study has once again highlighted the limitations of a 'normal' chromosome result
by G-banding. Macroscopic chromosome studies on 35 patients revealed only one
abnormality (trisomy 18). Leppig and Pagon studied the chromosomes of 21 of 58
patients with colobomatous malformations and only two were abnormal. One case
was an inherited balanced translocation of chromosome 2 and 21 (inherited from a
father whose eyes had not been examined) and the other was an individual with a low
level of mosaicism for a small marker chromosome that could not be characterised.
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This marker chromosome had been detected from peripheral blood and skin
fibroblasts (Leppig and Pagon, 1993).
Further work on the study cohort could look at skin chromosomes for mosaicism, if it
was felt that the likelihood of the chromosomes being abnormal was strong.
The paucity of macroscopic chromosome abnormalities (G-banding) in this study is
interesting. It is likely that the contribution of chromosomal deletions and
rearrangements has been overestimated in older studies since the eye diagnosis may be
imprecise or not specified (see chapter two). Cases for this study may have been
missed, particularly in children with multiple or life-threatening congenital
malformations. Documentation of eye abnormalities may be incomplete and not
appear on the congenital malformation registers if it is assumed that their presence is
part of a recognised systemic association or syndrome (Bianchi et al. 1994; Kallen et
al. 1996).
Why are systemic anomalies so common?
According to the developmental field concept (Opitz, 1985), in which body parts can
be affected in an identical manner by different insults, one can consider the eye as a
developmental field. If single gene defects exist, which act in the early stages of the
developing embryo prior to the definition of 'limb', 'midline' and 'ocular' fields, the
non-random occurrence of such malformations within syndromes is explained. Such a
theory is also consistent with environmental pathogens being the cause of such defects
during the sensitive developmental period (Maumenee and Mitchell, 1990).
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Congenital heart disease occurred in 11 cases, 9 of these in the OFD group and the
other two unclassified. This does suggest the possibility of a disruptive event
occurring at similar stages of embryogenesis for both the eye and the heart. The major
septa of the heart are formed between the 27th and 37th days of development, in
parallel with optic fissure formation and closure (Langman, 1984).
How can unilateral eye defects be genetic or inherited?
There were 61 (50.4%) of individuals bilaterally affected, with the pathology being
symmetrical in 17 of these cases. The asymmetry of ocular pathology is clearly
demonstrated in this study. Significant differences are often seen between the two
eyes of one individual, from completely normal, through minor eye abnormalities such
as iris coloboma, to complete anophthalmos. Such insults occur at an early
embryological stage, but repair could occur with the existence of pluripotent cells.
It seems reasonable to suppose that any individual has two genetically identical eyes
but for stochastic reasons, these two eyes may express the genetic defect differently.
For example, this could be the result of small differences in protein production by
dosage sensitive genes such as PAX6 (chapter nine).
Normal development depends on an ordered sequence of induction, so that growth,
migration and differentiation begin in the right place, time and direction. This ordered
sequence is regulated by genetic control, the genes being expressed during early
development. It is possible that teratogens and environmental agents act on the
genetic expression of early human differentiating cells. The genetic background of the
embryo could presumably determine the sensitivity to external agents.
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Classification of structural eye defects (see Table 8.6)
In chapter six a novel and simple classification system was proposed, grouping the eye
malformations according to whether the primary embryopathology occurred during
formation or closure of the optic fissure. The robustness of the classification system
can be tested since one would predict the following:
1. Concordance of the type of eye defect in bilaterally affected individuals within the
same sub-classification group
2. Concordance of the type of eye defect in family recurrences within the same sub
classification group.
3. A similar spectrum of associated congenital anomalies and syndrome diagnoses
within classification groups.
4. A different spectrum of associated congenital anomalies and syndrome diagnoses
between classification groups.
This type of classification system would imply the existence of aetiologically distinct
groups. This would improve genetic counselling and refine the analysis of
epidemiological data and assessment of the role of the environment. A more rational
approach to candidate gene selection and analysis is also possible.
Taking each of the above points (1-4) in turn, there was 100% concordance of the
type of defect in bilaterally affected individuals. There were no cases of an OFD in
combination with a non-OFD in the same individual (chapter six). In those cases with
a family history (chapter six page 164 and Table 8.5 page 228), the type of eye defect
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was consistent within the pedigree. Associations and syndromes were recognised
within all three groups but the rarity of these cases makes any comparison between
each group difficult (Table 8.6).
The associated congenital anomalies and syndromes were found amongst all three of
the classification groups. By definition, all three cases of CHARGE association were
from the OFD group. The percentage of each group affected by extraocular anomalies
was between 18% (non-OFD) and 66% (unclassifiable). Malformation syndromes and
associations were present in all groups but the rarity of these syndromes and the small
group sizes do not make it possible to make any firm conclusion (Table 8.6). The
small size of the non-OFD and unclassifiable groups does not justify statistical
comparison. Also, these two groups are almost certainly heterogeneous. The
unclassifiable group, consisting of those cases in which no ocular phenotype could be
established (e.g. clinical anophthalmos, sclerocornea) might well include cases with an
underlying optic fissure defect. The argument that the unclassifiable group is more
severely affected is not helpful, since the severity of eye malformation could be
determined by appearance (which is subjective), or visual function. Vision does not
necessarily relate to the 'severity' of the eye defect and can be surprisingly good
(Olsen et al. 1996). A study by Leppig did not find any relationship between the
severity of ocular coloboma (graded into three categories of vision: good vision in
both eyes, good vision in one eye and poor vision in both eyes) and the probability of
associated systemic malformations or mental retardation (Leppig and Pagon, 1993).
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Clinical implications
All children presenting with clinical anophthalmos or a uveal coloboma need careful
assessment by a clinical geneticist or paediatrician. Investigation should be guided by
the history and clinical examination with particular emphasis on dysmorphology and
family history. Laterality is not an indicator of the cause being genetic or hereditary.
Normal chromosomes do not exclude a genetic cause, and neither do congenital
abnormalities isolated to the eye. There are implications here for genetic counselling
(see below).
Further studies
It would be valuable to study in more detail a larger group of eyes without a fissure-
defect (non-OFD), since the relatively small numbers in the study do not allow sub-
classification or statistical comparison.
This study has contributed to understanding by the development and testing of a
rigorous and simple classification that is robust and can be built on. However, the ill-
defined 'optic nerve head disruption' defects ('optic disc coloboma') remain a
debatable mystery, as well as the limitations of the non-OFD and unclassifiable groups
since they represent different ocular phenotypes.
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RECURRENCE RISK OF UVEAL COLOBOMA, ANOPHTHALMOS AND
OTHER OPTIC FISSURE DEFECTS
INTRODUCTION
There are very few studies on the recurrence risk of inheriting uveal coloboma and
anophthalmos (Pagon, 1981; Maumenee and Mitchell, 1990) and reliable information
on which to base advice does not exist (Harper, 1998). One of the aims of genetic
counselling is to be able to give the parents of an affected subject some likelihood or
estimate of recurrence in another child or the offspring of the affected individual, and
this was one of the most important aims of this study. This is the empiric risk. Some
important points need to be remembered here. Firstly, the empiric risk is never nil, as
there is always a sporadic risk to any individual in a population, regardless of family
history. This equates to the birth prevalence of around 1 in 10,000 (0.0001%).
Secondly, the recurrence risk depends on the presumed or most likely mode of
inheritance based on as much information as possible from the pedigree of the
proband.
It is not so difficult to give an accurate recurrence risk in these first two examples.
The difficulty arises when the proband is the first child ofunaffected parents, when the
pattern of inheritance can be a new sporadic mutation, autosomal recessive, or 'not
genetic' but environmental in aetiology. It is not possible, as the data above has
shown, to distinguish these categories on examination. The presumption has always
been made that cases bearing resemblance to some clinical genetic 'syndromes' are
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more likely genetic. The problem lies in the fact that no genetic abnormality has been
demonstrated to date (see chapter two).
The purpose was to determine the empiric risk regardless of the presence of
extraocular anomalies. The numbers in the study and the very few affected individuals
with presumed familial inheritance does not make it possible to separate 'isolated'
from 'non-isolated' cases, and as has already been made clear in chapter two, such a
separation may be unjustified. For an individual to have truly 'isolated' ocular
abnormalities is a difficult definition to maintain. What is the significance, for example,
of subtle dysmorphism in the absence of a recognisable syndrome or demonstrated
chromosome abnormality?
The penetration of the genes responsible for optic fissure defects is considered to be
less than 100% but it has never been precisely calculated or estimated, and gene
expression is highly variable within the same pedigree (Pagon, 1981). One difficulty is
that a coloboma may be manifest only on fundus examination, with no easily visible
anterior segment abnormality such as iris coloboma, although this situation appears to
be very rare (see chapter six).
The recurrence risk for the child of an affected person has been estimated as 46%
(Maumenee and Mitchell, 1990). According to Pagon (Pagon, 1981), the apparently
unaffected offspring of a parent with autosomal dominant coloboma has an 8.6%
chance of having an affected child. Parents with normal eye examination and no family
history having a child with isolated ocular coloboma have a recurrence risk of less
than 25% but greater than the sporadic risk. Maumenee estimated this as 9%.
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METHODS
In this study, an attempt was made to examine all first-degree relatives (parents and
siblings if present) and when they were not present, confirmation of a normal eye
examination in the past by an ophthalmologist or optometrist was sought. The
remaining normal phenotypic classifications relied on family reports of normal eye
structure and vision.
The 122 index cases were identified from 115 families. The individuals with a family
history and the most likely mode of inheritance are listed in Table 8.5 (page 228).
Cases with known chromosomal or single gene defects were excluded, as were cases
with well-recognised patterns of malformation such as the CHARGE association.
Empirical recurrence risk
The empirical recurrence risk was calculated with the assistance of Dr David
FitzPatrick, consultant clinical geneticist. Sibling recurrence risks were calculated by
designating a single affected individual in each pedigree as the index case. Where two
study cases were identified in the same family the eldest individual was taken as the
index case. Two different segregation analyses were performed, taking into account
incomplete ascertainment.
RESULTS
A total of 122 index cases were examined from 115 different families. For the
recurrence risk analysis eight cases (seven families) were excluded: one adopted child
(ID 324), four cases with recognisable patterns of malformation (three CHARGE
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association [ID 35, 40 & 96; ID 35 and 96 were concordant monozygotic twins],
Schwartz-Jampel syndrome with nanophthalmos only [ID 60]), and three cases with
known chromosome anomalies (47,XX,+18 [ID 15]; 46,XX,del(22)(ql 1.22) [ID 55];
46,XY,del(5)(ql5;q22) [ID 45]). The remaining data set consisted of 114 index cases
in 108 pedigrees. 1/114 cases (ID 109) was the offspring of consanguineous (first
cousin) parents. Table 8.7 is a summary of the estimated empirical recurrence risks
and related confidence intervals for all 108 cases of MAC and for the sub-group of
cases with OFD. Details of the families with recurrences are given in Table 8.5 (page
228).
The empirical sibling recurrence risk was 6-8% in the whole group (OFD, non-OFD
and unclassified) and 8-13% in the OFD sub-group (Morrison et al. 2002).
Recurrence risks are higher than previous estimates.
All recurrences in siblings and first-degree relatives were in the OFD group. Although
similar, the recurrence risk was 33% higher in those with bilateral disease (6-11%)
compared with unilateral pathology (5-8%). The risk was significantly reduced (by
25-30%) if the parents did not have any structural eye defect. There were no
recurrences in the unclassifiable group, this group being the one that included all the
cases of clinical anophthalmos.
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OFB group 74 99 8 0.060 (0.000) 0.100 (0.001)
Non-OFD group 12 9 0 0.000 0.000
Unclassifiabte 22 26 0 0.000 0.000
Whole group Total 108 134 8 0.081 (0.001) 0.133 (0.002)
Unilaterally alTected 55 61 3 0.049 (0.001) 0.079 (0.002)
BUaterallv affected 53 73 5 0.068 (0.001) 0.117 (0.002)
Unilaterally alTeeted,
parents normal
55 61 3 0.049 (0.001) 0.079 (0.002)
Bilaterally affected*
parents normal
50 69 2 0.029 (0.000) 0.043 (0.001)
Parent and child
affected
3 4 3 0.750 (0.047) 0.857 (0.020)
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DISCUSSION
The recurrence risk for unilateral and bilateral OFD is similar. This is not entirely
surprising. The familial cases had unilateral as well as bilaterally affected individuals.
The possible reasons for this were discussed earlier in this chapter (page 235). In none
of the unilateral OFD recurrences was a parent affected, which may suggest the action
of a mutation of low penetrance in these families.
The calculated figures are only a guide and may have a degree of bias, since all of the
affected individuals, some of whom are relatively mildly affected, have survived and
therefore will not be the most severely affected from a systemic point of view.
The recurrence risk for 'isolated' cases has not been calculated separately. This is
justified on the basis that truly isolated cases cannot be defined or that any definition
could be re-interpreted. Not all of the cases studied had cytogenetic tests, although
the likelihood of any abnormality being detected in those not tested for a clinical
reason is extremely low.
The recurrence risk for sporadic clinical anophthalmos is a challenging question. If
clinical anophthalmos, an 'unclassifiable' defect, is the most severe form of optic
fissure defect, then the risk is the same as that for OFD i.e. 3-8% when both parents
are normal. There is, as discussed in chapter two, much evidence to suggest that
clinical anophthalmos and simple iris coloboma are related.
For the first time, calculated empirical recurrence risk figures are presented for these
rare but important eye malformations. The figures can be applied in counselling
affected families and individuals.
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The study data has been derived from a group of children. Longer-term follow up of
their offspring would yield further information.
Summary, chapter eight
• The systemic congenital anomalies in 121 children with congenital eye
anomalies are described.
• Common systemic associations were developmental delay and congenital heart
defect.
• Systemic malformations accompanied all three major classes of eye defect:
OFD, non-OFD and unclassifiable.
• Chromosomal abnormalities were rare, occurring in just two cases.
• Of the cases with multiple anomalies, some clinical genetic syndromes were
recognised, most commonly the CHARGE association.
• Unrecognised or new patterns of clinical malformation were present in some
individuals.
• Dysmorphism was common amongst this group of children.
• There were a significant number of familial cases; the pattern of inheritance
was autosomal dominant or recessive.
• The sibling recurrence risk for optic fissure defects (iris and fundus
colobomas) is 8-13%.
• The recurrence risk for anophthalmos is no more than that ofOFD.
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In the next and final chapter, this well phenotyped database of congenital eye
anomalies is used to try and determine whether or not certain gene mutations play a
role in the cause of the eye defects anophthalmos and coloboma. Modern molecular
genetic techniques are employed, using the candidate gene approach.
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CHAPTER NINE
AN INVESTIGATION INTO WHETHER PAX6 GENE MUTATIONS ARE
THE CAUSE OF HUMAN ANOPHTHALMOS, MICROPHTHALMOS OR
UVEAL COLOBOMA
'Master control genes that act as developmental switches can be detected on the
basis of their mutantphenotypes' (Haider et al. 1995).
Summary
84 subjects with a wide variety of ocular phenotypes from whom genomic DNA was
available were screened for PAX6 gene mutations using denaturing high performance
liquid chromatography (DHPLC) and sequencing where indicated.
A single PAX6 missense mutation was found in one subject, whose phenotype in
retrospect is likely to be an aniridia phenotypic variant.
PAX6 gene mutations are unlikely to play a significant role in the aetiology of
anophthalmos, microphthalmos or uveal coloboma.
Two subjects were screened by collaboration with a Canadian laboratory for CHX10
gene mutations and none was found. This demonstrates the use of an accurate
phenotypic database to screen for candidate gene mutations.
Cell lines have been established on 47 subjects with different ocular phenotypes.
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INTRODUCTION
Why look for PAX6 mutations in anophthalmos, microphthalmos and
coloboma?
Sufficient evidence exists to suspect that there are PAX6 mutations in human
anophthalmos, microphthalmos and coloboma. The possibilities include new
heterozygous mutations (especially missense) or homozygous mutations, although the
latter is unlikely due to the severity of the predicted phenotype. Some of this evidence
was introduced in chapter three and this is expanded below.
There is much evidence to suggest that the PAX6 gene is ofmajor importance to eye
development, although enthusiasm to hail PAX6 as the 'master control gene' of eye
development (Quiring et al. 1994; Gehring, 1996) must be tempered with the
recognition that the precise role ofPAX6 and its mechanism of action and interaction
with other developmental genes is not fully understood. There are four main points of
evidence, the strength of which gives sufficient reason to look for PAX6 mutations in
different congenital eye anomalies. These are:
1. Conserved role of PAX6 in eye development in many species.
2. Expression patterns of the PAX6 gene.
3. The range of ocular phenotypes with PAX6 gene mutations.
4. Haploinsufficiency and gene dosage effects.
Each of these points will be looked at in turn:
1. Conserved role of PAX6 in eye development in many species
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The PAX6 gene belongs to the paired-like class of developmental genes described in
the fruit fly Drosophila melanogoster (Bopp et al. 1986). These segmentation genes
play a key role in development by controlling pattern formation and morphogenesis,
and their vertebrate counterparts appear to have a similar function (Walther and
Gruss, 1991). The PAX6 gene, which includes a paired box, has been highly
conserved in evolution, being present in nematodes, zebrafish, Xenopus, chicken, mice
and man. It contains a protein domain of 128 amino acids shown to be a novel DNA-
binding motif. In addition to the paired domain, PAX6 contains a paired-type
homeodomain. These DNA binding motifs suggest that PAX6 acts as a transcriptional
regulator by binding to DNA.
The high conservation of PAX6 tells us that the protein has altered little over time,
although it does not tell us what the precise function may be. The function of PAX6,
at least in eye development, is conserved in many species.
Further evidence of a major influence of Pax6 on eye development has been provided
by work on targeted expression of the eyeless (ey) gene in Drosophila melanogoster,
which is homologous to the mouse Small eye Pax6 gene and the human aniridia gene
(Haider et al. 1995). Ectopic eye structures were induced on the wings, legs and
antennae by targeted expression of ey DNA in various imaginal discs (other than the
eye discs in which eye is normally expressed).
Small eye (Sey) mice homozygous for Pax6 gene (Sey/Sey) mutations have no eyes
and no nasal cavities and heterozygotes (Sey/+) have eyes with an abnormal optic
cup, lens abnormalities and reduced eye size (Hill et al. 1991). The similarities
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between mouse Small eye and aniridia extend to iris hypoplasia and corneal
vascularisation (Jordan et al. 1992).
Mutations in the mouse (Sey) and Drosophila (ey) genes lead to a reduction or
complete absence of all eye structures, and because these genes are similar in DNA
sequence and in expression pattern even at the earliest stage of eye development, it
has been suggested that ey and Sey may be the master control genes involved in eye
development (Quiring et al. 1994; Haider et al. 1995).
2. Expression patterns ofPAX6
The PAX6 gene is expressed in the developing eye and central nervous system (CNS)
and this has been demonstrated in both mice and humans (Walther and Gruss, 1991;
Grindley et al 1995; Nishina et al. 1999). The expression pattern suggests a
regulatory role for PAX6 in CNS and eye development. The temporal and spatial
expression patterns in the early stages of mouse embryogenesis have been examined
using mRNA in situ hybridisation (Walther and Gruss, 1991). Pax6 transcripts are
detected in the neural tube, the forebrain, midbrain and hindbrain. Pax6 is also
expressed in the pituitary and olfactory epithelium from its early pit stage to the adult¬
like nasal structure. In the eye, Pax6 expression is first detected in the optic sulcus
and at later stages in the eye vesicle, lens, differentiating retina and cornea. Pax6 is
expressed in the ectoderm overlying the optic vesicle before the lens has formed and
continues to be expressed in the surface epithelium from which the cornea develops.
Examination of the expression pattern of Pax6 in the Small eye mouse has shown
Pax6 to be essential in the formation of lens placodes from surface ectoderm
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(Grindley et al. 1995). The optic vesicle and surface ectoderm both express Pax6
during normal development and both show abnormalities in Sey/Sey mice.
PAX6 expression in the developing human eye (6-22 weeks gestation) has been
studied using immunohistochemistry and monoclonal antibodies reacting to PAX6
protein (Nishina et al. 1999) and also in situ hybridisation (Ton et al. 1991). In the
early stages, PAX6 was expressed in the surface and neuroectoderm, including the
corneal and conjunctival epithelium, lens, and optic cup, similar to murine expression.
Pax6 expression continues in the differentiating cells in the cornea, lens, ciliary body
and retina. In the retina, Pax6 is first expressed in all cells of the optic cup, and is then
restricted to the ganglion cell layer and the inner and outer portions of the inner
nuclear layer. The persistent Pax6 expression in the ganglion cells suggests an
important role in retinal morphogenesis.
The early expression pattern of the PAX6 gene is consistent with the idea that PAX6
mutations might underlie severe ocular malformations, such as coloboma and
anophthalmos.
3. The range of ocular phenotypes with PAX6 gene mutations
Aniridia
The PAX6 gene is the human aniridia gene. Aniridia is typified by almost complete
absence of the iris, with the associated ocular malformations including corneal
vascularisation (pannus), cataract, ectopia lentis, lens dislocation, glaucoma and
foveal hypoplasia (Nelson et al. 1984). The human aniridia and mouse Small eye
phenotypes arise from homologous defects in PAX6 (Ton et al. 1991; Glaser et al.
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1992) and mouse Small eye is an excellent animal model for human aniridia. Aniridia
is a semidominant disorder and the aniridia gene, PAX6, was isolated from the
chromosomal region 11 pl3 by deletion analysis and positional cloning (Ton et al.
1991). PAX6 gene mutations account for most cases of aniridia and occur in both the
familial and sporadic forms (Glaser et al. 1992; Jordan et al. 1992; Hanson et al.
1993).
The mode of inheritance of aniridia is autosomal dominant, with a third of all cases
being sporadic. The sporadic cases may occur as part of the WAGR (Wilms' tumour,
aniridia, genitourinary abnormalities and mental retardation) contiguous gene deletion
syndrome involving band p 13 of chromosome 11. Deletions are hemizygous.
Heterozygosity for PAX6 mutations produces the Small eye phenotype in mice and
aniridia in humans. Homozygous mouse Pax6 mutations produce the severe and lethal
phenotype of almost complete absence of the eyes and nose (Hogan et al. 1986; Hill
et al. 1991). A presumed case of a homozygous aniridia gene mutation (no analysis
was performed) was described by Hodgson (Hodgson and Saunders, 1980) in a
stillbirth resulting from the union of both parents having aniridia. The foetus had
complete absence of the eyes and palpebral fissures, nose and adrenal glands. In 1994,
Glaser (Glaser et al. 1994) demonstrated two different PAX6 mutations in a
compound heterozygote. The phenotype of the proband, who survived for eight days,
was anophthalmia (absent eyes and eyelids fused) with multiple craniofacial defects
(small head, external nose malformation and choanal atresia, multiple brain
abnormalities including absent corpus callosum). The anatomical CNS abnormalities
correlated well with mouse Pax6 homozygotes.
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Although typically in human aniridia there is no iris present, there is great phenotypic
variability, with some cases having an almost complete iris with coloboma-like defect
or thinning (Hittner et al. 1980; Negishi et al. 1999). This great variation in ocular
phenotype means that cases of aniridia may be missed in what is a predominantly
inherited condition.
PAX6 gene and protein structure organisation (Ton et al. 1991; Glaser et al.
1992; Epstein et al. 1994; Glaser et al. 1994). The PAX6 gene spans 22kb and
encodes a 422 amino acid protein that is probably a transcriptional regulator (Figure
9.1). The +5a alternatively spliced form encodes 436 amino acids. The gene has 14
exons with one alternative splicing site (exon 5a). The initiation codon is in exon 4
and the termination codon is in exon 13. The alternative splicing produces a second
protein with a 14 amino acid insertion in the paired domain and arises by alternative
mRNA splicing and exhibits unique DNA binding properties, an important
determinant of transcriptional activity (Epstein et al. 1994). There are three protein
domains. The paired domain (128 amino acids) is composed of two sub-domains,
each consisting of three alpha-helices, with the second and third helices being
arranged in a helix-turn-helix configuration. The N terminal half of the paired domain
is thought to specify DNA binding. The homeodomain (61 amino acids) is separated
from the paired domain by a 78 amino acid linker region. The homeodomain again is
made up of three alpha helices, the last of these being responsible for sequence
recognition and DNA binding. The 152 amino acid C-terminal segment of PAX6 is
rich in the amino acids proline, serine and threonine and is called the 'PST-domain'.
- 254 ■
The amino acid composition of this domain suggests that it is involved in
transcriptional activation, and this has been supported by functional studies (Glaser et
al. 1994).
Figure 9.1: Human PAX6 gene structure
PAX6 gene structure
5'UT 3'UT
1 2 3 4 5 5a 6 7 8 9 10 11 12 13 EXOflS
PAX6 gene mutations: the spectrum
By March 1999, over 100 PAX6 gene mutations have been described and these are
summarised in the database at http://www.hgu.mrc.ac.uk/Softdata/PAX6.
4. PAX6 dosage and pathogenetic mechanisms
The molecular basis of aniridia is most likely to be haploid insufficiency for PAX6,
caused by a simple loss of function of one copy of the PAX6 gene by deletion of the
gene or intragenic mutation. The eye appears particularly sensitive to PAX6 dosage
(Hanson et al. 1993; Glaser et al. 1994) (Hanson and van Heyningen, 1995).
Abnormal gene dosage is a common cause of spontaneous abortion and human birth
defects, the best-known example being Down's syndrome (trisomy 21), in which the
precise effect of increased dosage on the embryo is difficult to determine. In
abnormalities caused by deletions or any other inactivating mutation, e.g. nonsense
mutation, which leave only a single copy of certain critical genes such as PAX6,
'haploinsufficiency' occurs. Two copies are needed for a normal phenotype.
Haploinsufficiency genes show a wide range of penetrance and expressivity (Fisher
and Scambler, 1994) and there are a number of possible reasons. Some developmental
pathways are particularly susceptible to dosage effects because of the sensitivity to the
levels of certain proteins. The simplest effect of hemizygosity is insufficient protein
being produced. Haploinsufficiency gene products are often proteins that take part in
the assembly of intermolecular complexes that may have an exact stoichiometry, such
as the proposed role of PAX6 as a transcription factor. Another possible explanation
for the haploinsufficiency of PAX6 is that it has multiple DNA binding sites in any one
cell; these binding sites are likely to be of different affinity with some binding PAX6
very tightly and some not so tightly. If the level ofPAX6 protein is reduced by 50%,
some targets may not become bound at all, and those genes will not be activated.
Hemizygosity would therefore be particularly likely to result in dosage effects. The
levels of expression of the non-deleted gene will also have an influence on phenotype.
Other possibilities to account for the phenotypic variability are that hemizygosity
could increase the sensitivity of the embryo to the effects of environmental insults
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(infection, teratogen). Also to be considered is that cells hemizygous for a particular
gene might be targets for a 'second hit' of the non-deleted gene.
The extraordinary degree of conservation ofPAX6, which must have been maintained
by selection, indicates that any amino acid change would be expected to be
deleterious. In the next section, some of the published PAX6 mutations are discussed.
Beyond aniridia: The spectrum of PAX6 mutation phenotypes
PAX6 mutations have been found in Peters' anomaly (Hanson et al. 1994), autosomal
dominant keratitis (Mirzayans et al. 1995), isolated foveal hypoplasia (Azuma and
Nishina, 1996) and uveal ectropion (Azuma and Yamada, 1998). These studies, along
with the range of aniridia phenotypes, have broadly implicated PAX6 in human
anterior segment malformations.
In the Peters' anomaly phenotypes (Hanson et al. 1994), one case described was the
result of a deletion of the PAX6 gene. A further case was described due to amino acid
substitution from a point mutation within the paired box and this case is one of the
few missense mutations described. It was also noted that a proportion of Small eye
mice heterozygous for a murine Pax6 nonsense mutation, have an ocular phenotype
resembling Peters' anomaly (Hanson et al. 1994).
The autosomal dominant keratitis and corneal vascularisation phenotype described by
Mirzayans (Mirzayans et al. 1995) does have features which overlap with the various
forms of aniridia, including foveal hypoplasia. The condition was associated with a
mutation in the exon 11 splice-acceptor site. Once again, a truncated protein is
predicted.
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A PAX6 missense mutation (see missense mutations below) has been described in a
case of isolated foveal hypoplasia in the C-terminal part of the paired domain (Azuma
and Nishina, 1996). Foveal hypoplasia, which caused reduced visual acuity and
nystagmus in these cases, is a well-recognised feature of aniridia, making this an
interesting phenotype-genotype comparison.
Azuma et al (Azuma and Yamada, 1998) reported an isolated case of a non-specific
anterior segment anomaly (corneal opacification, invasion of cornea with conjunctival
epithelium, uveal ectropion of the pupil, and posterior embryotoxon). Here, a
missense mutation occurred in exon 13, affecting the PST domain.
The vast majority of aniridia patients have intragenic PAX6 mutations that are
predicted to cause premature termination of protein translation. These consist of
splice mutations, frameshift mutations and nonsense mutations. Much less common
are in-frame deletions or splice mutations that would be predicted to delete part of the
protein. Missense mutations (where one amino acid is substituted for another as a
result of a single nucleotide substitution) are very rare in aniridia patients, with only
two cases reported to 1999.
Missense mutations and PAX6
In 1998, the spectrum of PAX6 mutations in aniridia was heavily biased towards
premature protein truncation (nonsense, splicing, insertions and deletions), these
making up 92% of all reported mutations. Only 2% ofmutations lead to substitution
of one amino acid for another (missense mutations) (Hanson et al. 1999). The
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remaining 6% of aniridia mutations are caused by in-frame deletions or splice
mutations that would be predicted to delete part of the protein.
The high conservation of the PAX6 amino acid sequence would predict that
pathological PAX6 missense mutations should be much more common. When PAX6
missense mutations arise they are highly likely to be pathological and so because they
are so rare in 'textbook' aniridia patients, they must be associated with other
phenotypes. The few cases ofmissense mutations described for PAX6 have tended to
be non-aniridia phenotypes (see earlier) (Hanson et al. 1994; Mirzayans et al. 1995;
Azuma and Nishina, 1996; Azuma and Yamada, 1998; Gronskov et al. 1999; Hanson
et al. 1999). A major factor probably contributing to the lack ofmissense mutations is
ascertainment bias: missense mutations seem to have a tendency to cause eye
phenotypes that are not always considered for PAX6 mutation analysis. This is further
justification for screening patients with complex congenital eye disorders such as
anophthalmos and coloboma. Since 1998, many more missense mutations have been
found and there is increased awareness that variant eye phenotypes can be caused by
PAX6 mutations.
A missense mutation in the alternative splice region of the PAX6 gene (exon-5a)
within the paired-type domain has recently been described in combination with some
unusual eye phenotypes: Peters' anomaly, congenital cataract, Axenfeld anomaly and
foveal hypoplasia (Azuma et al. 1999).
Summary, PAX6 mutations
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• There is a bias towards nonsense, deletions, insertions, splice and frameshift
mutations
• Few PAX6 missense mutations have been described
• The PAX6 missense mutations are often unusual phenotypes
• Several PAX6 missense mutations have been described within the paired box
METHODS
DNA extraction
It was initially thought that a combined technique ofDNA and RNA extraction could
be used (Qiagen reagent kit), but this technique was abandoned after preliminary
testing because the procedure was lengthy, complicated, and did not produce very
large quantities ofDNA suitable for PCR.
DNA was extracted from venous blood samples or mouthwashes within 48 hours of
being taken. Venous blood was collected in sodium EDTA (ethylene diamine tetra-
acetic acid) tubes. The genomic DNA was extracted using a kit (Nucleon,
Biosciences) based on chloroform extraction.
DNA was extracted from mouthwashes, in 10-20ml of tap water, as follows: Spin for
10 minutes at 3000 rpm, discard supernatant and place the cell pellet in 50-200 micro
litres of 0.05M sodium hydroxide. Mix then boil for 20 minutes. Add 25 micro litres
of 1M TRIS (2-amino-2-(hydroxymethyl)-1,3-propanediol) buffer pH 7.7, mix and
then spin briefly to remove cell debris from suspension. 5 micro litres of the




Venous blood was collected in EDTA. Lymphoblastoid cell lines were established or
white blood cells stored from a number of subjects. Marie Robertson and Cath
Davidson at the MRC Human Genetics Unit, Edinburgh, carried out this preparation
and storage work. The purpose of these cell lines is to create a potentially limitless
supply of RNA suitable for PCR and mutation screening.
Some samples were sent to ECACC (European Collection of Animal and Cell
Cultures) in Wiltshire, England for storage and transformation.
Karyotyping
Where it was clinically indicated (significant delayed development plus another
congenital malformation or dysmorphic appearance), venous blood was collected in
heparinised tubes for G-banding of chromosomes (Cytogenetics Laboratory, Royal
Hospital for Sick Children, Edinburgh). These results are discussed in the previous
chapter (eight).
Polymerase Chain Reaction (PCR)
The genomic DNA samples were amplified by PCR. Samples were diluted to the
recommended concentration (see below) and the PAX6 exon-specific primers
(oligonucleotides) used were those published (Love et al. 1998).
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The polymerase used was Pfu (Stratagene). Pfu DNA polymerase is a proofreading
DNA polymerase isolated from Pyrococcus furiosus. It has a very low rate of
nucleotide incorporation errors.
The PCR conditions for optimal amplification of each exon had to be established in
accordance with the manufacturer's instructions. This required alteration of different
parameters (DNA concentration, annealing temperature, number of cycles, enzyme
concentration). In some cases, 10% Dimethylsulfoxide (DMSO) was required. It is
likely that DMSO helps keep the double stranded DNA denatured, particularly in the
regions that are G-C rich. Additional help and assistance to refine the PCR conditions
towards the end of this stage was from Dr Kathy Williamson PhD, MRC Human
Genetics Unit.
Reaction volumes of 50 micro litres were used with a DNA template concentration of
25-50 nanograms, 2.5 pM of forward and reverse primers, lOmM of dNTPs, and the
enzyme and buffer supplied by the manufacturer. Typically, PCR amplifications were
for 30 cycles: 94°C for 45s, Tm (melting temperature) for 30s and 72°C for 1 min,
final extension time 72°C for 10 min.
In addition to the patient samples, genomic DNA was amplified from some 'controls'
known to have PAX6 mutations within the relevant exon.
Following amplification a small aliquot of each PCR product was analysed on 2.5%
agarose gel electrophoresis to confirm and determine the efficiency of amplification.
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Denaturing high performance liquid chromatography (DHPLC)
This mutation screening method was chosen on the basis that it would allow rapid
screening of large numbers of PCR-amplified DNA samples (WAVE™ DNA
Fragment Analysis System, Transgenomic). Technical problems with the machinery
column and software delayed mutation screening by several months. The description
that follows is a summary of the methods and laboratory work initiated. Dr. Kathy
Williamson, PhD, completed this.
The DHPLC has a high mutation detection rate (Underhill et al. 1997; Liu et al.
1998). If analysis of the peaks shows a shift then a mutation is suggested and the
sample is reamplified, then sequenced to find the underlying change in DNA sequence
DHPLC exploits the differential retention of double-stranded heteroduplex and
homoduplex molecules, allowing the automatic comparison of PCR amplicons for
variation. The technique was chosen as it was considered to be efficient and relatively
inexpensive with high levels of automation. DNA segments of several hundred base
pairs in length can be analysed (up to 1 5kb).
Mutation/polymorphism scanning by DHPLC involves subjecting PCR products to
ion-pair reverse phase liquid chromatography in a column containing alkylated non-
porous particles (a divinylbenzene derivative). Reverse phase refers to the fact that the
column is hydrophobic and is the opposite phase to the hydrophilic DNA. The DNA is
bound to the column using an ion-pairing reagent TEAA (triethylammonium acetate)
Under conditions of partial heat denaturation within a linear acetonitrile gradient,
followed by cooling and hybridisation, heteroduplexes that form in PCR samples
having internal sequence variation have a reduced column retention time relative to
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their homoduplex counterparts. The resolution is temperature-dependent. In the
majority of cases the elution profiles for heteroduplexes are distinct from those having
homozygous sequence, making the identification of samples containing
polymorphisms or mutations a straightforward procedure.
The method requires heteroduplex DNA for detection of intrasample sequence
variation. It is possible that mutations could escape detection where loss of a wild
type allele occurs in combination with mutation of the remaining allele since the
predominant double stranded DNA formed would be mutant homoduplex. Therefore,
the DNA from individuals who have two mutant alleles (homozygous) must be mixed
with wild-type DNA and hybridised. After this, a sample will contain a mixture of
hetero- and homoduplexes.
Optimal separation of the DNA hetero- and homoduplexes depends on the gradient of
buffer concentration. Buffer A is 0.1M TEAA, and buffer B is 0.1M TEAA and 25%
acetonitrile. The acetonitrile elutes the DNA off the column in relation to DNA
fragment size. The recommended gradient is a 2% increase in buffer B per minute.
The resolution of hetero- from homoduplexes depends on performing the separation
at a partially denaturing temperature. The WAVE1M utility software is used to help
determine the correct temperature (melting or mobile phase temperature) for mutation
scanning based on the sequence of wild-type DNA for each exon, accounting for
length and G-C content.
DNA samples were used from all patients on whom samples were available, regardless
of extraocular abnormalities. All the patients were a subset of the clinically verified
and phenotyped database (chapter seven).
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DNA samples
The DHPLC methods for optimal mutation detection for each of the 14 exons were
tested on DNA samples from (mainly) aniridia patients already known to have
mutations within that exon. Both empirical methods and software-based algorithms
were used. DHPLC detected 100% of the known mutations, which included a variety
ofmutations (deletions, insertions and substitutions).
5 microlitres of each PCR product was used in the DHPLC.
Sequencing (Dr Kathy Williamson PhD, MRC Human Genetics Unit,
Edinburgh)
Following DHPLC analysis the trace for each sample was inspected and where a
shifted peak was seen, the DNA sample was sequenced using the Thermo Sequenase
Radiolabelled Terminator Cycle Sequencing Kit (Amersham/USB Corporation).
RESULTS
DNA was screened for PAX6 mutations in 84 subjects. A number of shifted peaks
were detected, but upon sequencing these were nearly always found to be intronic
polymorphisms which were considered unlikely to have any deleterious effect on the
PAX6 protein. Only one patient, ID 243 (male), was found to have a heterozygous
mutation. The mutation was a single nucleotide substitution (c,1087G>C) in which a
single nucleotide is changed from G to C in exon 9, within the homeodomain of
PAX6. This missense mutation is predicted to substitute a highly conserved arginine
residue encoded by AGA at position 242 with threonine (encoded by ACA). Arginine
• 265 -
242 is located in the middle of the second alpha helix of the paired type domain. This
second alpha helix stabilises the third helix, which makes sequence specific contacts
with the DNA. The G1087C mutation was not detected in over 160 other individuals
analysed. As already discussed, very few PAX6 missense mutations have been
described.
In several other cases there were abnormal profiles on DHPLC, but these were found
to be neutral base changes i.e. not predicted to alter the PAX6 amino acid sequence.
DISCUSSION
PAX6 gene mutations are not likely to be a significant cause of anophthalmos,
microphthalmos or coloboma in humans.
The finding of a new heterozygous PAX6 missense mutation in one individual
demonstrates the need to cast the net wide and that further PAX6 ocular 'non-
aniridia' phenotypes may exist, or that there is extensive variation in the aniridia
phenotype.
The ocular phenotype of patient ID 243 with the G1087C mutation is unusual and is
difficult to name or categorise retrospectively. The abnormality consists of a unilateral
(left) partial thickness defect of the iris at 6 o'clock. Only the anterior layer of the iris
was affected (Figure 9.2), leaving the darker posterior layer almost intact. The
external appearance when observed with the naked eye is that of an iris coloboma. No
other ocular abnormality was present. There were no systemic abnormalities. Family
history was negative and maternal eye examination was normal. Examination of the
father was not possible, but eye examination is reported as normal.
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Figure 9.2: Probable aniridia variant with PAX6 missense mutation. The left eye









It is very likely that the abnormality represents an aniridia variant or partial aniridia,
although missense mutations of aniridia variants have tended to be within the paired
domain, in contrast to the mutation in this case being within the homeodomain
(Gronskov et al. 1999; Hanson et al. 1999). The mother's DNA showed the same
heterozygous PAX6) exon 9 mutation, making this mutation likely to be inherited
rather than sporadic, with a low expressivity. It is unlikely that this mutation is a
polymorphism since it has not been previously recognised, is predicted to alter the
PAX6 protein, and is associated with an abnormal ocular phenotype. The substituted
arginine residue is conserved in this position in other PAX6 proteins (all vertebrates,
Drosophila melanogaster, nematode, squid and sea urchin) so it is likely to be very
important. The replacement of a positively charged arginine residue with a neutral
threonine predicts a change in function of this position, although the exact effect is
unknown. A functional analysis of the mutant protein might provide further evidence
of the significance of the c. 1087G>C mutation.
No other mutations were found. Some of the eyes initially classified as coloboma did
bear a strong resemblance to partial aniridia (ID 3, ID 121, ID 187). The finding of a
PAX6 mutation would have clarified the diagnosis.
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This study has highlighted the difficulty in separating the ocular phenotypes and the
need for detailed description. Only heterozygous mutations were screened for.
Homozygous mutations are highly unlikely as the resulting phenotype would probably
be lethal or non-viable (see above). Only true homozygous mutations, i.e. an identical
base change at the same position in both copies of the gene, are not screened for, and
such a mutation is so unlikely that it can almost be excluded. Two mutated copies of
PAX6 with different mutations (a compound heterozygote) would be detected by
DHPLC analysis. To screen for and exclude true homozygous mutations the DNA
samples would have required dilution with wild type DNA in order to form detectable
heteroduplexes. However, this study has screened for the genotypes most likely to
exist in this cohort, since homozygotes would probably be non-viable.
DHPLC is a relatively new technique and the mutation detection rate for the PAX6
gene under these conditions is unknown. Other, more established techniques of
screening for mutations exist such as single stranded conformational polymorphism
(SSCP) but may not be any more sensitive (Axton et al. 1997; Axton et al. 1997).
However, there is little doubt that for mass screening of large numbers of DNA
samples, DHPLC is a suitable tool.
It is difficult to establish the significance of finding a PAX6 gene mutation in a non-
aniridia ocular phenotype. Do all PAX6 mutations matter? Probably not. If not, why
not? Subtle and clinically undetectable changes may be present in the phenotype. Gene
interactions and the effect of other genes downstream may be just as important. One
cannot always consider mutations in isolation. In addition, environmental effects on
genes are a possibility. We do not know the significance of the c. 1087G>C mutation.
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The mutation is potentially of great interest as it is the first missense mutation to be
found in the homeodomain. Considering the mild phenotype, it is possible that the
homeodomain does not play as significant a role in eye development as the paired
domain, which harbours many pathological missense mutations.
CHX10, OCULAR RETARDATION
Mice homozygous for the gene ocular retardation (or) have very small eyes
(Truslove, 1962). Ocidar retardation is caused by a mutation in the ChxlO gene, a
homeobox gene (Burmeister et al. 1996). The significant morphological pathology is
the effect on the neuroretinal layer, degeneration of which somehow impairs the
overall development of the eye, causing microphthalmic mice. Homozygous or/or
mice have optic nerve aplasia, thin hypocellular retina, and reduced eye size. The
primary pathology is probably within the bipolar cells of the inner nuclear layer. The
expression pattern of the ChxlO protein in the developing mouse eye is almost entirely
localised to the cells of the inner nuclear layer (Liu et al. 1994).
Human CHX10 maps to chromosome 14q24.3 and has five known exons. CHXJO is
thought to be a transcription factor and contains a homeodomain of the paired class,
along with a second domain, the CVC domain. Like the homeodomain, the CVC
domain probably has a role in DNA binding (Burmeister et al. 1996).
The inability of or/or ganglion cell axons to exit from the eye may be due to
abnormalities in the formation of the optic stalk, which would include delayed
formation or closure (Burmeister et al. 1996).
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Based on the ocular retardation phenotype in mice, recessive mutations in the human
CHX10 gene might be predicted to cause developmental abnormalities of the eye. It is
for this reason that patients with optic nerve aplasia or optic nerve defects, defects in
retinal development, and microphthalmos were considered for screening of CHX10
mutations.
METHOD
The genomic DNA of two subjects in the study (ID 47, 234) were sent to Professor
R. Mclnnes for mutation screening (Department of Molecular and Medical Genetics,
University of Toronto, Canada). The phenotypes were as follows:
ID 47: Male. Right iris coloboma, dysplastic retina with coloboma, optic disc
hypoplastic and pale. Left anophthalmos. Delayed development, cerebral atrophy
(confirmed by CT scan), low set ears, doll-like features.
ID 234: Female, Bilateral iris and retinal colobomas, normal optic nerves. Broad nasal
root, smooth philtrum, low set posteriorly rotated ears. Suffers from absences.
RESULTS
All exons were assessed for mutations by PCR amplification and SSCP (single
stranded conformational polymorphisms). No mutations were found.
DISCUSSION
The CHX10 collaboration demonstrates the use of an accurate ocular phenotypic
database to screen for candidate gene mutations. That no CHX10 mutations were
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found may show that the wrong ocular phenotype has been looked at, or that the
mutation detection technique was not sensitive enough. Phenotypes worthy of further
consideration include optic nerve aplasia and cataract.
Professor Mclnnes' group have screened more than 300 samples for CHX10
mutations, including many with clinical microphthalmos and optic nerve aplasia. In
two families, recessive CHX10 mutations were found in the homeodomain at the
chromosome locus 14q24.3. The phenotype was clinical microphthalmia with
cataracts and severe iris abnormalities. Whilst these findings do not establish CHX10
as an anophthalmia gene, it reinforces the significance of CHX10 as a possible
regulator of eye development (Percin et al. 2000).
Summary, chapter nine
• In only one of the 84 subjects with the congenital eye anomalies of uveal
coloboma, clinical anophthalmos or microphthalmos, was a PAX6 gene mutation
found, after screening DNA.
• Mutation screening of the DNA samples was by the DHPLC method, which
has the potential to screen a large number ofDNA samples very efficiently.
• A new PAX6 gene missense mutation has been described in an individual with
an ocular phenotype that is probably an aniridia variant.




Anophthalmos, microphthalmos, and uveal coloboma are congenital eye anomalies
that can cause significant visual impairment. The introductory chapters of this thesis
(1-3) set out a number of arguments:
Anophthalmos, microphthalmos and coloboma have not been adequately
defined
In chapter one, the early development of the eye was outlined, with a description of
current terminology. Anophthalmos is best defined as clinical anophthalmos, where
no globe is apparent. Clinical microphthalmos refers to a heterogeneous group of eye
anomalies, all sharing the appearance of the eye being small. There is no current
accepted definition of microphthalmos and attempts to define microphthalmos based
on the axial length of the eye have not been successful. The term microphthalmos is
overused and has been applied as a phenotypic diagnosis, but the phrase clinical
microphthalmos is only helpful in the identification of a gross or generalised
congenital eye anomaly, pending a more detailed phenotypic eye examination.
There are many types of coloboma and, like microphthalmos, the term coloboma has
been applied inappropriately, although the range of definitions is narrower. In the case
of isolated optic nerve colobomas, there is a question mark about their relationship to
uveal colobomas and whether or not they are defects of optic fissure formation or
closure. There is a continuous spectrum from true anophthalmos to mild
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microphthalmos that includes the terms clinical (apparent) anophthalmos, extreme or
severe microphthalmos, microphthalmos and mild microphthalmos. Therefore, the
words anophthalmos and microphthalmos can be and have been applied to the same
condition.
Anophthalmos/microphthalmos have features that suggest both a genetic and
environmental aetiology
In chapter two, the birth prevalence of anophthalmos, microphthalmos and coloboma
in several epidemiological surveys was outlined. The quality of many of these surveys
and reports is hampered by the eye anomalies being poorly defined. The poorly
understood aetiology of anophthalmos, microphthalmos, and coloboma was
described, listing a number of alleged environmental causes. That there is also a
genetic component in the aetiology was demonstrated by a number of familial cases
described from the literature. The ocular and systemic features of
anophthalmos/microphthalmos and coloboma suggest in many cases both a genetic
and an environmental component in their aetiology. Examples include the significance
of these eye anomalies being unilateral or bilateral, and the presence of multiple
extraocular (systemic) congenital anomalies.
Proper investigation and the search for a cause rest on establishing a phenotypic
definition
In the second and third chapters, the point was reinforced that to investigate the
aetiology of anophthalmos, microphthalmos or coloboma, be it genetic or
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environmental, required the rigorous application of a phenotypic definition. The
difficulties with definition were introduced in chapter one, and these were added to
with a description of some of the similar problems encountered by laboratory
scientists when studying eye development anomalies in mice. A simple, reproducible,
consistent definition would greatly enhance the epidemiological surveys, recruitment
of subjects for research, clinical grouping and analysis of cases, and clinical and
molecular genetic analysis.
Candidate genes can be used to consider the genetic aetiology
The final part of chapter three, the last introductory chapter, described some of the
many approaches to finding a genetic aetiology or component to congenital eye
anomalies and identifying genes that may be involved. The candidate gene approach,
and the current knowledge of genes thought to be significant in human eye
development, was summarised. The human PAX6 homeobox gene and mice studies
were introduced to illustrate how the application of this information may lead to the
identification of a genetic cause of anophthalmos, microphthalmos or coloboma.
The studies and investigations described in the next six chapters of this thesis (4-9)
set out to substantiate the introductory arguments. In chapter four the overall
framework of the Scottish Microphthalmia Study is described, along with an overview
of the methods used to recruit patients into the study database. This national study
involved public health, ophthalmology, clinical genetics, and molecular genetic
approaches.
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More than 300 names were put forward as possibly being affected with
anophthalmos/microphthalmos or coloboma and born within the dates specified
(1981-1996). The total number of affected children was calculated as 183, and 122 of
these were examined clinically. The calculated birth prevalence in Scotland is 1.78 per
10,000. The birth prevalence of clinical anophthalmos in Scotland is 0.68 per 100,000.
The rarity of this condition has been confirmed, with just seven live births in 16 years.
Prevalence of anophthalmos/microphthalmos across the Scottish Health Boards
ranged from zero in the Western Isles to 2.59 per 10,000 in Fife. Birth prevalence did
not increase over the 16-year period studied and remained constant. Comparison of
these results with previous studies suggests that case ascertainment levels were high.
The difficulties of relying on a single source for case ascertainment based on records
and without clinical verification were demonstrated by the large number of exclusions
from the study of unaffected normal children and individuals with other ocular
phenotypes.
The Scottish Microphthalmia Study had a number of aims (chapter four). As many
cases as possible were identified using multiple sources of information gathering. The
database has provided the basis for a case control study into the environmental
aetiology of microphthalmos, anophthalmos, and coloboma in Scotland.
A simple case definition needed to be developed for congenital anomalies registration
and clinical record keeping which is sufficiently specific to allow cases to be searched
for and easily identified. Clinical anophthalmos is a term that has a useful meaning.
Microphthalmos, microphthalmia, and clinical microphthalmos have very limited use
and would be better dropped from current congenital anomalies registers or used as a
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suffix only, for example, corneal scar with microphthalmos. Microphthalmos could
retain use as a secondary descriptive clinical term. Iris coloboma and retinal coloboma
are sufficiently accurate terms to identify and capture the abnormalities sought. Optic
nerve head abnormalities will always be difficult to identify early because diagnosis
requires highly specialist ophthalmic examination and knowledge. In most cases of
optic nerve head abnormality the correct diagnosis is not made until months or even
years after the birth of the affected child.
Before embarking on any discussion of cause or investigations into the genetic cause
of the many eye defects observed in the study group, an improved definition was
needed, and this was based on phenotype. The eye examination findings were
reclassified on the basis of the presence or absence of a defect thought to be due to
optic fissure formation or closure. Both the non-optic fissure defects and
unclassifiable groups are phenotypically heterogeneous. This phenotypically based
classification system has no need for the term microphthalmos. Defects of the optic
nerve, previously called optic nerve coloboma or optic nerve head coloboma, are now
collectively grouped as optic nerve head disruption. This removes the term coloboma
that has continued to obfuscate the understanding of the underlying mechanism that
may have caused such an unusual defect of the optic nerve head. Colobomas were
classified into five types, although problems remain with certain types such as the
superior ('atypical') coloboma, which does not easily fall into any classification
system.
There was notable asymmetry of ocular malformations in bilaterally affected
individuals both with and without a family history. This is significant when considering
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the aetiology and the risk of recurrence, since it is likely that in the past too much
emphasis has been placed on unilateral and bilateral eye defects. A unilateral
abnormality does not necessarily seem to indicate a non-genetic defect, and a bilateral
abnormality does not necessarily imply a genetic cause.
The prevalence of iris coloboma-iris heterochromia has been found to be much higher
than previously thought, affecting almost one-fifth of cases. In less than 4% of cases
of iris or fundus coloboma there was a retinal detachment, which appeared to have
developed before birth.
Many eyes can look small. Some small eyes are normal in size, some are big, and
some really are small. The failure to define microphthalmos reinforces the point that
the term has limited clinical use. That there is no suitable definition has been
demonstrated in the ultrasound study of 106 eyes in chapter seven, in which nearly
half of the 55 clinically microphthalmic eyes had a normal axial length. The study also
made it clear that clinical macrophthalmos is probably a lot more common than
previously recognised. There is no value in further pursuing a definition of
microphthalmos or clinical microphthalmos and, as with the classification system for
coloboma, further time and effort should be directed towards identifying and
recognising new or different ocular phenotypes.
The eye anomalies studied were put in a systemic context in chapter eight, when
37.2% of 121 clinically examined cases were found to have a non-ocular congenital
anomaly. There was a significant number of individuals affected with congenital heart
disease and developmental delay. Many children's systemic anomalies did not fit into
any previously recognised syndrome, and cases with a genetic aetiology or family
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history were not distinguishable from sporadic cases of unknown aetiology. The
familial cases showed both autosomal dominant and recessive patterns of inheritance.
Chromosome abnormalities were tested for in 35 cases, with only one child having an
abnormal karyotype (G-banding).
Genetic counselling of families for these rare but sometimes devastating eye anomalies
is difficult, and the family pedigrees described in chapter eight provided data for
calculations of the empirical recurrence risk of anophthalmos and uveal coloboma. For
unaffected parents giving birth to an affected child, the sibling recurrence risk is
around 3-8%. The risk does not differ significantly for unilateral or bilaterally affected
individuals.
In the final part of the study in chapter nine, the candidate gene approach was used in
an attempt to further understand the genetic aetiology of anophthalmos, clinical
microphthalmos and coloboma. The genomic DNA of 84 individuals was extracted
from blood or saliva and screened for PAX6 gene mutations. Lymphoblastoid cell
lines were established in 50 cases. Denaturing high performance liquid
chromatography (D-HPLC) was used for mutation screening. A single heterozygous
PAX6 missense mutation was found in one individual. A review of the ocular
phenotype, a defect of the anterior iris in the 6 o'clock position, made it very likely
that this particular eye defect was an aniridia variant. The missense mutation, a single
nucleotide substitution, was in the homeodomain and has not been described
previously. The conclusion is that PAX6 mutations are unlikely to play a significant
role in the genetic aetiology of clinical microphthalmos, coloboma or anophthalmos.
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In a smaller collaborative study, two individuals had genomic DNA sent to Canada for
CHX10 gene mutation screening. No mutations were found in this homeobox gene.
The study has achieved the initial aims, which span from the identification and clinical
examination of as many cases as possible of anophthalmos, microphthalmos and
coloboma, to the calculation of the recurrence risk and identification of a PAX6 gene
mutation. Collaborative studies were established with laboratories in Canada and
Belgium, and cell lines were set up in Scotland and England. A database and register
of clinically verified diagnoses now exists, from which the birth prevalence of these
congenital eye anomalies was calculated for Scotland.
The major strength and uniqueness of the study was the detailed clinical examination
of so many cases drawn from an unselected population across a whole country. The
selection bias common to so many specialist and tertiary referral centres was therefore
not present. The large period of time studied (16 years) and the two-year study period
helped to maximise the amount of data which could be retrieved and allowed a more
thorough search for cases with, for example, second letters to non-responders and GP
letters for further information.
A retrospective study will always be disadvantaged by the need to retrieve data and
the problems associated with this. Attempts to enhance retrieval and improve case
finding included multiple sources of information gathering including a nationwide
publicity campaign and letters to special schools. Nevertheless, there is still a degree
of reliance on the memories and quality of records of clinicians.
A prospective study would not necessarily have avoided many of the problems
encountered, since many of the same sources would need to be contacted in a similar
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manner. Continued surveillance and monitoring requires a lot of publicity, education
of professionals, and updates. Ultimately, there is still a reliance on individuals to fill
in reporting cards. For a condition that is so rare and produces so few cases annually,
a study would have to take place over several years to yield sufficient numbers and
reveal any trends.
One of the implications for governmental organisations arising from this study is the
use of data in the congenital anomalies registers. In this study, much of this data has
been shown to be inaccurate in terms of the actual diagnosis and severity of eye
defects. These congenital anomaly registers should not be used for detailed data
analysis or monitoring of prevalence of rare conditions. The clinical register of
congenital eye anomalies produced has provided a research resource and a model for
future studies in ophthalmology, epidemiology, clinical genetics and molecular
genetics. Many of the results are significant to those involved in the planning of
resources and provision of education, special needs facilities and social services for
visually impaired children. It is important to recognise that in many cases there is
more than just an eye problem since multiple disability is not uncommon.
The classification system into optic fissure and non-optic fissure defects establishes a
pattern and facilitates future phenotype-genotype correlation studies. Such studies
may ultimately lead to a genotypic classification of eye defects.
It is still difficult to assess the undoubted genetic contribution to the aetiology of these
complex congenital eye anomalies. The easy answer is to ascribe the cause to many
genes interacting, since there is as yet no evidence that a single gene is culpable. None
of the seven cases of anophthalmos found in Scotland were familial, although one case
- 280 -
did arise within a consanguineous marriage, which increases the chance of autosomal
recessive inheritance. This may mean that these cases are non-genetic in aetiology, but
it could also mean that the genetic cause cannot be found.
The majority of cases of anophthalmos, clinical microphthalmos and coloboma present
sporadically, with fewer but significant cases where familial recurrence is seen. There
is a genetic component in the aetiology of these eye anomalies, although in many
families there is clearly reduced penetrance and extremely variable expression. The
latter observation is underlined by the frequently different phenotype in the left and
right eye. One or more of the following factors at play may explain these
observations: interaction with modifier genes; interaction with environmental factors;
involvement of stochastic factors in the developmental process. This variability makes
it more difficult to access the genetic component. There is clearly considerable genetic
as well as phenotypic heterogeneity. Defining the genes and developmental pathways
involved seems the only approach to understanding the aetiology of these
abnormalities. Critical environmental components are most likely to be identified and
understood in the context of knowing the genes implicated. The ultimate aim is to
know the genes involved in order to offer genetic analysis and eventually prenatal
diagnosis.
Colobomatous eye defects are seen in a wide range of chromosomal abnormalities and
yet cytogenetic chromosomal abnormalities are rarely found on routine screening of
individuals with only eye abnormalities and no developmental delay or systemic
congenital malformation. Not all of the children in the study had their blood tested by
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G-banding of chromosomes, as it was felt highly unlikely that any new abnormality
would be detected.
Colobomatous eye defects so often seem to be the harbinger of another congenital
abnormality so a careful examination is essential. It would seem that this particular
aspect of eye development is extremely sensitive to any disturbance of normal
development, and may have something to do with other events occurring at the time
of closure of the optic fissure in the embryo, which may occur over a number of days
or weeks. Chromosomal microdeletions remain as a possible cause and the 22q 11
microdeletion detected in one individual in this study suggests that other
microdeletions might be found if a more aggressive search is made.
The candidate gene approach was used as the basis of screening for PAX6 and
CHX10 mutations, using a relatively novel screening method, denaturing high
performance liquid chromatography (DHPLC). The technique allowed large numbers
of DNA samples to be tested. It is important to remember that mutations may have
been missed in the screening process. Further studies on selected individuals in the
group have been undertaken to screen for other candidate genes, PAX2 and DRES93
(VAX2). These were in collaboration with laboratories in Belgium (PAX2) and Italy
(DRES93). So far, no gene mutations have been found.
There is scope for further studies using the candidate gene approach. The DNA
samples and the phenotypic database allow matching of proposed candidate genes to
the ocular and systemic phenotype. Linkage analysis is still a possible route, but the
rarity of large families of affected individuals has always hindered further progress
using this method.
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A relatively unexplored area is that of chromosomal microdeletions, and there is
potential here for further work. Testing with probes using fluorescence in situ
hybridisation (FISH) is a relatively straightforward procedure.
The clinical significance and new implications of this study are that in all cases of
anophthalmos or clinical microphthalmos or coloboma, a careful eye examination
should be done to confirm and refine the ocular phenotype. First-degree relatives
should be examined in conjunction with a detailed family history. In specific cases, an
ultrasound B-scan may be indicated to confirm suspected clinical findings such as a
detached retina. Visual prognosis and later function in colobomatous eyes is very
difficult to assess, and refraction and low vision aids should be considered as soon as
such measurement is possible, in conjunction with any treatment for amblyopia.
In view of the large number of children with non-ocular abnormalities and
dysmorphism, a paediatrician or clinical geneticist should review all new cases.
Genetic counselling and advice should be appropriate for each case, with realistic and
more accurate recurrence risks quoted for future siblings. The only consistent feature
of a familial (and therefore probably genetic) case is the family history. All other cases
are sporadic.
It is tempting to ascribe a significant environmental role to the cause of anophthalmos,
clinical microphthalmos and coloboma, especially in the absence of hard genetic
evidence. But when the alleged causes are examined closely, there is often a
breakdown in the relationship between timing of exposure and the type of defect seen.
This may be due to an over-simplified view of the timings of events in embryogenesis
and of what effects the possible accumulation of toxins acquired before the onset of
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critical events may have later on in development. It is here that the lack of our
understanding of cause is further exposed, as little or nothing is known about the
dose, timing and duration of exposure that might bring about such eye defects. The
nature or type of environmental agents to which a parent might be exposed is
unknown, and the size of the human embryo at this early stage of development could
make it exquisitely sensitive to the tiniest concentration of a toxin. Some of these
questions about exposure to potential toxins may be answered by the current case-
control study in Scotland (Sheena Macdonald, Department of Public Health Sciences,
University ofEdinburgh).
In this study, the ocular features, systemic abnormalities, and family histories are all
evidence of both genetic and non-genetic (environmental) aetiologies for clinical
microphthalmos, anophthalmos, and coloboma. The eye findings of asymmetry in
bilaterally affected individuals and individuals with unilateral defects could be
interpreted as being due to an environmental agent. Conversely, bilaterally affected
cases, especially when symmetrical, could be seen as an indication of a genetic cause.
Extra-ocular congenital anomalies were not confined to the cases with a family
history: multiple congenital abnormalities are considered by many to be evidence of a
genetic aetiology but may also be interpreted as a sign of an external agent or toxin
acting in the early stages of embryogenesis. That the environment could be affecting
susceptible developmental genes to differing degrees is a real possibility. An
understanding of the underlying genetic causes of eye defects is necessary for the
optimal management of these conditions, for the counselling of the affected families
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and in order to provide insights into the biological processes involved in eye
development that may eventually lead to new prevention strategies.
There is a complex genetic and possibly an environmental aetiology of ocular
congenital clinical anophthalmos, microphthalmos and uveal coloboma. By exploring
the definition, closely examining the phenotype, studying the family history, and
testing for specific gene mutations, this thesis has made a significant contribution to
the search for causes of these eye defects.
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Tel: 0131 651 1012




Sex: male □ female □ unknown □
CHI/CI No: M | 1 | M | | | "
NHS No: I I I I I I I I I I "
Health Records ID No:














Race: Caucasian □ Black □ Asiatic Indian □ Oriental □
Other O





Surname at birth of child:
Date of Birth: / /
Obstetric History
No. of children:
No. of miscarriages: Stillbirths: Terminations:
Rubella vaccination: Yes □ No □ Unknown □
Scan: Yes □ No □
weeks Normal □ Abnormal [j Unknown □





Abnormal □ Unknown □
NoD
Chorionic Villus Sampling: Yes □ No □ weeks
Normal □ Abnormal □ Unknown □
Father's Details
Surname: First name(s):
Date of Birth: / /
Family History
Parental consanguinity: Yes □ No O




Multiple Birth: Yes □ No □ Number:
Comment:
1 No. of siblings: No. affected: ID No:
2 No. of 1/2 siblings maternal: No. affected: ID No:
2 No. of 1/2 siblings paternal: No. affected: ID No:
Birth order (including stillborns):
4
FamilyTree
Toinclude1/2sibs,tw nuncles/aunts,/uncles/aunts,gra dp rents,1 tcou ireau t / cles, nephews/nieces,1/2nep s/nieces. 5
1 Mother affected: Yes □ No □
1 Father affected: Yes □ No □
2 No. of maternal aunts/uncles:
2 No. of paternal aunts/uncles:
2 Maternal grandmother affected:
2 Maternal grandfather affected:
2 Paternal grandmother affected:
2 Paternal grandfather affected:
2 No. of 1/2 maternal aunts/uncles:
2 No. of 1/2 paternal aunts/uncles:
2 No. of maternal nephews/nieces:
2 No. of paternal nephews/nieces:
3 No. of 1/2 maternal nephews/nieces:
3 No. of 1/2 paternal nephews/nieces:
3 No. of maternal 1st cousins:
3 No. of paternal 1st cousins:
3 No. of maternal great aunts/uncles:
3 No. of paternal great aunts/uncles:
No. affected:
No. affected:
Yes □ No □













Total 1st degree relatives Affected.
Total 2nd degree relatives Affected..
Total 3rd degree relatives Affected..
Investigations




Virology (TORCH): Yes □ No □ Unknown □
Positive □ Negative Q Unknown □
Details
CT Scan of head: □ Yes Details:
□ No
□ Unknown
MRI: □ Yes Details:
□ No
□ Unknown









































Snellen □ SG □ Kay's □
R Iris: Normal □ Abnormal □
Coloboma Yes □ No □
R Lens: Normal □ Abnormal □
□
Coloboma Yes □ No □
R Pupil reaction:
direct: Yes □ No □




Snellen □ SG □ Kay's □
L Iris: Normal □ Abnormal □
Coloboma Yes □ No O
L Lens: Normal □ Abnormal
Coloboma Yes □ No □
L Pupil reaction:
direct: Yes □ No □
RAPD Yes □ No □
Horizontal Corneal Diameter
R Current mm L Current mm
/ / mm / / mm
/ / mm / / mm
/ / mm / / mm
Axial Length
R Current mm L Current mm
/ / mm / / mm
/ / mm / / mm
/ / mm / / mm
10
Palpebral fissure length: Right mm
Left mm
Inner canthal distance: mm
Outer canthal distance: mm
Inter-pupillary distance: mm





















Whole eye prosthesis: Right □ Left □
Implant: Right □ Left □
Corneoscleral shell: Right □ Left □
Blind registration: Yes □ No □ Date: / /
Special school: Yes □ No □
Special needs register: Yes Q No □
Special assistance within mainstream school: Yes □ No □














Anophthalmia: Right Yes □ No □
Left Yes □ No □
Unknown □
Unknown [
Microphthalmia: Right Yes □ No □
Left Yes □ No □
Coloboma: Right Iris Yes □ NoD
Lens Yes □ No □
Retina Yes □ NoD
Optic Disc Yes □ NoD
Left Iris Yes □ No □
Lens Yes □ NoD
Retina Yes □ No □
Optic Disc Yes □ No □
Unknown □
Unknown □
Unclassifiable malformation: Right Yes □ No □
Left Yes □ No □
13
Mother's eves






























Blood: Obtained □ Refused □ To be arranged □
For: Karyotyping □ DNA/RNA (Edinburgh) □ Canada O
Cell line (Edinburgh) □ Cell line (Porton) □ Mouth wash □
Maternal Blood Q
Paternal Blood □
Permission to be approached for future interview □
Contact address and telephone number:
Further examination needed: Yes □ No □
Name
Do you wish to know results of any blood tests: Yes □ No □
Member of MACS support group: Yes □ No □




Result: Sent to: Sent by: Date:
17
